CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><title>Aptose Biosciences (NASDAQ:APTO) Stock Quotes, Forecast and News Summary - Benzinga</title><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "WebPage", "publisher": {"@type":"Organization","logo":{"@type":"ImageObject","url":"/next-assets/images/schema-publisher-logo-benzinga.png"},"name":"Benzinga","url":"https://www.benzinga.com"}, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.benzinga.com/quote/APTO" }, "mainEntity": "WebPage", "headline": "Aptose Biosciences (NASDAQ:APTO) Stock Quotes, Forecast and News Summary", "url": "https://www.benzinga.com/quote/APTO", "dateCreated": "2019-01-01T01:01:01", "datePublished": "2019-01-01T01:01:01", "dateModified": "2024-11-26T22:58:22.887-05:00", "creator": { "@type": "Person", "name": "Benzinga" }, "author": { "@type": "Person", "name": "Benzinga" }, "description": "Aptose Biosciences Stock (NASDAQ: APTO) stock price, news, charts, stock research, profile.", "keywords": ["symbol: APTO","section: profile"], "mentions": [], "image": "https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60&max_width=&width=60&x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv&x-bz-exp=1732786269&x-bz-security-isin=CA03835T3091&x-bz-security-symbol=APTO&x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69" }</script><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "NewsMediaOrganization", "name": "Benzinga", "email": "info@benzinga.com", "legalName": "Benzinga", "telephone": "877-440-9464", "url": "https://www.benzinga.com/", "logo": "/next-assets/images/schema-publisher-logo-benzinga.png", "image": "/next-assets/images/schema-image-default.png", "address": { "@type": "PostalAddress", "addressLocality": "Detroit", "addressRegion": "MI", "postalCode": "48226", "streetAddress": "1 Campus Martius Suite 200", "addressCountry": "USA" }, "sameAs": [ "https://www.facebook.com/pages/Benzingacom/159483118580?v=app_7146470109", "https://twitter.com/benzinga", "https://www.linkedin.com/company/benzinga", "https://plus.google.com/108838891574408087738/posts", "https://www.youtube.com/user/BenzingaTV" ], "brand": [ { "@type": "Brand", "name": "Benzinga PreMarket Prep", "url": "https://www.benzinga.com/premarket" }, { "@type": "Brand", "name": "Benzinga Markets", "url": "https://www.benzinga.com/markets/" }, { "@type": "Brand", "name": "Benzinga Pro", "url": "https://pro.benzinga.com/" }, { "@type": "Brand", "name": "Benzinga Cloud: Data & APIs", "url": "https://www.benzinga.com/apis" }, { "@type": "Brand", "name": "Benzinga Events", "url": "https://www.benzinga.com/events" }, { "@type": "Brand", "name": "Benzinga Money", "url": "https://www.benzinga.com/money/" }, { "@type": "Brand", "name": "Benzinga Marketfy", "url": "https://marketfy.com/" } ] }</script><meta content="Copyright Benzinga. All rights reserved." name="copyright"/><link href="https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60&max_width=&width=60&x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv&x-bz-exp=1732786269&x-bz-security-isin=CA03835T3091&x-bz-security-symbol=APTO&x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69" rel="image_src"/><meta content="Aptose Biosciences Stock (NASDAQ: APTO) stock price, news, charts, stock research, profile." name="description"/><link href="https://www.benzinga.com/quote/APTO" rel="canonical"/><meta content="Benzinga" name="author"/><link color="#1177BA" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><link href="/next-assets/images/apple-touch-icon.png" rel="apple-touch-icon" sizes="180x180"/><link href="/next-assets/images/favicon-32x32.png" rel="icon" sizes="32x32" type="image/png"/><link href="/next-assets/images/favicon-16x16.png" rel="icon" sizes="16x16" type="image/png"/><link href="/next-assets/site.webmanifest" rel="manifest"/><link color="#5bbad5" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><meta content="#2d89ef" name="msapplication-TileColor"/><meta content="#ffffff" name="theme-color"/><meta content="159483118580" property="fb:app_id"/><link href="http://feeds.benzinga.com/benzinga" rel="alternate" title="Benzinga" type="application/rss+xml"/><meta content="https://www.benzinga.com/quote/APTO" name="syndication-source"/><meta content="summary" name="twitter:card"/><meta content="@benzinga" name="twitter:site"/><meta content="Aptose Biosciences (NASDAQ:APTO) Stock Quotes, Forecast and News Summary" name="twitter:title"/><meta content="Aptose Biosciences Stock (NASDAQ: APTO) stock price, news, charts, stock research, profile." name="twitter:description"/><meta content="https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60&max_width=&width=60&x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv&x-bz-exp=1732786269&x-bz-security-isin=CA03835T3091&x-bz-security-symbol=APTO&x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69" name="twitter:image:src"/><meta content="Benzinga" property="og:site_name"/><meta content="https://www.benzinga.com/quote/APTO" property="og:url"/><meta content="Aptose Biosciences (NASDAQ:APTO) Stock Quotes, Forecast and News Summary" property="og:title"/><meta content="website" property="og:type"/><meta content="Aptose Biosciences Stock (NASDAQ: APTO) stock price, news, charts, stock research, profile." property="og:description"/><meta content="/next-assets/images/schema-image-default.png" property="og:image"/><meta content="image/jpeg" property="og:image:type"/><meta content="1200" property="og:image:width"/><meta content="630" property="og:image:height"/><meta content="app-id=688949481, app-argument=https://itunes.apple.com/us/app/id688949481" name="apple-itunes-app" property="Benzinga for iOS"/><meta content="yes" name="apple-mobile-web-app-capable"/><meta content="black" name="apple-mobile-web-app-status-bar-style"/><meta content="max-image-preview:large" name="robots"/><link href="/manifest.json" rel="manifest"/><meta content="648186192" property="fb:admins"/><meta content="B01B3489A33F83DDA4083E88C260097C" name="msvalidate.01"/><meta content="84f3b1552db5dfbe" name="y_key"/><meta content="101a0095-334d-4935-b87e-0e8fc771214e" name="fo-verify"/><meta content="English" name="language"/><script id="voice-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebPage","name":"Benzinga","speakable":{"@type":"SpeakableSpecification","xpath":["/html/head/title","/html/head/meta[@name='description']/@content"]},"url":"https://www.benzinga.com/"}</script><script id="sitelink-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebSite","name":"Benzinga","potentialAction":{"@type":"SearchAction","query-input":"required name=search_term_string","target":"https://www.benzinga.com/search/fast?cx={search_term_string}"},"url":"https://www.benzinga.com/","hasPart":{"@type":"WebPageElement","cssSelector":".paywall-content","isAccessibleForFree":false},"isAccessibleForFree":false}</script><script id="navigation-header-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"SiteNavigationElement","Name":["Our Services","News","Markets","Options","Ratings","Ideas","Money","Crypto","Cannabis"],"Url":["https://www.benzinga.com/services","https://www.benzinga.com/news","https://www.benzinga.com/markets","https://www.benzinga.com/markets/options","https://www.benzinga.com/analyst-stock-ratings","https://www.benzinga.com/trading-ideas","https://www.benzinga.com/money","https://www.benzinga.com/crypto","https://www.benzinga.com/cannabis"]}</script><link href="https://capi.connatix.com" rel="dns-prefetch"/><link href="https://cds.connatix.com" rel="dns-prefetch"/><link as="script" href="https://cd.connatix.com/connatix.player.js?cid=89cc050a-c0fc-4f72-a746-d63fbd3dee72" rel="preload"/><link as="document" href="https://imasdk.googleapis.com/js/core/bridge3.615.0_en.html" rel="preload"/><script id="corporation-schema-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"Corporation","description":"","name":"Aptose Biosciences Inc","tickerSymbol":"APTO","url":"https://www.benzinga.com/quote/APTO"}</script><script id="faq-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>You can purchase shares of Aptose Biosciences (NASDAQ:APTO) through any online brokerage.</p><p><a href=\"https://www.benzinga.com/money/online-stock-trading/\" rel=\"noreferrer\" target=\"_blank\">View our list of the best stock brokerages</a></p>"},"name":"How do I buy Aptose Biosciences (APTO) stock?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>There are no as such competitors for Aptose Biosciences.</p>"},"name":"Who are Aptose Biosciences (APTO) competitors?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>Aptose Biosciences has a consensus price target of $13.14.</p>"},"name":"What is the forecast, or price target, for Aptose Biosciences (APTO) stock?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>The stock price for Aptose Biosciences (NASDAQ: APTO) is $0.19 last updated November 27, 2024 at 4:00 AM EST.</p>"},"name":"What is the current price for Aptose Biosciences (APTO)?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>There are no upcoming dividends for Aptose Biosciences.</p>"},"name":"Does Aptose Biosciences (APTO) pay a dividend?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>Aptose Biosciences’s Q3 earnings are confirmed for Friday, November 8, 2024.</p>"},"name":"When is Aptose Biosciences (NASDAQ:APTO) reporting earnings?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>There is no upcoming split for Aptose Biosciences.</p>"},"name":"Is Aptose Biosciences (APTO) going to split?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>Aptose Biosciences is in the <b>Healthcare</b> sector and <b>Biotechnology</b> industry. They are listed on the NASDAQ.</p>"},"name":"What sector and industry does Aptose Biosciences (APTO) operate in?"}]}</script><meta name="next-head-count" content="54"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-300.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-regular.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-500.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-600.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-700.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-800.woff2" rel="preload" type="font/woff2"/><link href="https://cdn.benzinga.com" rel="dns-prefetch"/><link href="https://cdn.segment.com" rel="preconnect"/><link href="https://www.googletagservices.com" rel="preconnect"/><link as="script" href="https://cdn.parsely.com/keys/benzinga.com/p.js" rel="preload"/><link as="script" href="https://www.google-analytics.com/analytics.js" rel="preload"/><style>:root, :host { --fa-font-solid: normal 900 1em/1 "Font Awesome 6 Solid"; --fa-font-regular: normal 400 1em/1 "Font Awesome 6 Regular"; --fa-font-light: normal 300 1em/1 "Font Awesome 6 Light"; --fa-font-thin: normal 100 1em/1 "Font Awesome 6 Thin"; --fa-font-duotone: normal 900 1em/1 "Font Awesome 6 Duotone"; --fa-font-sharp-solid: normal 900 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-regular: normal 400 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-light: normal 300 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-thin: normal 100 1em/1 "Font Awesome 6 Sharp"; --fa-font-brands: normal 400 1em/1 "Font Awesome 6 Brands"; } svg:not(:root).svg-inline--fa, svg:not(:host).svg-inline--fa { overflow: visible; box-sizing: content-box; } .svg-inline--fa { display: var(--fa-display, inline-block); height: 1em; overflow: visible; vertical-align: -0.125em; } .svg-inline--fa.fa-2xs { vertical-align: 0.1em; } .svg-inline--fa.fa-xs { vertical-align: 0em; } .svg-inline--fa.fa-sm { vertical-align: -0.0714285705em; } .svg-inline--fa.fa-lg { vertical-align: -0.2em; } .svg-inline--fa.fa-xl { vertical-align: -0.25em; } .svg-inline--fa.fa-2xl { vertical-align: -0.3125em; } .svg-inline--fa.fa-pull-left { margin-right: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-pull-right { margin-left: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-li { width: var(--fa-li-width, 2em); top: 0.25em; } .svg-inline--fa.fa-fw { width: var(--fa-fw-width, 1.25em); } .fa-layers svg.svg-inline--fa { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; } .fa-layers-counter, .fa-layers-text { display: inline-block; position: absolute; text-align: center; } .fa-layers { display: inline-block; height: 1em; position: relative; text-align: center; vertical-align: -0.125em; width: 1em; } .fa-layers svg.svg-inline--fa { -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-text { left: 50%; top: 50%; -webkit-transform: translate(-50%, -50%); transform: translate(-50%, -50%); -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-counter { background-color: var(--fa-counter-background-color, #ff253a); border-radius: var(--fa-counter-border-radius, 1em); box-sizing: border-box; color: var(--fa-inverse, #fff); line-height: var(--fa-counter-line-height, 1); max-width: var(--fa-counter-max-width, 5em); min-width: var(--fa-counter-min-width, 1.5em); overflow: hidden; padding: var(--fa-counter-padding, 0.25em 0.5em); right: var(--fa-right, 0); text-overflow: ellipsis; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-counter-scale, 0.25)); transform: scale(var(--fa-counter-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-bottom-right { bottom: var(--fa-bottom, 0); right: var(--fa-right, 0); top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom right; transform-origin: bottom right; } .fa-layers-bottom-left { bottom: var(--fa-bottom, 0); left: var(--fa-left, 0); right: auto; top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom left; transform-origin: bottom left; } .fa-layers-top-right { top: var(--fa-top, 0); right: var(--fa-right, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-top-left { left: var(--fa-left, 0); right: auto; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top left; transform-origin: top left; } .fa-1x { font-size: 1em; } .fa-2x { font-size: 2em; } .fa-3x { font-size: 3em; } .fa-4x { font-size: 4em; } .fa-5x { font-size: 5em; } .fa-6x { font-size: 6em; } .fa-7x { font-size: 7em; } .fa-8x { font-size: 8em; } .fa-9x { font-size: 9em; } .fa-10x { font-size: 10em; } .fa-2xs { font-size: 0.625em; line-height: 0.1em; vertical-align: 0.225em; } .fa-xs { font-size: 0.75em; line-height: 0.0833333337em; vertical-align: 0.125em; } .fa-sm { font-size: 0.875em; line-height: 0.0714285718em; vertical-align: 0.0535714295em; } .fa-lg { font-size: 1.25em; line-height: 0.05em; vertical-align: -0.075em; } .fa-xl { font-size: 1.5em; line-height: 0.0416666682em; vertical-align: -0.125em; } .fa-2xl { font-size: 2em; line-height: 0.03125em; vertical-align: -0.1875em; } .fa-fw { text-align: center; width: 1.25em; } .fa-ul { list-style-type: none; margin-left: var(--fa-li-margin, 2.5em); padding-left: 0; } .fa-ul > li { position: relative; } .fa-li { left: calc(var(--fa-li-width, 2em) * -1); position: absolute; text-align: center; width: var(--fa-li-width, 2em); line-height: inherit; } .fa-border { border-color: var(--fa-border-color, #eee); border-radius: var(--fa-border-radius, 0.1em); border-style: var(--fa-border-style, solid); border-width: var(--fa-border-width, 0.08em); padding: var(--fa-border-padding, 0.2em 0.25em 0.15em); } .fa-pull-left { float: left; margin-right: var(--fa-pull-margin, 0.3em); } .fa-pull-right { float: right; margin-left: var(--fa-pull-margin, 0.3em); } .fa-beat { -webkit-animation-name: fa-beat; animation-name: fa-beat; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-bounce { -webkit-animation-name: fa-bounce; animation-name: fa-bounce; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); } .fa-fade { -webkit-animation-name: fa-fade; animation-name: fa-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-beat-fade { -webkit-animation-name: fa-beat-fade; animation-name: fa-beat-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-flip { -webkit-animation-name: fa-flip; animation-name: fa-flip; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-shake { -webkit-animation-name: fa-shake; animation-name: fa-shake; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 2s); animation-duration: var(--fa-animation-duration, 2s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin-reverse { --fa-animation-direction: reverse; } .fa-pulse, .fa-spin-pulse { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, steps(8)); animation-timing-function: var(--fa-animation-timing, steps(8)); } @media (prefers-reduced-motion: reduce) { .fa-beat, .fa-bounce, .fa-fade, .fa-beat-fade, .fa-flip, .fa-pulse, .fa-shake, .fa-spin, .fa-spin-pulse { -webkit-animation-delay: -1ms; animation-delay: -1ms; -webkit-animation-duration: 1ms; animation-duration: 1ms; -webkit-animation-iteration-count: 1; animation-iteration-count: 1; -webkit-transition-delay: 0s; transition-delay: 0s; -webkit-transition-duration: 0s; transition-duration: 0s; } } @-webkit-keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @-webkit-keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @-webkit-keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @-webkit-keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @-webkit-keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @-webkit-keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @-webkit-keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } @keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } .fa-rotate-90 { -webkit-transform: rotate(90deg); transform: rotate(90deg); } .fa-rotate-180 { -webkit-transform: rotate(180deg); transform: rotate(180deg); } .fa-rotate-270 { -webkit-transform: rotate(270deg); transform: rotate(270deg); } .fa-flip-horizontal { -webkit-transform: scale(-1, 1); transform: scale(-1, 1); } .fa-flip-vertical { -webkit-transform: scale(1, -1); transform: scale(1, -1); } .fa-flip-both, .fa-flip-horizontal.fa-flip-vertical { -webkit-transform: scale(-1, -1); transform: scale(-1, -1); } .fa-rotate-by { -webkit-transform: rotate(var(--fa-rotate-angle, none)); transform: rotate(var(--fa-rotate-angle, none)); } .fa-stack { display: inline-block; vertical-align: middle; height: 2em; position: relative; width: 2.5em; } .fa-stack-1x, .fa-stack-2x { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; z-index: var(--fa-stack-z-index, auto); } .svg-inline--fa.fa-stack-1x { height: 1em; width: 1.25em; } .svg-inline--fa.fa-stack-2x { height: 2em; width: 2.5em; } .fa-inverse { color: var(--fa-inverse, #fff); } .sr-only, .fa-sr-only { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .sr-only-focusable:not(:focus), .fa-sr-only-focusable:not(:focus) { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .svg-inline--fa .fa-primary { fill: var(--fa-primary-color, currentColor); opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa .fa-secondary { fill: var(--fa-secondary-color, currentColor); opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-primary { opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-secondary { opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa mask .fa-primary, .svg-inline--fa mask .fa-secondary { fill: black; } .fad.fa-inverse, .fa-duotone.fa-inverse { color: var(--fa-inverse, #fff); }</style><script type="text/javascript">window.OneSignal = window.OneSignal || [];</script><script id="parsely" type="text/javascript" data-nscript="beforeInteractive">window.PARSELY = window.PARSELY || {}; window.PARSELY.use_localstorage = true;</script><link rel="preload" href="/_next/static/css/133610ba03279ac0.css" as="style"/><link rel="stylesheet" href="/_next/static/css/133610ba03279ac0.css" data-n-g=""/><link rel="preload" href="/_next/static/css/3916720a5fae312c.css" as="style"/><link rel="stylesheet" href="/_next/static/css/3916720a5fae312c.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-78c92fac7aa8fdd8.js"></script><script src="/_next/static/chunks/webpack-7f2936a10d256c07.js" defer=""></script><script src="/_next/static/chunks/framework-e6b7f5edbdf1e600.js" defer=""></script><script src="/_next/static/chunks/main-a8bae8723e38c3f7.js" defer=""></script><script src="/_next/static/chunks/pages/_app-cac6b44375ca3d63.js" defer=""></script><script src="/_next/static/chunks/93656207-e022531f02d0f1e1.js" defer=""></script><script src="/_next/static/chunks/4c744e84-475c8634f7d1af26.js" defer=""></script><script src="/_next/static/chunks/ad54e6ef-d46e761f1147ca7a.js" defer=""></script><script src="/_next/static/chunks/aeb74aa0-2bdcc805ac1c6490.js" defer=""></script><script src="/_next/static/chunks/8eec4907-3b52a9e94580c3e0.js" defer=""></script><script src="/_next/static/chunks/a981ec11-57883dfa93c2b67f.js" defer=""></script><script src="/_next/static/chunks/69bd6bf3-71dff3b3a37cc29b.js" defer=""></script><script src="/_next/static/chunks/8c469d57-278636cb3035cd4d.js" defer=""></script><script src="/_next/static/chunks/5adc83ef-393b37d1f739f830.js" defer=""></script><script src="/_next/static/chunks/74927-e6eca17cfd52e04d.js" defer=""></script><script src="/_next/static/chunks/25491-a2c0d84c469150a7.js" defer=""></script><script src="/_next/static/chunks/37149-3c57e32bee25fc30.js" defer=""></script><script src="/_next/static/chunks/73737-bc29be1038094f29.js" defer=""></script><script src="/_next/static/chunks/73268-e15b89d697dd4508.js" defer=""></script><script src="/_next/static/chunks/42568-379ea60ff3a1ea4f.js" defer=""></script><script src="/_next/static/chunks/80478-55b510ca744c711f.js" defer=""></script><script src="/_next/static/chunks/97209-33e9c9fa12e49518.js" defer=""></script><script src="/_next/static/chunks/48834-0b3427eb40669fa3.js" defer=""></script><script src="/_next/static/chunks/39097-9e1fd452247607ca.js" defer=""></script><script src="/_next/static/chunks/67326-7eb512377123f4f0.js" defer=""></script><script src="/_next/static/chunks/90162-9baeeb2b96ad8c1c.js" defer=""></script><script src="/_next/static/chunks/6479-3dbc0f000f0bbdc9.js" defer=""></script><script src="/_next/static/chunks/2052-f87ebf4b92a62c84.js" defer=""></script><script src="/_next/static/chunks/67732-a439f69c1a3ec43f.js" defer=""></script><script src="/_next/static/chunks/10960-bbfebdcf6a53f138.js" defer=""></script><script src="/_next/static/chunks/24609-e6c6f256225974e7.js" defer=""></script><script src="/_next/static/chunks/62070-f076aa04acde823f.js" defer=""></script><script src="/_next/static/chunks/78283-a0f9e26c29b01da4.js" defer=""></script><script src="/_next/static/chunks/59392-e5eea99f00426be0.js" defer=""></script><script src="/_next/static/chunks/43058-5783a66391012083.js" defer=""></script><script src="/_next/static/chunks/87249-43298e6458be0b59.js" defer=""></script><script src="/_next/static/chunks/55479-608f5bd0a6221992.js" defer=""></script><script src="/_next/static/chunks/26212-66b5594b77072bcf.js" defer=""></script><script src="/_next/static/chunks/72876-c2a2c8d76ffa6c75.js" defer=""></script><script src="/_next/static/chunks/50570-4dd11d576c861f08.js" defer=""></script><script src="/_next/static/chunks/62314-9b2028cacd765027.js" defer=""></script><script src="/_next/static/chunks/89859-eebef04218c04174.js" defer=""></script><script src="/_next/static/chunks/71604-6b04bc10138f34c1.js" defer=""></script><script src="/_next/static/chunks/44084-7e8a4c6c6d428863.js" defer=""></script><script src="/_next/static/chunks/60114-164c33ddfb0439bc.js" defer=""></script><script src="/_next/static/chunks/58260-151951153c272be7.js" defer=""></script><script src="/_next/static/chunks/30807-0d49be9d1265d829.js" defer=""></script><script src="/_next/static/chunks/5677-72bcd94f689f2e09.js" defer=""></script><script src="/_next/static/chunks/77039-20e35d04f2791bd6.js" defer=""></script><script src="/_next/static/chunks/13871-fd1d8f152654290b.js" defer=""></script><script src="/_next/static/chunks/28204-d8f20d6a51e15050.js" defer=""></script><script src="/_next/static/chunks/66130-deda31ae92bb0ab5.js" defer=""></script><script src="/_next/static/chunks/84427-15ea251a604f4b7e.js" defer=""></script><script src="/_next/static/chunks/39129-04a555dd9037befd.js" defer=""></script><script src="/_next/static/chunks/81120-bb780fc7a9458199.js" defer=""></script><script src="/_next/static/chunks/80361-7f529d538d6bdb6e.js" defer=""></script><script src="/_next/static/chunks/69691-ab51b572072c5b80.js" defer=""></script><script src="/_next/static/chunks/60880-16e80e614dca5113.js" defer=""></script><script src="/_next/static/chunks/31462-9af863c2c01881e0.js" defer=""></script><script src="/_next/static/chunks/89473-265746280ed68e8a.js" defer=""></script><script src="/_next/static/chunks/pages/quotev2/%5Bticker%5D-92df6ce2511ab87a.js" defer=""></script><script src="/_next/static/R05fxUUF7rvKgc3Bg3jzA/_buildManifest.js" defer=""></script><script src="/_next/static/R05fxUUF7rvKgc3Bg3jzA/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="6.1.8">.bz-featured-ad{position:relative;}/*!sc*/ .bz-featured-ad::after{position:absolute;content:'Featured Ad';padding:1px 10px;vertical-align:super;font-size:12px;display:inline-block;background:#f5f5f5;border-radius:16px;margin-left:3px;border:1px solid #cacaca;bottom:5px;left:inherit;}/*!sc*/ data-styled.g37[id="sc-global-jWNYke1"]{content:"sc-global-jWNYke1,"}/*!sc*/ .iXXfGA{font-size:14px;color:#192940;font-weight:600;display:inline-flex;text-decoration:none;align-items:center;justify-content:center;line-height:1rem;background:#ffffff;box-shadow:0 1px 2px 0 rgba(0, 0, 0, 0.05);border:solid 1px #E1EBFA;border-radius:4px;padding-top:0.5rem;padding-bottom:0.5rem;padding-left:0.75rem;padding-right:0.75rem;transition:0.25s background-color ease-in-out,0.25s color ease-in-out,0.25s border-color ease-in-out;}/*!sc*/ .iXXfGA >span{display:contents;}/*!sc*/ .iXXfGA.sm{padding-left:0.35rem;padding-right:0.35rem;width:auto;height:24px;font-size:0.75rem;border-radius:0.25rem;}/*!sc*/ .iXXfGA.lg{height:56px;padding:1rem 2.5rem;font-weight:700;font-size:1rem;line-height:1.25rem;}/*!sc*/ .iXXfGA.fusion-md{height:40px;padding:0 1rem;font-weight:700;flex-shrink:0;}/*!sc*/ .iXXfGA:focus{outline:none;}/*!sc*/ .iXXfGA.danger{color:#c81e1e;border:solid 1px #f98080;background:#fdf2f2;}/*!sc*/ .iXXfGA.danger:hover{background:#fde8e8;}/*!sc*/ .iXXfGA.flat{color:#395173;border:solid 1px #E1EBFA;background:transparent;}/*!sc*/ .iXXfGA.danger-filled{color:#ffffff;border:solid 1px #e02424;background:#e02424;}/*!sc*/ .iXXfGA.danger-filled:hover{background:#f05252;}/*!sc*/ .iXXfGA.primary{color:#1a56db;border:solid 1px #3f83f8;background:#c3ddfd;}/*!sc*/ .iXXfGA.primary:hover{background:#a4cafe;}/*!sc*/ .iXXfGA.success-filled{color:#ffffff;border:solid 1px #0e9f6e;background:#0e9f6e;}/*!sc*/ .iXXfGA.success-filled:hover{background:#31c48d;}/*!sc*/ .iXXfGA.success{color:#046c4e;border:solid 1px #0e9f6e;background:#bcf0da;}/*!sc*/ .iXXfGA.success:hover{background:#84e1bc;}/*!sc*/ .iXXfGA.warning{color:#b43403;border:solid 1px #ff5a1f;background:#fcd9bd;}/*!sc*/ .iXXfGA.warning:hover{background:#fdba8c;}/*!sc*/ .iXXfGA.full{width:100%;display:inherit;}/*!sc*/ .iXXfGA.full span{width:100%;text-align:center;}/*!sc*/ .iXXfGA.cta{background-color:#002d45;color:#ffffff;height:2.5rem;letter-spacing:0.1em;text-transform:uppercase;width:100%;}/*!sc*/ .iXXfGA.cta:hover{background-color:rgb(217, 105, 0);box-shadow:0 4px 6px -1px rgba(0, 0, 0, 0.1),0 2px 4px -1px rgba(0, 0, 0, 0.06);position:relative;bottom:2px;}/*!sc*/ .iXXfGA.flat-orange{color:#ffffff;border:solid 1px #ff5a1f;background:#ff5a1f;}/*!sc*/ .iXXfGA.flat-orange:hover{background:#d03801;}/*!sc*/ .iXXfGA.flat-black{color:#ffffff;border:solid 1px #000000;background:#000000;transition:0.2s;}/*!sc*/ .iXXfGA.flat-black:hover{background:#ffffff;color:#000000;}/*!sc*/ .iXXfGA.flat-gray{color:#ffffff;border:solid 1px #5B7292;background:#5B7292;transition:0.2s;}/*!sc*/ .iXXfGA.flat-gray:hover{background:#ffffff;color:#000000;}/*!sc*/ .iXXfGA.light-gray{color:#000000;border:solid 1px #CEDDF2;background:#CEDDF2;transition:0.2s;}/*!sc*/ .iXXfGA.light-gray:hover{background:#B8CBE6;color:#000000;}/*!sc*/ .iXXfGA.flat-blue{color:#ffffff;border:solid 1px #3f83f8;background:#3f83f8;}/*!sc*/ .iXXfGA.flat-blue:hover{background:#1c64f2;}/*!sc*/ .iXXfGA.dark-blue{color:#ffffff;border:solid 1px #233876;background:#233876;}/*!sc*/ .iXXfGA.dark-blue:hover{background:#1e429f;}/*!sc*/ .iXXfGA.flat-light-blue{color:#3f83f8;border:solid 1px #e1effe;background:#e1effe;}/*!sc*/ .iXXfGA.flat-light-blue:hover{background:#c3ddfd;}/*!sc*/ .iXXfGA.flat-light-blue-outlined{color:#3f83f8;border:solid 1px #CEDDF2;background:#e1effe;box-shadow:unset;}/*!sc*/ .iXXfGA.flat-light-blue-outlined:hover{background:#c3ddfd;}/*!sc*/ .iXXfGA.flat-red{color:#ffffff;border:solid 1px #f05252;background:#f05252;}/*!sc*/ .iXXfGA.flat-red:hover{background:#e02424;}/*!sc*/ .iXXfGA.flat-ind-blue{color:#ffffff;border:solid 1px #24344F;background:#24344F;}/*!sc*/ .iXXfGA.flat-ind-blue:hover{background:#24344F;}/*!sc*/ .iXXfGA.white-outline{background:rgba(26, 121, 255, 0.05);border:1px solid #ffffff;color:#ffffff;}/*!sc*/ .iXXfGA.white-outline:hover{background:rgba(210, 210, 210, 0.1);}/*!sc*/ .iXXfGA.fusion-outline{background:rgba(26, 121, 255, 0.05);border:1px solid rgba(26, 121, 255, 0.75);color:#3f83f8;}/*!sc*/ .iXXfGA.fusion-outline:hover{background:rgba(26, 121, 255, 0.1);}/*!sc*/ .iXXfGA.fusion-secondary{background:#E1EBFA;border:0;color:#3f83f8;}/*!sc*/ .iXXfGA.fusion-secondary:hover{background:rgba(26, 121, 255, 0.1);}/*!sc*/ .iXXfGA.fusion-white{background:#ffffff;color:#3f83f8;border:none;}/*!sc*/ .iXXfGA.fusion-white:hover{background:#3f83f8;color:#ffffff;}/*!sc*/ data-styled.g53[id="sc-cPtzlb"]{content:"iXXfGA,"}/*!sc*/ .cxpDKR.spinner{flex:1;display:flex;flex-direction:column;font-size:25px;align-items:center;justify-content:center;}/*!sc*/ .cxpDKR.spinner .spinner-icon{color:transparent;fill:#1A79FF;-webkit-animation:spin 1s linear infinite;animation:spin 1s linear infinite;width:2rem;height:2rem;}/*!sc*/ .cxpDKR.spinner .text-text{font-size:14px;color:#1A79FF;margin-top:0.5rem;}/*!sc*/ .cxpDKR.spinner .sr-only{display:none;}/*!sc*/ @-moz-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @-webkit-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @-o-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @-ms-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ data-styled.g78[id="sc-hnmNqB"]{content:"cxpDKR,"}/*!sc*/ .ftxYyE{font-size:24px;font-weight:bold;margin-bottom:0;text-transform:capitalize;width:100%;}/*!sc*/ .ftxYyE >h1,.ftxYyE >h2,.ftxYyE >h3,.ftxYyE >h4,.ftxYyE >h5,.ftxYyE >h6,.ftxYyE >span{font-size:inherit;}/*!sc*/ .ftxYyE.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .ftxYyE.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .ftxYyE.border-through >h1,.ftxYyE.border-through >h2,.ftxYyE.border-through >h3,.ftxYyE.border-through >h4,.ftxYyE.border-through >h5,.ftxYyE.border-through >h6,.ftxYyE.border-through >span{position:relative;display:inline-block;}/*!sc*/ .ftxYyE.border-through >h1:before,.ftxYyE.border-through >h2:before,.ftxYyE.border-through >h3:before,.ftxYyE.border-through >h4:before,.ftxYyE.border-through >h5:before,.ftxYyE.border-through >h6:before,.ftxYyE.border-through >span:before,.ftxYyE.border-through >h1:after,.ftxYyE.border-through >h2:after,.ftxYyE.border-through >h3:after,.ftxYyE.border-through >h4:after,.ftxYyE.border-through >h5:after,.ftxYyE.border-through >h6:after,.ftxYyE.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .ftxYyE.border-through >h1:before,.ftxYyE.border-through >h2:before,.ftxYyE.border-through >h3:before,.ftxYyE.border-through >h4:before,.ftxYyE.border-through >h5:before,.ftxYyE.border-through >h6:before,.ftxYyE.border-through >span:before{right:100%;}/*!sc*/ .ftxYyE.border-through >h1:after,.ftxYyE.border-through >h2:after,.ftxYyE.border-through >h3:after,.ftxYyE.border-through >h4:after,.ftxYyE.border-through >h5:after,.ftxYyE.border-through >h6:after,.ftxYyE.border-through >span:after{left:100%;}/*!sc*/ .ftxYyE.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .ftxYyE .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ .iMnyge{font-size:24px;font-weight:bold;margin-bottom:0;text-transform:uppercase;width:100%;}/*!sc*/ .iMnyge >h1,.iMnyge >h2,.iMnyge >h3,.iMnyge >h4,.iMnyge >h5,.iMnyge >h6,.iMnyge >span{font-size:inherit;}/*!sc*/ .iMnyge.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .iMnyge.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .iMnyge.border-through >h1,.iMnyge.border-through >h2,.iMnyge.border-through >h3,.iMnyge.border-through >h4,.iMnyge.border-through >h5,.iMnyge.border-through >h6,.iMnyge.border-through >span{position:relative;display:inline-block;}/*!sc*/ .iMnyge.border-through >h1:before,.iMnyge.border-through >h2:before,.iMnyge.border-through >h3:before,.iMnyge.border-through >h4:before,.iMnyge.border-through >h5:before,.iMnyge.border-through >h6:before,.iMnyge.border-through >span:before,.iMnyge.border-through >h1:after,.iMnyge.border-through >h2:after,.iMnyge.border-through >h3:after,.iMnyge.border-through >h4:after,.iMnyge.border-through >h5:after,.iMnyge.border-through >h6:after,.iMnyge.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .iMnyge.border-through >h1:before,.iMnyge.border-through >h2:before,.iMnyge.border-through >h3:before,.iMnyge.border-through >h4:before,.iMnyge.border-through >h5:before,.iMnyge.border-through >h6:before,.iMnyge.border-through >span:before{right:100%;}/*!sc*/ .iMnyge.border-through >h1:after,.iMnyge.border-through >h2:after,.iMnyge.border-through >h3:after,.iMnyge.border-through >h4:after,.iMnyge.border-through >h5:after,.iMnyge.border-through >h6:after,.iMnyge.border-through >span:after{left:100%;}/*!sc*/ .iMnyge.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .iMnyge .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ .iTzbfE{font-weight:bold;margin-bottom:0;text-transform:uppercase;width:100%;}/*!sc*/ .iTzbfE >h1,.iTzbfE >h2,.iTzbfE >h3,.iTzbfE >h4,.iTzbfE >h5,.iTzbfE >h6,.iTzbfE >span{font-size:inherit;}/*!sc*/ .iTzbfE.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .iTzbfE.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .iTzbfE.border-through >h1,.iTzbfE.border-through >h2,.iTzbfE.border-through >h3,.iTzbfE.border-through >h4,.iTzbfE.border-through >h5,.iTzbfE.border-through >h6,.iTzbfE.border-through >span{position:relative;display:inline-block;}/*!sc*/ .iTzbfE.border-through >h1:before,.iTzbfE.border-through >h2:before,.iTzbfE.border-through >h3:before,.iTzbfE.border-through >h4:before,.iTzbfE.border-through >h5:before,.iTzbfE.border-through >h6:before,.iTzbfE.border-through >span:before,.iTzbfE.border-through >h1:after,.iTzbfE.border-through >h2:after,.iTzbfE.border-through >h3:after,.iTzbfE.border-through >h4:after,.iTzbfE.border-through >h5:after,.iTzbfE.border-through >h6:after,.iTzbfE.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .iTzbfE.border-through >h1:before,.iTzbfE.border-through >h2:before,.iTzbfE.border-through >h3:before,.iTzbfE.border-through >h4:before,.iTzbfE.border-through >h5:before,.iTzbfE.border-through >h6:before,.iTzbfE.border-through >span:before{right:100%;}/*!sc*/ .iTzbfE.border-through >h1:after,.iTzbfE.border-through >h2:after,.iTzbfE.border-through >h3:after,.iTzbfE.border-through >h4:after,.iTzbfE.border-through >h5:after,.iTzbfE.border-through >h6:after,.iTzbfE.border-through >span:after{left:100%;}/*!sc*/ .iTzbfE.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .iTzbfE .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ data-styled.g368[id="sc-fgisPL"]{content:"ftxYyE,iMnyge,iTzbfE,"}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-list-wrapper{overflow-x:auto;overflow-y:hidden;min-width:0;}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-list-wrapper{-ms-overflow-style:none;scrollbar-width:none;}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-list-wrapper::-webkit-scrollbar{display:none;}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-list{display:grid;grid-template-columns:repeat(auto-fit, minmax(160px, 1fr));gap:8px;min-width:max-content;padding-top:14px;padding-bottom:14px;}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-listbutton.tab{width:100%;border-radius:4px;background-color:#ffffff;border:1px solid #E1EBFA;color:#5B7292;font-weight:700;font-size:14px;height:36px;padding:0 16px;transition:0.25s color ease-in-out,0.25s box-shadow ease-in-out;}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-listbutton.tab:hover{color:#3f83f8;box-shadow:0 2px 16px rgba(25, 68, 128, 0.1);}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-listbutton.tab.active{background-color:#3f83f8;color:#ffffff;}/*!sc*/ .kqzvuv.tabs-container.full-variant.tab-listbutton.tab.active:hover{color:#ffffff;}/*!sc*/ @media screen and (max-width: 959px){.kqzvuv.tabs-container.full-variant.tab-list{grid-auto-flow:column;grid-auto-columns:minmax(160px, 1fr);grid-template-columns:unset;}}/*!sc*/ @media screen and (max-width: 567px){.kqzvuv.tabs-container.full-variant.tab-list{grid-auto-columns:minmax(140px, 1fr);}}/*!sc*/ .kqzvuv.tabs-container .tab-list{gap:0;}/*!sc*/ .kqzvuv.tabs-container .tab-list button.tab.active{color:#1c64f2;}/*!sc*/ .kqzvuv.tabs-container .tab-list button.tab.active:hover{color:#1c64f2;}/*!sc*/ .kqzvuv.tabs-container .ellipsis-icon{color:#1c64f2;}/*!sc*/ .kqzvuv.tabs-container.default-variant .more-items-button,.kqzvuv.tabs-container.lifted-variant .more-items-button{margin-left:auto;}/*!sc*/ .kqzvuv.tabs-container.bordered-variant .tab-list button.tab{border-bottom:2px solid #CEDDF2;}/*!sc*/ .kqzvuv.tabs-container.bordered-variant .tab-list button.tab.active{border-bottom-color:#1c64f2;}/*!sc*/ .kqzvuv.tabs-container.bordered-variant .tab-list button.tab:hover{border-bottom-color:#76a9fa;}/*!sc*/ .kqzvuv.tabs-container.bordered-variant .ellipsis-icon{color:#1c64f2;}/*!sc*/ .kqzvuv.tabs-container.pill-variant .tab-list{background-color:#F2F8FF;border-radius:6px;padding:6px;gap:0.5rem;}/*!sc*/ .kqzvuv.tabs-container.pill-variant .tab-list button.tab{padding:2px 8px;border-radius:6px;}/*!sc*/ .kqzvuv.tabs-container.pill-variant .tab-list button.tab:hover{background-color:#E1EBFA;}/*!sc*/ .kqzvuv.tabs-container.pill-variant .tab-list button.tab.active{background-color:#3f83f8;color:#ffffff;}/*!sc*/ .kqzvuv.tabs-container.pill-variant .tab-list button.tab.active:hover{color:#ffffff;}/*!sc*/ .kqzvuv.tabs-container.pill-variant .more-items-button{margin-left:auto;color:#3f83f8;}/*!sc*/ .kqzvuv.tabs-container.lifted-variant .tab-list-wrapper{border-bottom:1px solid #99AECC;margin-bottom:1rem;}/*!sc*/ .kqzvuv.tabs-container.lifted-variant .tab-list-wrapper::-webkit-scrollbar{display:none;}/*!sc*/ .kqzvuv.tabs-container.lifted-variant .tab-list button.tab{border-bottom:1px solid transparent;background-color:transparent;border-radius:4px 4px 0 0;text-align:center;}/*!sc*/ .kqzvuv.tabs-container.lifted-variant .tab-list button.tab.active{background-color:transparent;border:1px solid #395173;border-bottom-color:#fff;color:#17253A;}/*!sc*/ .kqzvuv.tabs-container.lifted-variant .tab-list button.tab.promo-offer{color:#ff5a1f!important;}/*!sc*/ .kqzvuv.tabs-container:not(.pill-variant) .more-items-button{padding:5px 16px;width:40px;}/*!sc*/ .kqzvuv.tabs-container:not(.pill-variant) .more-items-button .ellipsis-icon{color:#5B7292;}/*!sc*/ .kqzvuv.tabs-container .secondary-tabs-dropdown{position:relative;top:20px;}/*!sc*/ .kqzvuv.tabs-container .secondary-tabs-dropdown button{padding:4px;min-width:70px;text-align:left;font-size:12px;}/*!sc*/ .kqzvuv.tabs-container .secondary-tabs-dropdown button:hover{background-color:#E1EBFA;}/*!sc*/ .kqzvuv.tabs-container .tab-list{white-space:nowrap;display:flex;align-items:center;overflow-x:auto;}/*!sc*/ .kqzvuv.tabs-container .tab-list.overflow-shadow-left{-webkit-mask-image:linear-gradient(270deg, #000 85%, transparent);mask-image:linear-gradient(270deg, #000 85%, transparent);}/*!sc*/ .kqzvuv.tabs-container .tab-list.overflow-shadow-right{-webkit-mask-image:linear-gradient(90deg, #000 85%, transparent);mask-image:linear-gradient(90deg, #000 85%, transparent);}/*!sc*/ .kqzvuv.tabs-container .tab-list.overflow-shadow-both{--scroll-shadow-size:20px;-webkit-mask-image:linear-gradient( to right, #000, #000, transparent 0, #000 var(--scroll-shadow-size), #000 calc(100% - var(--scroll-shadow-size)), transparent );mask-image:linear-gradient( to right, #000, #000, transparent 0, #000 var(--scroll-shadow-size), #000 calc(100% - var(--scroll-shadow-size)), transparent );}/*!sc*/ .kqzvuv.tabs-container .tab-list button.tab{cursor:pointer;padding:8px 16px;border:0;background:none;}/*!sc*/ .kqzvuv.tabs-container .more-items-button{display:flex;align-items:center;justify-content:center;height:100%;width:40px;min-width:40px;color:#395173;border-bottom-color:#395173;}/*!sc*/ .kqzvuv.tabs-container .more-items-button .ellipsis-icon{font-size:1.5rem;}/*!sc*/ .kqzvuv.tabs-container .tab-content{display:none;}/*!sc*/ .kqzvuv.tabs-container .tab-content.selected{display:block;}/*!sc*/ .kqzvuv.tabs-container .select-menu .position-right{right:5px;min-width:12rem;}/*!sc*/ .kqzvuv.tabs-container .select-menu .select-menu-list-item{min-height:35px;font-size:14px;}/*!sc*/ data-styled.g386[id="sc-gopctv"]{content:"kqzvuv,"}/*!sc*/ .knMeVD.tooltip-container{display:inline-flex;position:relative;align-items:center;}/*!sc*/ .knMeVD.tooltip-container.click{cursor:pointer;}/*!sc*/ data-styled.g388[id="sc-glxhRN"]{content:"knMeVD,"}/*!sc*/ .iDWzoL.qa-container{display:flex;flex-direction:column;width:100%;padding:0.5rem;border-bottom:1px solid #c3ddfd;}/*!sc*/ .iDWzoL.qa-container .question{font-size:16px;}/*!sc*/ @media screen and (min-width: 600px){.iDWzoL.qa-container .question{font-size:18px;}}/*!sc*/ .iDWzoL.qa-container >div{display:flex;align-items:baseline;}/*!sc*/ .iDWzoL.qa-container >div .qa-letter-icon{color:#3f83f8;font-weight:700;background-color:#e1effe;border-radius:0.25rem;display:flex;justify-content:center;align-items:center;width:2rem;height:2rem;min-width:2rem;margin-right:1rem;margin-top:0.25rem;margin-bottom:0.25rem;float:left;}/*!sc*/ .iDWzoL.qa-container >div .answer-container p{margin-bottom:0!important;}/*!sc*/ @media screen and (max-width: 600px){.iDWzoL.qa-container{border:none;border-bottom:1px solid #e1ebfa;max-width:100%;}.iDWzoL.qa-container:nth-of-type(odd){padding-left:0.5rem;}}/*!sc*/ data-styled.g397[id="sc-jKBaTn"]{content:"iDWzoL,"}/*!sc*/ .cvbRHX h2{margin-bottom:6px;}/*!sc*/ data-styled.g398[id="sc-dXGmlw"]{content:"cvbRHX,"}/*!sc*/ .dOUStP{border:solid 1px #c3ddfd;border-radius:4px;background:white;}/*!sc*/ .dOUStP .qa-container:last-of-type{border-bottom:none;}/*!sc*/ .dOUStP h2{font-weight:700;font-size:18px;line-height:1.75rem;margin-left:0.5rem;margin-top:0.5rem;text-transform:uppercase;}/*!sc*/ data-styled.g399[id="sc-jUULvF"]{content:"dOUStP,"}/*!sc*/ .jcwHna.get-report-button button{width:100%;}/*!sc*/ data-styled.g444[id="sc-hdemLX"]{content:"jcwHna,"}/*!sc*/ .fcPNlb{display:flex;position:relative;width:100%;padding-left:unset;}/*!sc*/ .fcPNlb .search-icon{align-items:center;color:#378aff;display:flex;height:44px;justify-content:center;width:44px;}/*!sc*/ .fcPNlb .cancel-button{font-size:1.2rem;padding:0 10px;color:#378aff;}/*!sc*/ .fcPNlb .search-button{border-radius:0;width:50px;}/*!sc*/ .fcPNlb input{background-color:transparent;border-width:0;outline:none;width:100%;font-weight:bold;font-size:16px;}/*!sc*/ data-styled.g464[id="sc-gUDIDV"]{content:"fcPNlb,"}/*!sc*/ .jnspZt.benzinga-logo{display:inline-block;}/*!sc*/ .jnspZt.benzinga-logo.desktop{width:192px;min-width:192px;max-width:192px;}/*!sc*/ .jnspZt.benzinga-logo img,.jnspZt.benzinga-logo svg{width:100%;height:100%;}/*!sc*/ data-styled.g469[id="sc-eRxdlV"]{content:"jnspZt,"}/*!sc*/ .hQVzmp{height:24px;width:80px;}/*!sc*/ data-styled.g501[id="sc-gfCqec"]{content:"hQVzmp,"}/*!sc*/ .eZXymS{position:relative;width:100%;}/*!sc*/ data-styled.g506[id="sc-vZZzB"]{content:"eZXymS,"}/*!sc*/ .cfstRH.searchbar-wrapper{box-shadow:0px 0px 2px 0 rgb(0 0 0 / 15%);background:#ffffff;padding:4px 12px;padding-right:10px;flex-grow:1;max-width:290px;position:relative;max-width:none;}/*!sc*/ @media screen and (max-width: 800px){.cfstRH.searchbar-wrapper{max-width:none;}}/*!sc*/ .cfstRH.searchbar-wrapper a{text-decoration:none;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box,.cfstRH.searchbar-wrapper.searchbar-inline{padding:0;border:solid 1px #E1EBFA;box-shadow:none;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box .search-results-wrapper,.cfstRH.searchbar-wrapper.searchbar-inline .search-results-wrapper{padding:0;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box .search-result-wrapper,.cfstRH.searchbar-wrapper.searchbar-inline .search-result-wrapper{padding:0;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box .search-icon,.cfstRH.searchbar-wrapper.searchbar-inline .search-icon{height:36px;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box input ::placeholder,.cfstRH.searchbar-wrapper.searchbar-inline input ::placeholder{color:#99AECC;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-inline{box-shadow:none;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-inline .search-dropdown{position:relative;box-shadow:none;border:none;}/*!sc*/ .cfstRH.searchbar-wrapper input:focus{box-shadow:none;}/*!sc*/ .cfstRH.searchbar-wrapper input ::placeholder{color:#395173;}/*!sc*/ data-styled.g518[id="sc-cieYuS"]{content:"cfstRH,"}/*!sc*/ .bRJFnU{width:100%;position:relative;}/*!sc*/ .bRJFnU .content-feed-list{display:flex;flex-direction:column;gap:1rem;}/*!sc*/ .bRJFnU .newsfeed-card{color:#000000;}/*!sc*/ .bRJFnU .newsfeed-card.highlight.fade .post-card-wrapper{animation:fade 5s forwards;}/*!sc*/ @keyframes fade{0%{background-color:#fdf8db;}100%{background-color:transparent;}}/*!sc*/ .bRJFnU .newsfeed-card .post-teaser{color:#7c7c7c;font-weight:400;font-size:12px;}/*!sc*/ .bRJFnU .news-block{border-bottom:solid 1px #CEDDF2;line-height:1.5;padding:12px 0;}/*!sc*/ .bRJFnU .news-block .news-block-headline{color:#000000;}/*!sc*/ .bRJFnU .news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ data-styled.g570[id="sc-emhixo"]{content:"bRJFnU,"}/*!sc*/ .jzzteW .small-gray{font-size:12px;color:#828282;font-weight:400;}/*!sc*/ .jzzteW .financials-right-spacer{margin-top:56px;position:relative;}/*!sc*/ .jzzteW .divider{height:1px;width:100%;background:#f1f1f1;padding:0px 16px;}/*!sc*/ .jzzteW .body-row{border-bottom:1px solid #f1f1f1;padding:8px 0px;}/*!sc*/ .jzzteW .body-row:last-child{border-bottom:none;}/*!sc*/ .jzzteW .table-row{display:grid;grid-template-columns:1.5fr repeat(4, 1fr);}/*!sc*/ .jzzteW .table-row .table-title{font-size:12px;color:#828282;line-height:15px;font-weight:400;text-align:left;}/*!sc*/ .jzzteW .table-row .table-cell{display:flex;flex-direction:column;padding:2px 4px;}/*!sc*/ .jzzteW .table-row .table-cell .table-cell-title{font-size:14px;font-weight:700;line-height:17px;}/*!sc*/ @media (max-width: 768px){.jzzteW .table-row .table-cell .table-cell-title{font-size:12px;line-height:14px;font-weight:600;}}/*!sc*/ .jzzteW .table-row .table-cell .table-cell-subtitle{font-size:12px;line-height:14px;color:#333333;}/*!sc*/ @media (max-width: 768px){.jzzteW .table-row .table-cell .table-cell-subtitle{font-size:10px;line-height:12px;}}/*!sc*/ data-styled.g713[id="sc-jIOndm"]{content:"jzzteW,"}/*!sc*/ .dWAhon{align-items:center;background-color:#30BF60;border-radius:4px;display:flex;height:4px;}/*!sc*/ .dWAhon .quote-slider-bar{background-color:#FF4050;border-radius:4px;height:4px;}/*!sc*/ .dWAhon .quote-slider-tick{background-color:#FF4050;border-radius:4px;height:15px;margin-left:-5px;width:4px;}/*!sc*/ .iaCkFP{align-items:center;background-color:#FF4050;border-radius:4px;display:flex;height:4px;}/*!sc*/ .iaCkFP .quote-slider-bar{background-color:#30BF60;border-radius:4px;height:4px;}/*!sc*/ .iaCkFP .quote-slider-tick{background-color:#30BF60;border-radius:4px;height:15px;margin-left:-5px;width:4px;}/*!sc*/ data-styled.g715[id="sc-jFWsBE"]{content:"dWAhon,iaCkFP,"}/*!sc*/ .dDpTqW{width:100%;}/*!sc*/ .dDpTqW .stats-wrapper{display:flex;justify-content:space-between;}/*!sc*/ .dDpTqW .stats-wrapper .stat-column{display:flex;flex-direction:column;}/*!sc*/ .dDpTqW .stats-wrapper .stat-column .label{font-size:0.875rem;line-height:1.25rem;color:rgb(75, 85, 99);}/*!sc*/ .dDpTqW .stats-wrapper .stat-column .value{font-size:1.125rem;line-height:1.5rem;font-weight:500;}/*!sc*/ .dDpTqW .stats-wrapper .stat-column.start{text-align:left;}/*!sc*/ .dDpTqW .stats-wrapper .stat-column.end{text-align:right;}/*!sc*/ .dDpTqW .open-price-wrapper{width:100%;display:flex;}/*!sc*/ .dDpTqW .open-price-wrapper .transparent-box{background-color:transparent;}/*!sc*/ .dDpTqW .open-price-wrapper .open-price-container{display:flex;flex-direction:column;justify-content:flex-start;margin-top:-5px;}/*!sc*/ .dDpTqW .open-price-wrapper .open-price-container span{font-size:0.875rem;line-height:1.25rem;color:rgb(75, 85, 99);line-height:6px;margin-left:2px;}/*!sc*/ data-styled.g716[id="sc-dXIwAT"]{content:"dDpTqW,"}/*!sc*/ .djKghV.news-block{line-height:1.5;}/*!sc*/ .djKghV.news-block .news-block-headline a{color:#000000;}/*!sc*/ .djKghV.news-block .news-block-headline a:hover{color:#69a5ff;}/*!sc*/ .djKghV.news-block .news-block-headline .news-item-sponsored-tag{display:block;font-size:13px;color:#3f83f8;font-weight:600;}/*!sc*/ .djKghV.news-block .news-block-image-wrapper{width:90px;height:90px;min-width:90px;margin-right:1rem;border-radius:4px;overflow:hidden;}/*!sc*/ .djKghV.news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ .djKghV.news-block .article-teaser{font-size:14px;font-weight:400;}/*!sc*/ .djKghV.news-block .date-box{min-width:130px;}/*!sc*/ data-styled.g717[id="sc-hwDNbq"]{content:"djKghV,"}/*!sc*/ .jzrfof{text-overflow:ellipsis;overflow:hidden;display:-webkit-box;-webkit-line-clamp:2;-webkit-box-orient:vertical;}/*!sc*/ @media (max-width: 768px){.jzrfof{-webkit-line-clamp:4;font-weight:normal;}}/*!sc*/ data-styled.g720[id="sc-nqTvk"]{content:"jzrfof,"}/*!sc*/ .fyUiDy .content-feed-list{display:flex;flex-direction:column;gap:1rem;}/*!sc*/ .fyUiDy .see-more-button-wrapper .show-more-button{padding:0.5rem 2rem;}/*!sc*/ .fyUiDy .content-feed-no-results{height:200px;}/*!sc*/ .fyUiDy .quote-news-item{display:flex;}/*!sc*/ .fyUiDy .quote-news-item .article-title{-webkit-line-clamp:3;}/*!sc*/ .fyUiDy .quote-news-item .article-teaser{color:#395173;text-overflow:ellipsis;overflow:hidden;display:-webkit-box;-webkit-line-clamp:1;}/*!sc*/ .fyUiDy .quote-news-item .article-author{color:#395173;}/*!sc*/ .fyUiDy .quote-news-item .article-datetime{color:#99AECC;}/*!sc*/ .fyUiDy .quote-news-item .news-block{all:unset;}/*!sc*/ data-styled.g721[id="sc-gkFsFt"]{content:"fyUiDy,"}/*!sc*/ .kgFmXr .tabs-container .tab-list-wrapper{display:flex;flex-direction:column;position:relative;width:100%;}/*!sc*/ .kgFmXr .tabs-container .tab-list-wrapper .recent-news-title{margin-bottom:1rem;}/*!sc*/ @media screen and (min-width: 550px){.kgFmXr .tabs-container .tab-list-wrapper{flex-direction:row;}.kgFmXr .tabs-container .tab-list-wrapper .recent-news-title{margin-bottom:unset;}}/*!sc*/ .kgFmXr .tabs-container .tab-list{font-weight:600;color:#3f83f8;max-width:540px;width:100%;margin-left:auto;}/*!sc*/ .kgFmXr .tabs-container .tab-list .tab{flex:1;max-width:200px;}/*!sc*/ .kgFmXr .tabs-container .tab-content{padding:1rem 0;}/*!sc*/ data-styled.g723[id="sc-jGeVcH"]{content:"kgFmXr,"}/*!sc*/ .gxAabO{display:flex;gap:0.5rem;}/*!sc*/ data-styled.g725[id="sc-jQyFEZ"]{content:"gxAabO,"}/*!sc*/ .gbXfrc.company-logo{padding:0.25rem;background-color:#ffffff;border:1px solid #E1EBFA;border-radius:0.25rem;justify-content:center;align-items:center;display:flex;}/*!sc*/ data-styled.g726[id="sc-bwFVQC"]{content:"gbXfrc,"}/*!sc*/ .eEFlAV{display:flex;flex-direction:column;align-items:flex-start;}/*!sc*/ data-styled.g728[id="sc-iPOUNt"]{content:"eEFlAV,"}/*!sc*/ .ilZWRW{color:#ffffff;}/*!sc*/ .ilZWRW.missing-data .color-box{background:#e5e5e5;color:#000000;}/*!sc*/ .ilZWRW .hold{background:#ffd644;color:#000000;}/*!sc*/ .ilZWRW .sell{background:#ff9244;}/*!sc*/ .ilZWRW .strong_sell{background:#ff4050;}/*!sc*/ .ilZWRW .color-box{display:flex;align-items:center;justify-content:center;height:29px;width:100%;font-weight:600;font-size:14px;gap:8px;}/*!sc*/ data-styled.g729[id="sc-iBpinA"]{content:"ilZWRW,"}/*!sc*/ .kEZlwm{background:#f2f8ff;border-radius:4px;}/*!sc*/ .kEZlwm .buy{background:#30bf60;}/*!sc*/ data-styled.g730[id="sc-cNGRH"]{content:"kEZlwm,"}/*!sc*/ .kQRHRb{display:flex;height:26px;width:26px;border-radius:4px;justify-content:center;align-items:center;padding:3px;}/*!sc*/ .kQRHRb.up{background-color:#d3efe5;}/*!sc*/ .kQRHRb.down{background-color:#f4dae3;}/*!sc*/ data-styled.g748[id="sc-iWHcIr"]{content:"kQRHRb,"}/*!sc*/ .izTmBY{min-height:375px;}/*!sc*/ data-styled.g750[id="sc-iTPigJ"]{content:"izTmBY,"}/*!sc*/ .kJGCHJ .chart-body{border:1px solid #E1EBFA;background:#ffffff;}/*!sc*/ .kJGCHJ .symbol-menu{background:#ffffff;}/*!sc*/ .kJGCHJ .symbol-menu .searchbar{border-bottom:1px solid #E1EBFA;display:flex;align-items:center;gap:0.5rem;padding:0.5rem 1rem;}/*!sc*/ .kJGCHJ .symbol-menu .searchbar .inner-searchbar{border:none;background:transparent;}/*!sc*/ .kJGCHJ .symbol-menu .searchbar .inner-searchbar:focus{outline:none;}/*!sc*/ .kJGCHJ .symbol-menu .symbol-entry{display:flex;align-items:center;gap:0.5rem;margin-left:0.25rem;padding:0.5rem 1rem;}/*!sc*/ .kJGCHJ .symbol-menu .symbol-entry .symbol-pill-dot{width:0.5rem;height:0.5rem;border-radius:50%;}/*!sc*/ .kJGCHJ .symbol-menu .symbol-entry .symbol-pill{display:flex;padding:2px 4px;align-items:flex-start;gap:8px;border-radius:4px;background:#F2F8FF;border:1px solid #CEDDF2;}/*!sc*/ .kJGCHJ .green-chip{background:#d3efe5;}/*!sc*/ .kJGCHJ .green-chip .label-text{color:#30bf60;}/*!sc*/ .kJGCHJ .red-chip{background:#f4dae3;}/*!sc*/ .kJGCHJ .red-chip .label-text{color:#eb5757;}/*!sc*/ .kJGCHJ .compare-tab{cursor:pointer;width:100%;background:#F2F8FF;display:flex;height:72px;padding:12px 12px 9px 12px;flex-direction:column;align-items:center;gap:16px;flex:1 0 0;border-top-left-radius:4px;border-top-right-radius:4px;border:1px solid #CEDDF2;}/*!sc*/ @media (min-width: 768px){.kJGCHJ .compare-tab{max-width:160px;}}/*!sc*/ .kJGCHJ .compare-tab.active{background:#F2F8FF;border-bottom:none;}/*!sc*/ .kJGCHJ .compare-tab .compare-tab__label{font-size:16px;font-weight:700;color:#4f4f4f;line-height:normal;}/*!sc*/ .kJGCHJ .compare-tab .compare-tab__value{font-size:12px;color:#828282;font-weight:700;line-height:normal;}/*!sc*/ .kJGCHJ .tab-content{background:linear-gradient( 180deg, #F2F8FF 100%, #F2F8FF 0% );border:1px solid #CEDDF2;padding:16px;margin-top:-1px;}/*!sc*/ data-styled.g751[id="sc-bdoPik"]{content:"kJGCHJ,"}/*!sc*/ .VeaVV{color:#000000;min-height:125px;position:relative;}/*!sc*/ .VeaVV.quote-header{display:flex;flex-direction:column;justify-content:space-between;position:relative;background:linear-gradient(#f3f9ff, #e1ebfa);border-bottom:none;}/*!sc*/ .VeaVV.quote-header .header-top-half{padding-top:0.85rem;padding-bottom:0.85rem;}/*!sc*/ .VeaVV .raptive-header-ad{display:none;margin-top:unset;margin-bottom:unset;}/*!sc*/ @media (min-width: 1100px){.VeaVV .raptive-header-ad{display:flex;}}/*!sc*/ .VeaVV .raptive-ben-header-sml #AdThrive_Header_1_desktop{min-width:320px!important;max-width:320px!important;}/*!sc*/ .VeaVV .quote-actions-desktop{display:none;}/*!sc*/ @media (min-width: 940px){.VeaVV .quote-actions-desktop{display:block;}}/*!sc*/ .VeaVV .quote-actions-tablet{display:none;max-width:400px;margin-left:unset;margin-right:unset;}/*!sc*/ @media (min-width: 768px){.VeaVV .quote-actions-tablet{display:block;}}/*!sc*/ @media (min-width: 940px){.VeaVV .quote-actions-tablet{display:none;}}/*!sc*/ .VeaVV .add-to-watchlist-wrapper{width:100%;}/*!sc*/ .VeaVV .add-to-watchlist-wrapper button{padding:0.35rem 0.75rem;}/*!sc*/ .VeaVV .comments-count-button button{width:100%;}/*!sc*/ .VeaVV .get-report-button{white-space:nowrap;width:100%;}/*!sc*/ .VeaVV .get-report-button button{padding:0.5rem 0.75rem;}/*!sc*/ .VeaVV .more-quote-actions-button{background:#3f83f81a;box-shadow:unset;}/*!sc*/ .VeaVV .more-quote-actions-button{height:34px;width:40px;}/*!sc*/ .VeaVV button.add-to-watchlist-button{box-shadow:unset;}/*!sc*/ .VeaVV button.add-to-watchlist-button.compact{padding:1rem 0.75rem;}/*!sc*/ .VeaVV button.more-quote-actions-button{width:40px;background-color:#ffffff;}/*!sc*/ .VeaVV button.more-quote-actions-button:hover{background-color:#ffffff;}/*!sc*/ .VeaVV a.perks-button,.VeaVV a.buy-button,.VeaVV a.compare-brokers-button{width:100%;background:#3f83f81a;box-shadow:unset;}/*!sc*/ .VeaVV .quote-actions-container.bottom-buttons{justify-content:center;display:flex;}/*!sc*/ @media (max-width: 600px){.VeaVV .quote-actions-container.bottom-buttons{flex-direction:column;}}/*!sc*/ .VeaVV .profile-call-to-action-container .call-to-action-container{margin-top:16px;}/*!sc*/ .VeaVV .section-title{font-size:24px;font-weight:700;text-transform:uppercase;}/*!sc*/ .VeaVV .main-quote-tabs-wrapper{display:flex;}/*!sc*/ @media (min-width: 800px){.VeaVV .main-quote-tabs-wrapper{padding:0 2rem;}}/*!sc*/ .VeaVV .main-quote-tabs{width:100%;margin:0 auto;max-width:1280px;display:flex;align-items:center;flex-wrap:nowrap;overflow-x:auto;-webkit-overflow-scrolling:touch;}/*!sc*/ .VeaVV .main-quote-tabs a{color:unset;}/*!sc*/ .VeaVV .main-quote-tabs .tab{font-size:14px;font-weight:700;border-top-right-radius:4px;border-top-left-radius:4px;cursor:pointer;white-space:nowrap;color:#5b7292;padding:0.8rem 1.3rem;}/*!sc*/ @media (min-width: 800px){.VeaVV .main-quote-tabs .tab{padding:0.5rem 1.2rem;}}/*!sc*/ .VeaVV .main-quote-tabs .tab.mobile-tab{padding:12px 16px;height:48px;}/*!sc*/ .VeaVV .main-quote-tabs .tab:hover{color:#3f83f8;}/*!sc*/ .VeaVV .main-quote-tabs .tab.active{color:#3f83f8;border-bottom:2px solid #3f83f8;}/*!sc*/ .VeaVV .company-logo{height:64px;width:64px;}/*!sc*/ @media (min-width: 768px){.VeaVV .header-left-text{font-size:20px;line-height:22px;}.VeaVV .leave-a-comment-wrapper button{padding:0.35rem 0.75rem;}}/*!sc*/ data-styled.g752[id="sc-lgHmWD"]{content:"VeaVV,"}/*!sc*/ .bNhbjD .section-description{color:#5b7292;}/*!sc*/ .bNhbjD .divider-bottom{border-bottom:1px solid #e1ebfa;}/*!sc*/ .bNhbjD .top-area-and-sidebar-container{display:flex;flex-direction:column;}/*!sc*/ @media screen and (min-width: 1020px){.bNhbjD .top-area-and-sidebar-container{flex-direction:row;}}/*!sc*/ .bNhbjD .metrics-mobile{display:block;}/*!sc*/ .bNhbjD .metrics-desktop{display:none;}/*!sc*/ @media screen and (min-width: 1020px){.bNhbjD .metrics-mobile{display:none;}.bNhbjD .metrics-desktop{display:block;}}/*!sc*/ .bNhbjD .quote-actions-container.bottom-buttons{justify-content:center;}/*!sc*/ .bNhbjD .video-card{cursor:pointer;}/*!sc*/ .bNhbjD .video-card img{width:100%;aspect-ratio:16/9;}/*!sc*/ .bNhbjD .profile-call-to-action-container .call-to-action-container{margin-top:16px;}/*!sc*/ .bNhbjD .inline-image-banner{background-size:contain;background-repeat:no-repeat;background-position:center;}/*!sc*/ .bNhbjD .top-tabs-wrapper{display:flex;flex-direction:row;align-items:center;background:#f2f8ff;border-radius:4px;padding:4px;}/*!sc*/ .bNhbjD .top-tabs-wrapper .top-tabs__tab{cursor:pointer;padding:4px 8px;border-radius:4px;color:#3f83f8;border:none!important;background:#f2f8ff;}/*!sc*/ .bNhbjD .top-tabs-wrapper .top-tabs__tab:hover{color:#ffffff;background:#61a9ff;}/*!sc*/ .bNhbjD .top-tabs-wrapper .top-tabs__tab--active{background:#3f83f8;color:white;}/*!sc*/ .bNhbjD .card{padding:16px;border-radius:4px;border:1px solid #ceddf2;}/*!sc*/ .bNhbjD .card.technical-card{height:164px;}/*!sc*/ .bNhbjD .simple-tab-wrapper{display:flex;flex-direction:row;align-items:center;background:#f2f8ff;border-radius:4px;padding:4px;}/*!sc*/ .bNhbjD .simple-tab-wrapper .simple-tab{cursor:pointer;padding:2px 8px;border-radius:4px;color:#3f83f8;}/*!sc*/ .bNhbjD .simple-tab-wrapper .simple-tab.active{background:#3f83f8;color:white;}/*!sc*/ .bNhbjD .simple-tab-wrapper .simple-tab .simple-tab-text{font-weight:600;}/*!sc*/ .bNhbjD .news-tab-wrapper{flex-direction:row;align-items:center;gap:14px;background:#f2f8ff;border-radius:4px;padding:4px;display:inline-flex;}/*!sc*/ .bNhbjD .news-tab-wrapper .simple-tab{cursor:pointer;padding:2px 4px;border-radius:4px;color:#3f83f8;}/*!sc*/ .bNhbjD .news-tab-wrapper .simple-tab.active{background:#3f83f8;color:white;}/*!sc*/ .bNhbjD .news-tab-wrapper .simple-tab .simple-tab-text{font-weight:600;}/*!sc*/ .bNhbjD .faq-container .faq-block{border:none;}/*!sc*/ .bNhbjD .faq-container .faq-block .qa-container{padding:0rem;margin-bottom:0.5rem;border-radius:0.5rem;border:1px solid #ceddf2;}/*!sc*/ .bNhbjD .faq-container .faq-block .qa-container .qa-header{color:#283d59;padding:0.5rem;border-top-right-radius:0.5rem;border-top-left-radius:0.5rem;}/*!sc*/ .bNhbjD .faq-container .faq-block .qa-container .qa-body{color:#395173;padding:0.5rem;}/*!sc*/ .bNhbjD .bottom-buttons{margin-bottom:12px;}/*!sc*/ .bNhbjD .main-div{margin-left:auto;margin-right:auto;max-width:1280px;width:100%;padding:0 1rem;}/*!sc*/ .bNhbjD .solid-text{font-size:14px;line-height:17px;font-weight:700;}/*!sc*/ .bNhbjD .under-calendar-text{padding:4px;}/*!sc*/ .bNhbjD .quote-calendar{max-width:1280px;}/*!sc*/ .bNhbjD .server-side-calendar-container{display:flex;width:100%;max-width:1280px;overflow-x:auto;}/*!sc*/ .bNhbjD .ag-root-wrapper .ag-header-cell{border-left:none!important;border-right:none!important;}/*!sc*/ .bNhbjD .ag-root-wrapper .ag-header-cell{padding:4px 6px!important;background:#3f83f8!important;}/*!sc*/ .bNhbjD .ag-root-wrapper .ag-header-cell .ag-header-cell-text{color:#ffffff;font-weight:700;}/*!sc*/ .bNhbjD .ag-root-wrapper .ag-header-container{background:#e1ebfa!important;}/*!sc*/ .bNhbjD .ag-root-wrapper .ag-header-viewport{background:#3f83f8!important;}/*!sc*/ .bNhbjD .ag-root-wrapper .ag-icon-asc,.bNhbjD .ag-root-wrapper .ag-icon-desc{color:#ffffff;}/*!sc*/ .bNhbjD .benzinga-core-table-container .benzinga-core-table-thead tr{background:#3f83f8;border-bottom-color:#3f83f8;}/*!sc*/ .bNhbjD .benzinga-core-table-container .benzinga-core-table-thead tr th{border-left:none;}/*!sc*/ .bNhbjD .benzinga-core-table-container .benzinga-core-table-thead tr th:first-of-type{border-left-color:#3f83f8;}/*!sc*/ .bNhbjD .benzinga-core-table-container .benzinga-core-table-thead tr th:last-of-type{border-right-color:#3f83f8;}/*!sc*/ .bNhbjD .benzinga-core-table-container .benzinga-core-table-wrapper{border-color:rgb(224, 224, 224);}/*!sc*/ data-styled.g755[id="sc-dnoZww"]{content:"bNhbjD,"}/*!sc*/ .dVtUSe .analyst-rating-score-circle{color:#ffffff;background-color:#d0d4da;}/*!sc*/ .dVtUSe .analyst-rating-label{background:#e1eaf9;color:#000000;}/*!sc*/ .dVtUSe .strong-buy .analyst-rating-score-circle{background:#30BF60;}/*!sc*/ .dVtUSe .strong-buy .analyst-rating-label{background:#D9F2DF;color:#30BF60;}/*!sc*/ .dVtUSe .buy .analyst-rating-score-circle{background:#84CC16;}/*!sc*/ .dVtUSe .buy .analyst-rating-label{background:#E1F1D2;color:#84CC16;}/*!sc*/ .dVtUSe .hold .analyst-rating-score-circle{background:#FFD644;color:#7e6a22;}/*!sc*/ .dVtUSe .hold .analyst-rating-label{background:#FAF3D8;color:#ac9339;}/*!sc*/ .dVtUSe .sell .analyst-rating-score-circle{background:#F97316;font-weight:600;}/*!sc*/ .dVtUSe .sell .analyst-rating-label{background:#FAE0D1;color:#F97316;}/*!sc*/ .dVtUSe .strong-sell .analyst-rating-score-circle{background:#EF4444;}/*!sc*/ .dVtUSe .strong-sell .analyst-rating-label{background:#F8D8D8;color:#EF4444;}/*!sc*/ data-styled.g756[id="sc-kqpPGb"]{content:"dVtUSe,"}/*!sc*/ .ktMpoo .color-key-box{height:6px;width:6px;}/*!sc*/ data-styled.g757[id="sc-czPwHC"]{content:"ktMpoo,"}/*!sc*/ .kEwkjg{margin-top:0;padding-top:10px;font-size:12px;line-height:21px;text-decoration:none;}/*!sc*/ data-styled.g760[id="sc-gFYmAs"]{content:"kEwkjg,"}/*!sc*/ .KOtsp{transition:color 0.2s cubic-bezier(0.25, 0.46, 0.45, 0.94),color 0.2s ease;text-decoration:none;}/*!sc*/ data-styled.g761[id="sc-bnRclF"]{content:"KOtsp,"}/*!sc*/ .fgxyIy{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .fgxyIy:hover{color:#3b5998;}/*!sc*/ .fgxyIy svg{fill:#ffffff;}/*!sc*/ .XrAQw{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .XrAQw:hover{color:#e1306c;}/*!sc*/ .XrAQw svg{fill:#ffffff;}/*!sc*/ .cjvdFo{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .cjvdFo:hover{color:#0072b1;}/*!sc*/ .cjvdFo svg{fill:#ffffff;}/*!sc*/ .jlbEXg{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .jlbEXg:hover{color:#fe5000;}/*!sc*/ .jlbEXg svg{fill:#ffffff;}/*!sc*/ .jldMrO{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .jldMrO:hover{color:#000000;}/*!sc*/ .jldMrO svg{fill:#ffffff;}/*!sc*/ .gXlNji{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .gXlNji:hover{color:red;}/*!sc*/ .gXlNji svg{fill:#ffffff;}/*!sc*/ data-styled.g762[id="sc-iFEMmm"]{content:"fgxyIy,XrAQw,cjvdFo,jlbEXg,jldMrO,gXlNji,"}/*!sc*/ .brbZLb.button-wrapper{border-radius:6px;overflow:hidden;background-color:#ffffff;display:flex;align-items:center;justify-content:center;padding:5px;min-width:140px;-webkit-transition:all 200ms ease;transition:all 200ms ease;height:50px;box-sizing:border-box;}/*!sc*/ .brbZLb.button-wrapper:hover{background-color:#CEDDF2;}/*!sc*/ data-styled.g763[id="sc-dnxBXz"]{content:"brbZLb,"}/*!sc*/ .bnEqKR.footer-row{display:grid;grid-auto-flow:column;grid-gap:20px;width:100%;padding-top:0.5rem;padding-bottom:2rem;padding-left:1rem;padding-right:1rem;margin-left:auto;margin-right:auto;}/*!sc*/ @media screen and (min-width: 480px){.bnEqKR.footer-row{max-width:480px;}}/*!sc*/ @media screen and (min-width: 768px){.bnEqKR.footer-row{padding-left:4rem;padding-right:4rem;max-width:100%;grid-gap:30px;}}/*!sc*/ @media screen and (max-width: 1000px){.bnEqKR.footer-row{grid-auto-flow:row;grid-template-columns:repeat(auto-fill, minmax(200px, 1fr));}}/*!sc*/ data-styled.g765[id="sc-dxRmzR"]{content:"bnEqKR,"}/*!sc*/ .dfdtYF{display:flex;flex-direction:column;text-align:left;}/*!sc*/ .dfdtYF h3{display:flex;color:#ffffff;font-size:18px;font-weight:600;margin:0;}/*!sc*/ @media screen and (min-width: 480px){.dfdtYF h3{margin-top:0;}}/*!sc*/ @media screen and (min-width: 768px){.dfdtYF h3{font-size:16px;margin-top:2rem;}}/*!sc*/ .dfdtYF ul{list-style:none;padding:0;}/*!sc*/ .dfdtYF ul li{font-size:16px;}/*!sc*/ @media screen and (min-width: 768px){.dfdtYF ul li{font-size:14px;}}/*!sc*/ .dfdtYF ul li >a{color:#CEDDF2;}/*!sc*/ .dfdtYF ul li >a:hover{color:#ffffff;}/*!sc*/ data-styled.g766[id="sc-hPnoVK"]{content:"dfdtYF,"}/*!sc*/ .hqxlow{display:flex;align-items:center;margin:0 4px;padding-right:0px;width:192px;min-width:144px;}/*!sc*/ .hqxlow .benzinga-crypto-logo-wrapper{margin-bottom:-1px;}/*!sc*/ .hqxlow >a{display:inline-flex;}/*!sc*/ data-styled.g771[id="sc-ggVnwW"]{content:"hqxlow,"}/*!sc*/ .jieYJc{align-items:center;display:flex;justify-content:space-between;}/*!sc*/ data-styled.g776[id="sc-fmJrrp"]{content:"jieYJc,"}/*!sc*/ .iqcSMz{color:#CEDDF2;font-weight:600;font-size:14px;line-height:20px;}/*!sc*/ data-styled.g777[id="sc-eYjERw"]{content:"iqcSMz,"}/*!sc*/ .fHqnwx{color:#ffffff;font-size:12px;line-height:16px;}/*!sc*/ data-styled.g778[id="sc-brYdJo"]{content:"fHqnwx,"}/*!sc*/ .gvTojD{color:#99AECC;font-weight:700;display:flex;align-items:center;}/*!sc*/ .gvTojD .quote-icon{margin:0 4px;font-size:12px;}/*!sc*/ data-styled.g779[id="sc-hpmCTx"]{content:"gvTojD,"}/*!sc*/ .kjFNA{display:block;width:100%;max-width:145px;min-width:132px;padding:8px;background:linear-gradient(90deg, #f0525200 0%, #f052520d 100%);}/*!sc*/ .kjFNA .dark{color:#99AECC!important;}/*!sc*/ .kjFNA .light{color:#395173!important;}/*!sc*/ data-styled.g780[id="sc-ehEeqy"]{content:"kjFNA,"}/*!sc*/ .iPnQNb{display:flex;flex-grow:1;height:52px;}/*!sc*/ data-styled.g781[id="sc-keSDAH"]{content:"iPnQNb,"}/*!sc*/ .cLmgSw{position:relative;overflow:hidden;white-space:nowrap;}/*!sc*/ .cLmgSw::before{animation:jBCTCY 5s ease-in-out infinite;content:'';position:absolute;top:0;width:100%;height:100%;background:linear-gradient(120deg, transparent, rgba(255, 255, 255, 0.2), transparent);}/*!sc*/ data-styled.g782[id="sc-dBYnXA"]{content:"cLmgSw,"}/*!sc*/ .fVNyRC{line-height:48px;padding:0 10px;font-family:Manrope,Manrope-fallback,sans-serif;font-weight:bold;font-size:14px;color:#000000;height:100%;display:inline-flex;align-items:center;justify-content:center;}/*!sc*/ .fVNyRC:hover{background-color:#e1effe;color:unset;}/*!sc*/ .fVNyRC.trading-school{color:#298ccd!important;}/*!sc*/ @media screen and (min-width: 1292px){.fVNyRC.trading-school svg{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.fVNyRC{color:white;width:100%;text-align:left;display:inline-flex;justify-content:start;}.fVNyRC:hover{background-color:inherit;}}/*!sc*/ data-styled.g783[id="sc-jzmNhJ"]{content:"fVNyRC,"}/*!sc*/ .hnMSQP{line-height:2em;}/*!sc*/ .hnMSQP a{color:black;}/*!sc*/ .hnMSQP a:hover{color:#1a56db;}/*!sc*/ data-styled.g784[id="sc-grEoEK"]{content:"hnMSQP,"}/*!sc*/ .DsgvI{line-height:2em;}/*!sc*/ .DsgvI a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .DsgvI:hover{color:#1a79ff;}/*!sc*/ .DsgvI.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .DsgvI.highlight a{color:#ffffff;background-color:unset;font-weight:unset;text-align:center;}/*!sc*/ .DsgvI.highlight:hover{color:unset;}/*!sc*/ .cvPhYw{line-height:2em;}/*!sc*/ .cvPhYw a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .cvPhYw:hover{color:#1a79ff;}/*!sc*/ .cvPhYw.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .cvPhYw.highlight a{color:#ffffff;background-color:#63bc47;font-weight:600;text-align:center;}/*!sc*/ .cvPhYw.highlight:hover{color:#ffffff;}/*!sc*/ data-styled.g785[id="sc-ZxepX"]{content:"DsgvI,cvPhYw,"}/*!sc*/ .hkDVfA{display:grid;gap:8px;grid-template-columns:repeat(2, minmax(0px, 1fr));}/*!sc*/ data-styled.g786[id="sc-cLGQGY"]{content:"hkDVfA,"}/*!sc*/ .bUPzLk{border-bottom:1px solid #B8CBE6;color:#395173;font-weight:bold;margin-top:4px;margin-bottom:4px;margin-left:16px;margin-right:16px;padding-bottom:4px;}/*!sc*/ data-styled.g787[id="sc-iIVpRh"]{content:"bUPzLk,"}/*!sc*/ .hxeoeN{display:none;position:absolute;width:max-content;top:48px;z-index:2000;background-color:#ffffff;box-shadow:0 4px 6px -1px rgba(0, 0, 0, 0.1),0 2px 4px -1px rgba(0, 0, 0, 0.06);}/*!sc*/ .hxeoeN:hover{display:flex;}/*!sc*/ .hxeoeN .subnav{right:0;}/*!sc*/ .hxeoeN .menu-wrapper a{width:100%;justify-content:left;}/*!sc*/ @media screen and (min-width: 910px){.hxeoeN{min-width:initial;}}/*!sc*/ @media screen and (min-width: 950px){.hxeoeN >div:nth-of-type(1){display:none;}}/*!sc*/ @media screen and (min-width: 1000px){.hxeoeN >div:nth-of-type(2){display:none;}}/*!sc*/ @media screen and (min-width: 1100px){.hxeoeN >div:nth-of-type(3){display:none;}}/*!sc*/ @media screen and (min-width: 1130px){.hxeoeN >div:nth-of-type(4){display:none;}}/*!sc*/ @media screen and (min-width: 1190px){.hxeoeN >div:nth-of-type(5){display:none;}}/*!sc*/ @media screen and (min-width: 1250px){.hxeoeN >div:nth-of-type(6){display:none;}}/*!sc*/ @media screen and (min-width: 1315px){.hxeoeN >div:nth-of-type(7){display:none;}}/*!sc*/ data-styled.g788[id="sc-jNBTOL"]{content:"hxeoeN,"}/*!sc*/ .lcKdMO.sub-group-wrapper{background-color:#ffffff;border-width:1px;border-top-width:1px;border-color:#CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;padding:8px 0;scrollbar-width:thin;max-height:calc(90vh - 100px);}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar{width:6px!important;}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar-track{background:#f1f1f1;}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar-thumb{background:#888;}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar-thumb:hover{background:#555;}/*!sc*/ data-styled.g789[id="sc-bXbAQm"]{content:"lcKdMO,"}/*!sc*/ .jBcAho.secondary{position:relative;}/*!sc*/ .jBcAho.secondary .subnav{position:absolute;right:0;top:48px;}/*!sc*/ .jBcAho .subnav{display:none;position:absolute;z-index:2000;}/*!sc*/ .jBcAho .subnav .third-level-menu{display:none;position:absolute;left:100%;background:#ffffff;border:1px solid #CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;height:100%;z-index:999999;overflow:auto;top:0;height:auto;min-width:160px;}/*!sc*/ .jBcAho .subnav .more-nav-menu{position:absolute;top:50%;right:0;transform:translateY(-50%);}/*!sc*/ .jBcAho:hover .subnav{display:block;}/*!sc*/ .jBcAho .menu-items{padding:4px;}/*!sc*/ .jBcAho .menu-items .dropdown-menu-item{position:relative;}/*!sc*/ .jBcAho .menu-items .dropdown-menu-item:hover .third-level-menu{display:block;}/*!sc*/ @media screen and (max-width: 800px){.jBcAho .subnav{display:none!important;}}/*!sc*/ data-styled.g790[id="sc-jKJZnd"]{content:"jBcAho,"}/*!sc*/ .ciyAWD{text-align:left;}/*!sc*/ .ciyAWD.has-groups{width:480px;}/*!sc*/ .ciyAWD.has-groups.money-app{max-width:480px;width:auto;min-width:180px;}/*!sc*/ data-styled.g791[id="sc-bUjGoE"]{content:"ciyAWD,"}/*!sc*/ .ievizW{display:flex;align-items:center;justify-content:center;font-size:12px;font-weight:700;white-space:nowrap;}/*!sc*/ .ievizW.others-btn{height:48px;color:#192940;text-transform:capitalize;padding:0 8px;}/*!sc*/ .ievizW.others-btn:hover{color:#1a56db;}/*!sc*/ .ievizW.research-btn{height:34px;color:white;text-transform:uppercase;border-radius:5px;letter-spacing:1px;padding:0 14px;}/*!sc*/ .ievizW.research-btn:hover{opacity:100;color:white;}/*!sc*/ .ievizW.invest-in-art-btn{height:34px;color:#000000;border-radius:5px;letter-spacing:1px;padding:0 10px;margin-right:8px;}/*!sc*/ .ievizW.invest-in-art-btn:hover{background-color:#a4cafe;}/*!sc*/ data-styled.g792[id="sc-cdZxpv"]{content:"ievizW,"}/*!sc*/ .dYSTha.menu-wrapper{background-color:#033251;position:relative;min-width:65px;}/*!sc*/ .dYSTha.menu-wrapper:hover .global-menu-dropdown{display:block;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper{background-color:transparent;}}/*!sc*/ .dYSTha.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .dYSTha.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper .menu-button{padding:0px 6px;}.dYSTha.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;}.dYSTha.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .dYSTha.menu-wrapper .global-menu-dropdown{background-color:#033251;display:none;position:absolute;width:110px;width:max-content;z-index:100;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper .global-menu-dropdown{right:0px;}}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item{color:white;cursor:pointer;font-size:12px;padding:8px 12px;display:block;margin:0;}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item a{color:white;display:flex;align-items:center;}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item span{display:inline-block;vertical-align:middle;line-height:1;margin-right:10px;}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item img{width:30px;display:inline-block;vertical-align:middle;}/*!sc*/ .dYSTha.menu-wrapper .global-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper .global-text{margin-right:0;}}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper{width:3rem;text-align:center;}}/*!sc*/ data-styled.g793[id="sc-fCUNPS"]{content:"dYSTha,"}/*!sc*/ .kNrvGp.menu-wrapper{background-color:#033251;position:relative;width:140px;white-space:nowrap;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper{background-color:transparent;}}/*!sc*/ @media screen and (min-width: 800px){.kNrvGp.menu-wrapper:hover .account-menu-dropdown{display:block;box-shadow:0 1px 2px 0 rgba(0, 0, 0, 0.05);}}/*!sc*/ .kNrvGp.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .kNrvGp.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;margin-right:0;}.kNrvGp.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-dropdown{background-color:#ffffff;border:1px solid #E1EBFA;display:none;position:absolute;width:140px;z-index:104;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper .account-menu-dropdown{right:0px;}}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-dropdown.open{display:block;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-dropdown .checkbox-container label{display:flex;font-size:12px;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item{color:#000000;cursor:pointer;font-size:12px;font-weight:700;padding:8px 12px;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item a{color:#000000;display:inline-flex;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item.benzinga-plus a{color:#ff5a1f;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item.benzinga-pro a{color:#1A79FF;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item.benzinga-edge a{color:#3f83f8;}/*!sc*/ .kNrvGp.menu-wrapper .divider{margin:0 auto;width:85%;border-color:#CEDDF2;}/*!sc*/ .kNrvGp.menu-wrapper .my-account-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper .my-account-text{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper{width:3rem;}}/*!sc*/ data-styled.g794[id="sc-cbhCNN"]{content:"kNrvGp,"}/*!sc*/ .iUXfuo{position:fixed;z-index:100;top:0;left:0;right:0;width:100%;transition:all linear 0.12s;}/*!sc*/ .iUXfuo .mobile-header,.iUXfuo .mobile-menu-wrapper,.iUXfuo .mobile-quote-bar{background-color:#08244d;}/*!sc*/ .iUXfuo .mobile-header{border-bottom:1px solid #36537e;}/*!sc*/ .iUXfuo .menu-icon-wrapper{display:flex;align-items:center;justify-content:center;cursor:pointer;flex-shrink:0;width:3rem;height:3rem;color:#CEDDF2;font-size:18px;}/*!sc*/ .iUXfuo.fullscreen .account-menu{pointer-events:none;}/*!sc*/ .iUXfuo .search-wrapper{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);width:100%;z-index:30;}/*!sc*/ .iUXfuo .search-wrapper.fixed{position:fixed;top:181px;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen{position:fixed;background:#242424e0;z-index:999;height:100vh;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .searchbar-wrapper{padding:0;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .searchbar-wrapper .search-input-container{border-bottom:1px solid #a4a4a4;padding:8px 12px;background-color:#1d446a;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .searchbar-wrapper .search-input-wrapper{background-color:white;border-radius:4px;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .search-dropdown{border-radius:unset;border:none;box-shadow:none;position:unset;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .search-result-wrapper{border-radius:unset;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;line-height:15px;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper input{font-size:14px;height:45px;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media screen and (max-width: 800px){.iUXfuo .search-wrapper .searchbar-wrapper input{font-size:16px;}}/*!sc*/ .iUXfuo .mobile-menu-wrapper{z-index:999999;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button{color:white;line-height:40px;padding:4px 10px;position:fixed;height:min-content;bottom:0px;z-index:10000;background-color:#062b4c;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button div{background-color:#ff5a1f;border-radius:10px;padding:0px 10px;width:100%;border-radius:5px;margin:2px 0px;text-align:center;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button svg{font-size:20px;padding-right:5px;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button:hover div{background-color:#ff8a4c;border-bottom:3px solid #d03801;}/*!sc*/ .iUXfuo .bz-pro-logo{height:60px;background:#062b4c;margin-bottom:60px;}/*!sc*/ .iUXfuo .bz-pro-logo a{border-top:solid 1px #666;padding:1rem;width:100%;}/*!sc*/ .iUXfuo .mobile-logo-wrapper{margin:0;padding:0;width:205px;margin-right:auto;}/*!sc*/ .iUXfuo .mobile-logo-wrapper .benzinga-crypto-logo-wrapper{margin-top:5px;}/*!sc*/ .iUXfuo .mobile-logo-wrapper .benzinga-logo{height:18.2px;width:134.35px;}/*!sc*/ .iUXfuo .mobile-logo-wrapper .benzinga-logo.reactive-holiday-logo{height:30px;}/*!sc*/ data-styled.g798[id="sc-hmzteu"]{content:"iUXfuo,"}/*!sc*/ .hQNIgN{margin-top:242px;width:100%;}/*!sc*/ data-styled.g799[id="sc-bUsiPH"]{content:"hQNIgN,"}/*!sc*/ .WbPfG.top-bar-wrapper{background-color:#072232;height:32px;}/*!sc*/ .WbPfG.top-bar-wrapper .bar-layout-width{max-width:1400px;margin:0 auto;}/*!sc*/ .WbPfG.top-bar-wrapper .top-bar-inner-wrapper{display:flex;justify-content:space-between;}/*!sc*/ .WbPfG.top-bar-wrapper .top-bar-list{list-style:none;display:flex;margin:0;}/*!sc*/ .WbPfG.top-bar-wrapper .auth-buttons{display:flex;height:32px;min-width:234px;}/*!sc*/ .WbPfG.top-bar-wrapper .auth-link-button{color:#ffffff;cursor:pointer;line-height:32px;padding:0 12px;text-transform:uppercase;font-size:14px;font-weight:700;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-pro-btn{display:flex;align-items:center;justify-content:space-between;padding:0 12px;border-radius:3px;height:26px;color:white;font-weight:semi-bold;background-color:#0075cd;margin:3px 3px 0px 0px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item-label{color:white;font-size:12px;line-height:30px;margin:0 8px;white-space:nowrap;}/*!sc*/ .WbPfG.top-bar-wrapper .contributor-link{align-items:center;color:white;display:inline-flex;font-size:12px;height:32px;margin:0 12px;}/*!sc*/ .WbPfG.top-bar-wrapper .contributor-link a{color:white;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item{border-top:2px solid #3f83f8;color:#ffffff;text-transform:uppercase;line-height:28px;font-weight:500;font-size:14px;margin:0;text-align:center;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item.ProLabel{border-top:none;text-transform:none;min-width:140px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(2){border-top-color:#f05252;min-width:84px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(3){border-top-color:#c27803;min-width:66px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(4){border-top-color:#046c4e;min-width:83px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(5){border-top-color:#c81e1e;min-width:93px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(6){border-top-color:#0e9f6e;min-width:59px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(7){min-width:86px;}/*!sc*/ data-styled.g803[id="sc-fAlvPn"]{content:"WbPfG,"}/*!sc*/ .kimWDA.quote-bar-container{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);}/*!sc*/ .kimWDA.quote-bar-container .quote-bar-layout-width{max-width:1400px;margin:0 auto;height:52px;}/*!sc*/ .kimWDA.quote-bar-container .quote-bar-wrapper,.kimWDA.quote-bar-container .quotes-list{display:flex;flex-grow:1;}/*!sc*/ .kimWDA.quote-bar-container .quote-list-container{flex-grow:1;overflow-x:auto;scrollbar-width:none;}/*!sc*/ .kimWDA.quote-bar-container .quote-list-container ::-webkit-scrollbar{display:none;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper{width:100%;max-width:288px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;font-size:16px;line-height:15px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper input{font-size:12px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media (min-width: 1300px){.kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper{padding-right:0;}.kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:36px;}}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .search-icon{height:36px;}/*!sc*/ data-styled.g804[id="sc-lcMqGs"]{content:"kimWDA,"}/*!sc*/ .frfjnD.quote-switcher-wrapper{overflow-y:auto;height:52px;width:70px;scrollbar-width:none;flex:none;}/*!sc*/ .frfjnD.quote-switcher-wrapper ::-webkit-scrollbar{display:none;}/*!sc*/ .frfjnD.quote-switcher-wrapper .quote-switcher-container{display:flex;flex-direction:column;}/*!sc*/ data-styled.g805[id="sc-fKFgrF"]{content:"frfjnD,"}/*!sc*/ .hsnbJt.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #99AECC;background:linear-gradient(90deg, #99AECC1a 0%, #99AECC00 100%);text-align:left;color:#99AECC;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .hsnbJt.quote-switcher-button :focus{outline:none;}/*!sc*/ .iQNatV.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #E1EBFA;background:linear-gradient(90deg, #1c64f21a 0%, #1c64f200 100%);text-align:left;color:#ffffff;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .iQNatV.quote-switcher-button :focus{outline:none;}/*!sc*/ data-styled.g806[id="sc-fCzvdW"]{content:"hsnbJt,iQNatV,"}/*!sc*/ .eLZlCJ{display:flex;overflow-x:scroll;scrollbar-width:none;justify-content:flex-start;}/*!sc*/ .eLZlCJ ::-webkit-scrollbar{display:none;}/*!sc*/ .eLZlCJ li{flex-shrink:0;}/*!sc*/ .eLZlCJ li:nth-of-type(3),.eLZlCJ li:nth-of-type(4),.eLZlCJ li:nth-of-type(5),.eLZlCJ li:nth-of-type(6),.eLZlCJ li:nth-of-type(7),.eLZlCJ li:nth-of-type(8),.eLZlCJ li:nth-of-type(9),.eLZlCJ li:nth-of-type(10),.eLZlCJ li:nth-of-type(11),.eLZlCJ li:nth-of-type(12){display:none;}/*!sc*/ @media screen and (min-width: 850px){.eLZlCJ li:nth-of-type(3){display:initial;}}/*!sc*/ @media screen and (min-width: 900px){.eLZlCJ li:nth-of-type(4){display:initial;}}/*!sc*/ @media screen and (min-width: 950px){.eLZlCJ li:nth-of-type(5){display:initial;}}/*!sc*/ @media screen and (min-width: 1000px){.eLZlCJ li:nth-of-type(6){display:initial;}}/*!sc*/ @media screen and (min-width: 1100px){.eLZlCJ li:nth-of-type(7){display:initial;}}/*!sc*/ @media screen and (min-width: 1130px){.eLZlCJ li:nth-of-type(8){display:initial;}}/*!sc*/ @media screen and (min-width: 1190px){.eLZlCJ li:nth-of-type(9){display:initial;}}/*!sc*/ @media screen and (min-width: 1250px){.eLZlCJ li:nth-of-type(10){display:initial;}}/*!sc*/ @media screen and (min-width: 1315px){.eLZlCJ li:nth-of-type(11){display:initial;}}/*!sc*/ @media screen and (min-width: 1360px){.eLZlCJ li:nth-of-type(12){display:initial;}}/*!sc*/ data-styled.g809[id="sc-bCcCHF"]{content:"eLZlCJ,"}/*!sc*/ .jfzrPN{display:block;position:unset;top:unset;width:unset;z-index:999;box-shadow:unset;}/*!sc*/ @media (max-width: 800px){.jfzrPN{display:none;}}/*!sc*/ .jfzrPN .breaking-news-banner{position:absolute;top:-50px;transition:all ease-in 0.5s;z-index:-1;}/*!sc*/ .jfzrPN .breaking-news-wrapper{position:relative;}/*!sc*/ .jfzrPN .breaking-news-wrapper--visible .breaking-news-banner{position:unset;top:0;}/*!sc*/ .jfzrPN .more-nav-tabs-icon-container{position:relative;display:flex;align-items:center;justify-content:center;margin-left:5px;margin-right:5px;cursor:pointer;}/*!sc*/ .jfzrPN .more-nav-tabs-icon-container:hover >div{display:flex;}/*!sc*/ @media screen and (min-width: 1315px){.jfzrPN .more-nav-tabs-icon-container{display:none!important;}}/*!sc*/ data-styled.g810[id="sc-iGzcki"]{content:"jfzrPN,"}/*!sc*/ .hwhdcM{background-color:#ffffff;border-bottom:0px solid #B8CBE6;width:100%;padding:0;}/*!sc*/ data-styled.g811[id="sc-fPkcnn"]{content:"hwhdcM,"}/*!sc*/ .gigmnn{height:48px;max-width:1400px;margin:0 auto;}/*!sc*/ data-styled.g812[id="sc-dIoOVQ"]{content:"gigmnn,"}/*!sc*/ .bkHEtM{display:flex;position:relative;height:100%;justify-content:center;}/*!sc*/ data-styled.g815[id="sc-fehoED"]{content:"bkHEtM,"}/*!sc*/ .SrdfA{flex-grow:1;margin-left:20px;}/*!sc*/ data-styled.g816[id="sc-izxAxU"]{content:"SrdfA,"}/*!sc*/ .dSjbGr{display:inline-flex;align-items:center;justify-content:flex-end;height:48px;min-width:244px;}/*!sc*/ data-styled.g817[id="sc-fIiAAZ"]{content:"dSjbGr,"}/*!sc*/ .cpYKRp.header-container .navbar-placeholder{height:132px;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar{background-color:#192940;border:none;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .main-menu-wrapper{max-width:1300px;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .main-menu-wrapper .menu-wrapper:hover{background-color:#151f2e;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .logo-wrapper{width:260px;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .menu-item-link{color:#ceddf2;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .menu-item-link:hover{background-color:transparent;}/*!sc*/ data-styled.g830[id="sc-jHrLvE"]{content:"cpYKRp,"}/*!sc*/ .inqlyg{display:block;margin-bottom:0;}/*!sc*/ @media screen and (min-width: 800px){.inqlyg{display:none;}}/*!sc*/ data-styled.g832[id="sc-kjwMja"]{content:"inqlyg,"}/*!sc*/ @keyframes jBCTCY{0%{left:-100%;transition-property:left;}11.504424778761061%,100%{left:100%;transition-property:left;}}/*!sc*/ data-styled.g833[id="sc-keyframes-jBCTCY"]{content:"jBCTCY,"}/*!sc*/ </style></head><body><div id="__next"><div class="sc-jHrLvE cpYKRp header-container "><div class="sc-kjwMja inqlyg mobile-header-wrapper"><div class="sc-bUsiPH hQNIgN"><div id="navigation-header" class="sc-hmzteu iUXfuo"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="left-0 right-0 top-0 z-[9999999]" id="mobile-main-block"><div class="mobile-header flex items-center justify-between relative" style="transition:all linear 0.3s;z-index:20"><div class="menu-icon-wrapper"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M0 80c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16C7.2 96 0 88.8 0 80zM0 240c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16c-8.8 0-16-7.2-16-16zM448 400c0 8.8-7.2 16-16 16H16c-8.8 0-16-7.2-16-16s7.2-16 16-16H432c8.8 0 16 7.2 16 16z" fill="currentColor"></path></svg></div></div><div class="sc-ggVnwW hqxlow logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-eRxdlV jnspZt benzinga-logo light mobile"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span></a></div><div class="flex h-12 items-center text-blue-300"><div class="sc-fCUNPS dYSTha global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><div class="sc-cbhCNN kNrvGp account-menu menu-wrapper"><button class="menu-button"><span role="img" aria-label="user" class="anticon anticon-user"><svg viewBox="64 64 896 896" focusable="false" data-icon="user" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M858.5 763.6a374 374 0 00-80.6-119.5 375.63 375.63 0 00-119.5-80.6c-.4-.2-.8-.3-1.2-.5C719.5 518 760 444.7 760 362c0-137-111-248-248-248S264 225 264 362c0 82.7 40.5 156 102.8 201.1-.4.2-.8.3-1.2.5-44.8 18.9-85 46-119.5 80.6a375.63 375.63 0 00-80.6 119.5A371.7 371.7 0 00136 901.8a8 8 0 008 8.2h60c4.4 0 7.9-3.5 8-7.8 2-77.2 33-149.5 87.8-204.3 56.7-56.7 132-87.9 212.2-87.9s155.5 31.2 212.2 87.9C779 752.7 810 825 812 902.2c.1 4.4 3.6 7.8 8 7.8h60a8 8 0 008-8.2c-1-47.8-10.9-94.3-29.5-138.2zM512 534c-45.9 0-89.1-17.9-121.6-50.4S340 407.9 340 362c0-45.9 17.9-89.1 50.4-121.6S466.1 190 512 190s89.1 17.9 121.6 50.4S684 316.1 684 362c0 45.9-17.9 89.1-50.4 121.6S557.9 534 512 534z"></path></svg></span><span class="my-account-text">My Account</span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></button><div class="account-menu-dropdown"><div class="account-menu-item"><span><a href="/account">My Account</a></span></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=notifications">Notifications</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio">Overview</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=new_watchlist">+ New Watchlist</a></div><hr class="divider"/><div class="account-menu-item benzinga-edge"><a href="https://www.benzinga.com/profile/portfolio">Benzinga Edge</a></div><div class="account-menu-item benzinga-plus"><a href="https://www.benzinga.com/research">Benzinga Research</a></div><div class="account-menu-item benzinga-pro"><a href="https://pro.benzinga.com">Benzinga Pro</a></div><hr class="divider"/><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=login">Log In</a></div></div></div></div></div></div><div class="mobile-quote-bar overflow-x-scroll" id="mobile-quote-bar"><div class="sc-keSDAH iPnQNb quote-list-wrapper"><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a></div></div><div class="search-wrapper transition" id="mobile-search-bar" style="transition:all linear 0.3s"><div class="sc-cieYuS cfstRH searchbar-wrapper searchbar-default"><div class="sc-vZZzB eZXymS searchbar-container"><div class="sc-ifVVRW kOhchH search-input-container"><div class="sc-gUDIDV fcPNlb search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div><div class="sc-iGzcki jfzrPN desktop-menu-wrapper" id="navigation-header"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="sc-fAlvPn WbPfG top-bar-wrapper"><div class="bar-layout-width"><div class="top-bar-inner-wrapper"><ul class="top-bar-list"><li class="bz-top-bar-list-item ProLabel"><a aria-label="Get Benzinga Pro" class="sc-dBYnXA cLmgSw shine-effect text-white bz-pro-btn" href="https://www.benzinga.com/pro/register?utm_source=homepage-blue-button">Get Benzinga Pro </a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/apis"><div class="bz-top-bar-list-item-label">Data & APIs</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/events"><div class="bz-top-bar-list-item-label">Events</div></a></li><li class="bz-top-bar-list-item"><a href="https://marketfy.com/?__hstc=258999573.1ab86f21505b156c04ee556f3ea4a8de.1617281961141.1623244531459.1623314433592.60&__hssc=258999573.1.1623314433592&__hsfp=58102761"><div class="bz-top-bar-list-item-label">Marketfy</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/premarket"><div class="bz-top-bar-list-item-label">Premarket</div></a></li><li class="bz-top-bar-list-item"><a href="https://boost.benzinga.com"><div class="bz-top-bar-list-item-label">Boost</div></a></li><li class="bz-top-bar-list-item"><a href="https://advertise.benzinga.com"><div class="bz-top-bar-list-item-label">Advertise</div></a></li></ul><div class="auth-buttons"><div class="contributor-link"><a href="https://contributor.benzinga.com/contributor-onboarding">Contribute</a></div><div class="sc-fCUNPS dYSTha global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><button class="auth-link-button">Login</button><button class="auth-link-button bg-orange-600">Register</button></div></div></div></div><div class="sc-fPkcnn hwhdcM main-menu-bar"><div class="sc-dIoOVQ gigmnn main-menu-wrapper"><div class="sc-fehoED bkHEtM bar-content-layout"><div class="sc-ggVnwW hqxlow logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-eRxdlV jnspZt benzinga-logo dark desktop"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#093451"></path></svg></span></a></div><div class="sc-izxAxU SrdfA primary-menu-wrapper"><ul class="sc-bCcCHF eLZlCJ menu-item-container"><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/services" style="min-width:108px" title="Our Services">Our Services </a></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/news" style="min-width:57px" title="News">News </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings">Earnings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance">Guidance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividends">Dividends</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&amp;A">M&A</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/buybacks" title="Buybacks">Buybacks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/legal" title="Legal">Legal</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/interview" title="Interviews">Interviews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/management" title="Management">Management</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/offerings" title="Offerings">Offerings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPOs">IPOs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/insider-trades" title="Insider Trades">Insider Trades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="Biotech/FDA">Biotech/FDA</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/general/politics" title="Politics">Politics</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/healthcare" title="Healthcare">Healthcare</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options </a></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav has-groups"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="sc-cLGQGY hkDVfA group-list"><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Best Stocks & ETFs</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&P 500 ETFs">Best S&P 500 ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto </a></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX cvPhYw highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></li></ul></div><button aria-label="Click to open more navbar items" class="more-nav-tabs-icon-container"><div class="text-2xl text-black"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M432 256a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zm-160 0a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zM64 304a48 48 0 1 1 0-96 48 48 0 1 1 0 96z" fill="currentColor"></path></svg></div><div class="sc-jNBTOL hxeoeN more-menu-items-dropdown-container"><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options </a></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav has-groups"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="sc-cLGQGY hkDVfA group-list"><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Best Stocks & ETFs</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&P 500 ETFs">Best S&P 500 ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto </a></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX cvPhYw highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></div></button><div class="sc-fIiAAZ dSjbGr secondary-menu-wrapper"><div class="sc-jKJZnd jBcAho menu-wrapper secondary"><a aria-label="This opens Research in a new tab" class="sc-cdZxpv ievizW others-btn primary-toolbar-button" href="https://www.benzinga.com/research" style="min-width:110px" target="_blank" title="Research"><div class="text-xl pr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M96 32C60.7 32 32 60.7 32 96V384H96V96l384 0V384h64V96c0-35.3-28.7-64-64-64H96zM224 384v32H32c-17.7 0-32 14.3-32 32s14.3 32 32 32H544c17.7 0 32-14.3 32-32s-14.3-32-32-32H416V384c0-17.7-14.3-32-32-32H256c-17.7 0-32 14.3-32 32z" fill="currentColor"></path></svg></div>Research</a></div><div class="sc-jKJZnd jBcAho menu-wrapper secondary"><a aria-label="This opens My Stocks in a new tab" class="sc-cdZxpv ievizW others-btn primary-toolbar-button" href="https://www.benzinga.com/login?action=register&next=https://www.benzinga.com/profile/portfolio" style="min-width:105px" target="_blank" title="My Stocks"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M500 89c13.8-11 16-31.2 5-45s-31.2-16-45-5L319.4 151.5 211.2 70.4c-11.7-8.8-27.8-8.5-39.2 .6L12 199c-13.8 11-16 31.2-5 45s31.2 16 45 5L192.6 136.5l108.2 81.1c11.7 8.8 27.8 8.5 39.2-.6L500 89zM160 256V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32zM32 352v96c0 17.7 14.3 32 32 32s32-14.3 32-32V352c0-17.7-14.3-32-32-32s-32 14.3-32 32zm288-64c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V320c0-17.7-14.3-32-32-32zm96-32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32z" fill="currentColor"></path></svg></div>My Stocks</a></div><div class="sc-jKJZnd jBcAho menu-wrapper secondary"><a aria-label="This opens Tools in a new tab" class="sc-cdZxpv ievizW others-btn primary-toolbar-button" href="https://www.benzinga.com/tools" style="min-width:100px" target="_blank" title="Tools"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M352 320c88.4 0 160-71.6 160-160c0-15.3-2.2-30.1-6.2-44.2c-3.1-10.8-16.4-13.2-24.3-5.3l-76.8 76.8c-3 3-7.1 4.7-11.3 4.7H336c-8.8 0-16-7.2-16-16V118.6c0-4.2 1.7-8.3 4.7-11.3l76.8-76.8c7.9-7.9 5.4-21.2-5.3-24.3C382.1 2.2 367.3 0 352 0C263.6 0 192 71.6 192 160c0 19.1 3.4 37.5 9.5 54.5L19.9 396.1C7.2 408.8 0 426.1 0 444.1C0 481.6 30.4 512 67.9 512c18 0 35.3-7.2 48-19.9L297.5 310.5c17 6.2 35.4 9.5 54.5 9.5zM80 408a24 24 0 1 1 0 48 24 24 0 1 1 0-48z" fill="currentColor"></path></svg></div>Tools</a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav has-groups"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><a aria-label="Free Benzinga Pro Trial" class="sc-dBYnXA cLmgSw shine-effect text-white block py-2 rounded-sm bg-bzblue-600 text-center mx-2 md:mx-4 my-2" href="https://pro.benzinga.com/register/?utm_source=tools-bz-pro-free-trial">Free Benzinga Pro Trial </a><div class="sc-cLGQGY hkDVfA group-list"><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Calendars</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings Calendar">Analyst Ratings Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/conference-calls" title="Conference Call Calendar">Conference Call Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividend Calendar">Dividend Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings Calendar">Earnings Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Economic Calendar">Economic Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="FDA Calendar">FDA Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance Calendar">Guidance Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPO Calendar">IPO Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&A Calendar">M&A Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/spac" title="SPAC Calendar">SPAC Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/stock-splits" title="Stock Split Calendar">Stock Split Calendar</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/reports" title="Free Stock Reports">Free Stock Reports</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/sec/insider-trades/" title="Insider Trades">Insider Trades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas" title="Trade Idea Feed">Trade Idea Feed</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings">Analyst Ratings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/unusual-options-activity" title="Unusual Options Activity">Unusual Options Activity</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/heatmap" title="Heatmaps">Heatmaps</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/free-newsletters" title="Free Newsletter">Free Newsletter</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/gov-trades" title="Government Trades">Government Trades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/perfect-stock-portfolio" title="Perfect Stock Portfolio">Perfect Stock Portfolio</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/easy-income-portfolio" title="Easy Income Portfolio">Easy Income Portfolio</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Short Interest</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/most-shorted" title="Most Shorted">Most Shorted</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-increase" title="Largest Increase">Largest Increase</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-decrease" title="Largest Decrease">Largest Decrease</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Calculators</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/margin-calculator" title="Margin Calculator">Margin Calculator</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/forex-profit-calculator" title="Forex Profit Calculator">Forex Profit Calculator</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/100x-options-profit-calculator" title="100x Options Profit Calculator">100x Options Profit Calculator</a></div></div></div></div></div></div></div></div></div></div></div></div></div><div class="sc-lcMqGs kimWDA quote-bar-container"><div class="quote-bar-layout-width"><div class="quote-bar-wrapper"><div class="sc-fKFgrF frfjnD quote-switcher-wrapper"><div class="quote-switcher-container"><button class="sc-fCzvdW hsnbJt quote-switcher-button">Recent</button><button class="sc-fCzvdW iQNatV quote-switcher-button">Markets</button></div></div><div class="quote-list-container"><div class="sc-keSDAH iPnQNb quote-list-wrapper"><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a></div></div><div class="search-wrapper"><div class="sc-cieYuS cfstRH searchbar-wrapper searchbar-default"><div class="sc-vZZzB eZXymS searchbar-container"><div class="sc-ifVVRW kOhchH search-input-container"><div class="sc-gUDIDV fcPNlb search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div></div></div><div class="sc-dnoZww bNhbjD quote-page-container profile"><div class="sc-lgHmWD VeaVV quote-header"><div class="flex"><div aria-labelledby="comments-drawer" class="fixed top-0 right-0 z-40 h-screen p-4 overflow-y-auto transition-transform bg-white w-full max-w-[700px] z-[9999999] translate-x-full" tabindex="-1"><div class="flex items-center justify-between mb-4"><div class="flex items-center"><div class="mr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M512 240c0 114.9-114.6 208-256 208c-37.1 0-72.3-6.4-104.1-17.9c-11.9 8.7-31.3 20.6-54.3 30.6C73.6 471.1 44.7 480 16 480c-6.5 0-12.3-3.9-14.8-9.9c-2.5-6-1.1-12.8 3.4-17.4l0 0 0 0 0 0 0 0 .3-.3c.3-.3 .7-.7 1.3-1.4c1.1-1.2 2.8-3.1 4.9-5.7c4.1-5 9.6-12.4 15.2-21.6c10-16.6 19.5-38.4 21.4-62.9C17.7 326.8 0 285.1 0 240C0 125.1 114.6 32 256 32s256 93.1 256 208z" fill="currentColor"></path></svg></div><h5 class="inline-flex items-center text-base font-bold text-gray-700" id="comments-drawer">Comments</h5></div><button class="text-gray-400 bg-transparent hover:bg-gray-200 hover:text-gray-900 rounded-lg text-sm w-8 h-8 flex items-center justify-center" type="button"><div class="w-3.5 h-3.5"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 384 512" xmlns="http://www.w3.org/2000/svg"><path d="M345 137c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-119 119L73 103c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9l119 119L39 375c-9.4 9.4-9.4 24.6 0 33.9s24.6 9.4 33.9 0l119-119L311 409c9.4 9.4 24.6 9.4 33.9 0s9.4-24.6 0-33.9l-119-119L345 137z" fill="currentColor"></path></svg></div><span class="sr-only">Close menu</span></button></div><div id="coral_thread"><div class="sc-hnmNqB cxpDKR spinner"><div role="status"><svg aria-hidden="true" class="spinner-icon" fill="none" viewBox="0 0 100 101" xmlns="http://www.w3.org/2000/svg"><path d="M100 50.5908C100 78.2051 77.6142 100.591 50 100.591C22.3858 100.591 0 78.2051 0 50.5908C0 22.9766 22.3858 0.59082 50 0.59082C77.6142 0.59082 100 22.9766 100 50.5908ZM9.08144 50.5908C9.08144 73.1895 27.4013 91.5094 50 91.5094C72.5987 91.5094 90.9186 73.1895 90.9186 50.5908C90.9186 27.9921 72.5987 9.67226 50 9.67226C27.4013 9.67226 9.08144 27.9921 9.08144 50.5908Z" fill="currentColor"></path><path d="M93.9676 39.0409C96.393 38.4038 97.8624 35.9116 97.0079 33.5539C95.2932 28.8227 92.871 24.3692 89.8167 20.348C85.8452 15.1192 80.8826 10.7238 75.2124 7.41289C69.5422 4.10194 63.2754 1.94025 56.7698 1.05124C51.7666 0.367541 46.6976 0.446843 41.7345 1.27873C39.2613 1.69328 37.813 4.19778 38.4501 6.62326C39.0873 9.04874 41.5694 10.4717 44.0505 10.1071C47.8511 9.54855 51.7191 9.52689 55.5402 10.0491C60.8642 10.7766 65.9928 12.5457 70.6331 15.2552C75.2735 17.9648 79.3347 21.5619 82.5849 25.841C84.9175 28.9121 86.7997 32.2913 88.1811 35.8758C89.083 38.2158 91.5421 39.6781 93.9676 39.0409Z" fill="currentFill"></path></svg><span class="sr-only">Loading...</span></div></div></div></div><div class="bg-black/40 w-screen h-screen fixed z-[998] top-0 left-0 hidden"></div></div><div class="header-top-half flex items-center justify-between w-full main-div"><div class="flex flex-col"><div class="lg:text-lg flex items-center"><div class="sc-bwFVQC gbXfrc company-logo"><span class="ticker-logo" style="background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%"><img alt="" aria-hidden="true" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNTAiIGhlaWdodD0iNTAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+" style="background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial"/></span><img alt="Aptose Biosciences" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain"/><noscript><img alt="Aptose Biosciences" src="https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60&max_width=&width=60&x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv&x-bz-exp=1732786269&x-bz-security-isin=CA03835T3091&x-bz-security-symbol=APTO&x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69" srcSet="https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60&max_width=&width=60&x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv&x-bz-exp=1732786269&x-bz-security-isin=CA03835T3091&x-bz-security-symbol=APTO&x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69 1x, https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60&max_width=&width=60&x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv&x-bz-exp=1732786269&x-bz-security-isin=CA03835T3091&x-bz-security-symbol=APTO&x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69 2x" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain"/></noscript></span></div><div class="flex gap-2 header-left-text items-center"><div class="flex items-center gap-2"><div class="flex flex-col items-start ml-2"><h1 class="quote-name text-bzblue-1000 text-3xl">Aptose Biosciences</h1><div class="flex items-center gap-3 mt-1"><div class="quote-exchange-information flex items-center font-semibold sm:text-sm text-grey-darker"><span class="text-bzgray-900 py-0.5 px-2.5 rounded-full border border-bzblue-400 mr-2">APTO</span><span class="text-bzgray-600">NASDAQ</span></div><div class="hidden md:flex gap-3 mr-2"><div class="md:ml-1 items-center w-full add-to-watchlist-wrapper"><div class="relative w-fit"><div class="inline-flex relative truncate w-full"><button aria-label="Add to watchlist" class="sc-cPtzlb iXXfGA flat-blue md add-to-watchlist-button whitespace-nowrap default" type="button"><span><div class="mr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M287.9 0c9.2 0 17.6 5.2 21.6 13.5l68.6 141.3 153.2 22.6c9 1.3 16.5 7.6 19.3 16.3s.5 18.1-5.9 24.5L433.6 328.4l26.2 155.6c1.5 9-2.2 18.1-9.7 23.5s-17.3 6-25.3 1.7l-137-73.2L151 509.1c-8.1 4.3-17.9 3.7-25.3-1.7s-11.2-14.5-9.7-23.5l26.2-155.6L31.1 218.2c-6.5-6.4-8.7-15.9-5.9-24.5s10.3-14.9 19.3-16.3l153.2-22.6L266.3 13.5C270.4 5.2 278.7 0 287.9 0zm0 79L235.4 187.2c-3.5 7.1-10.2 12.1-18.1 13.3L99 217.9 184.9 303c5.5 5.5 8.1 13.3 6.8 21L171.4 443.7l105.2-56.2c7.1-3.8 15.6-3.8 22.6 0l105.2 56.2L384.2 324.1c-1.3-7.7 1.2-15.5 6.8-21l85.9-85.1L358.6 200.5c-7.8-1.2-14.6-6.1-18.1-13.3L287.9 79z" fill="currentColor"></path></svg></div>Watchlist</span></button></div></div></div><div class="leave-a-comment-wrapper whitespace-nowrap"><div class="flex comments-count-button"><button class="sc-cPtzlb iXXfGA flat-blue md" type="button"><span><div class="mr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M512 240c0 114.9-114.6 208-256 208c-37.1 0-72.3-6.4-104.1-17.9c-11.9 8.7-31.3 20.6-54.3 30.6C73.6 471.1 44.7 480 16 480c-6.5 0-12.3-3.9-14.8-9.9c-2.5-6-1.1-12.8 3.4-17.4l0 0 0 0 0 0 0 0 .3-.3c.3-.3 .7-.7 1.3-1.4c1.1-1.2 2.8-3.1 4.9-5.7c4.1-5 9.6-12.4 15.2-21.6c10-16.6 19.5-38.4 21.4-62.9C17.7 326.8 0 285.1 0 240C0 125.1 114.6 32 256 32s256 93.1 256 208z" fill="currentColor"></path></svg></div>Leave a Comment</span></button></div></div></div></div></div></div></div></div><a class="benzinga-logo-copy text-sm text-blue-500 mt-2" href="https://www.benzinga.com/apis/cloud-product/company-logo-api/" rel="noreferrer noopener" target="_blank">Logo brought to you by Benzinga Data</a></div><span class="md:hidden"><div class="relative w-fit"><div class="inline-flex relative truncate w-full"><button aria-label="Add to watchlist" class="sc-cPtzlb iXXfGA flat-blue sm add-to-watchlist-button whitespace-nowrap compact" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M287.9 0c9.2 0 17.6 5.2 21.6 13.5l68.6 141.3 153.2 22.6c9 1.3 16.5 7.6 19.3 16.3s.5 18.1-5.9 24.5L433.6 328.4l26.2 155.6c1.5 9-2.2 18.1-9.7 23.5s-17.3 6-25.3 1.7l-137-73.2L151 509.1c-8.1 4.3-17.9 3.7-25.3-1.7s-11.2-14.5-9.7-23.5l26.2-155.6L31.1 218.2c-6.5-6.4-8.7-15.9-5.9-24.5s10.3-14.9 19.3-16.3l153.2-22.6L266.3 13.5C270.4 5.2 278.7 0 287.9 0zm0 79L235.4 187.2c-3.5 7.1-10.2 12.1-18.1 13.3L99 217.9 184.9 303c5.5 5.5 8.1 13.3 6.8 21L171.4 443.7l105.2-56.2c7.1-3.8 15.6-3.8 22.6 0l105.2 56.2L384.2 324.1c-1.3-7.7 1.2-15.5 6.8-21l85.9-85.1L358.6 200.5c-7.8-1.2-14.6-6.1-18.1-13.3L287.9 79z" fill="currentColor"></path></svg></div></span></button></div></div></span><div class="quote-actions-desktop"><div class="sc-jQyFEZ gxAabO quote-actions-container bottom-buttons"><div class="sc-hdemLX jcwHna get-report-button flex"><button class="sc-cPtzlb iXXfGA flat-blue md" type="button"><span>Get Report</span></button></div><a data-action="Click Perks" href="https://www.tiicker.com/brand/APTO/perks?utm_campaign=benzinga-perks-button&utm_medium=benzinga-tiicker-pages&utm_source=benzinga-perks" rel="noreferrer nofollow" target="_blank" class="sc-cPtzlb iXXfGA flat-light-blue md perks-button w-full" type="button"><span>Perks</span></a><a href="https://www.benzinga.com/go/start-investing/?pl=buy&utm_source=/quote/APTO" rel="noreferrer" target="_blank" class="sc-cPtzlb iXXfGA flat-light-blue md buy-button block full" type="button"><span>Buy</span></a><a data-action="Compare Brokers Button Click" href="https://www.benzinga.com/money/compare-online-brokers" rel="noreferrer" target="_blank" class="sc-cPtzlb iXXfGA flat-light-blue md compare-brokers-button flex justify-center w-full whitespace-nowrap" type="button"><span>Compare Brokers</span></a></div></div></div><div class="quote-actions-tablet main-div"><div class="sc-jQyFEZ gxAabO quote-actions-container bottom-buttons"><div class="sc-hdemLX jcwHna get-report-button flex"><button class="sc-cPtzlb iXXfGA flat-blue md" type="button"><span>Get Report</span></button></div><a data-action="Click Perks" href="https://www.tiicker.com/brand/APTO/perks?utm_campaign=benzinga-perks-button&utm_medium=benzinga-tiicker-pages&utm_source=benzinga-perks" rel="noreferrer nofollow" target="_blank" class="sc-cPtzlb iXXfGA flat-light-blue md perks-button w-full" type="button"><span>Perks</span></a><a href="https://www.benzinga.com/go/start-investing/?pl=buy&utm_source=/quote/APTO" rel="noreferrer" target="_blank" class="sc-cPtzlb iXXfGA flat-light-blue md buy-button block full" type="button"><span>Buy</span></a><a data-action="Compare Brokers Button Click" href="https://www.benzinga.com/money/compare-online-brokers" rel="noreferrer" target="_blank" class="sc-cPtzlb iXXfGA flat-light-blue md compare-brokers-button flex justify-center w-full whitespace-nowrap" type="button"><span>Compare Brokers</span></a></div></div><div class="main-div flex"><div class="w-full md:w-auto flex flex-col items-center justify-center"><div class="flex flex-wrap gap-2 w-full"><div class="quote-price-data flex items-center gap-x-4 p-4 rounded-md w-full md:w-auto min-h-[84px] bg-bzgray-200 text-bzgray-900 border border-bzgray-400"><div class="text-3xl md:text-5xl text-bzgray-900 leading-none">$0.190000</div><div><div class="quote-change-data flex items-center gap-2 text-base min-h-[26px]"><div class="flex items-center justify-center p-3 rounded w-5 h-5 bg-bzgreen-500/20 text-green-600"><span><svg class="feather feather-arrow-up-right" fill="none" height="20" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="3" viewBox="0 0 24 24" width="20" xmlns="http://www.w3.org/2000/svg"><path d="M7 17L17 7"></path><path d="M7 7L17 7 17 17"></path></svg></span></div><span class="font-bold quote-change text-green-600">0.01</span><span class="px-1 py-[1px] rounded bg-bzgreen-500/20"><span class="font-bold quote-change-percent text-green-600">6.74%</span></span></div><div class="text-bzgray-600 text-sm font-semibold uppercase mt-1">Pre-Market: 4:00 AM EDT</div></div></div></div></div></div><div class="main-div"><div class="w-full my-4"></div></div><div class="main-div md:hidden w-full flex flex-col gap-2 mb-2"><div class="flex gap-2 items-center w-full"><div class="sc-hdemLX jcwHna get-report-button flex"><button class="sc-cPtzlb iXXfGA flat-blue md" type="button"><span>Get Report</span></button></div><div class="flex items-center w-full"><div class="leave-a-comment-wrapper whitespace-nowrap w-full"><div class="flex comments-count-button"><button class="sc-cPtzlb iXXfGA flat-blue md" type="button"><span><div class="mr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M512 240c0 114.9-114.6 208-256 208c-37.1 0-72.3-6.4-104.1-17.9c-11.9 8.7-31.3 20.6-54.3 30.6C73.6 471.1 44.7 480 16 480c-6.5 0-12.3-3.9-14.8-9.9c-2.5-6-1.1-12.8 3.4-17.4l0 0 0 0 0 0 0 0 .3-.3c.3-.3 .7-.7 1.3-1.4c1.1-1.2 2.8-3.1 4.9-5.7c4.1-5 9.6-12.4 15.2-21.6c10-16.6 19.5-38.4 21.4-62.9C17.7 326.8 0 285.1 0 240C0 125.1 114.6 32 256 32s256 93.1 256 208z" fill="currentColor"></path></svg></div>Comment</span></button></div></div></div><button aria-label="Toggle more quote actions" class="sc-cPtzlb iXXfGA flat-light-blue md more-quote-actions-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></span></button></div></div><div class="main-div"><div class="sc-iPOUNt eEFlAV"></div></div><div class="mx-2"><div class="main-quote-tabs-wrapper"><div class="main-quote-tabs"><h2 class="tab active" id="active-tab-item">Aptose Biosciences (APTO) Forecast</h2><a class="tab" href="/quote/APTO/news">News</a><a class="tab" href="/quote/APTO/earnings">Earnings</a><a class="tab" href="/quote/APTO/option-chain">Aptose Biosciences (APTO) Options</a><a class="tab" href="/quote/APTO/guidance">Guidance</a><a class="tab" href="/quote/APTO/dividends">Dividends</a><a class="tab" href="/quote/APTO/analyst-ratings">Analyst Ratings</a><a class="tab" href="/quote/APTO/insider-trades">Insider Trades</a><a class="tab" href="/quote/APTO/short-interest">Short Interest</a></div></div></div></div><div class="quote-page-above-layout-ads"></div><div class="sc-ldPsuV gNOUyV flex flex-col gap-y-8 w-full ml-auto py-4"><div class="main-dev w-full flex gap-4 px-4"><div class="w-full flex flex-col gap-8 md:gap-4"><div class="main-div"></div><div class="main-div flex flex-col gap-2"><div class="sc-fgisPL ftxYyE section-title"><h1>Aptose Biosciences (NASDAQ:APTO) Stock Quotes, Forecast and News Summary</h1></div><p class="section-description">Aptose Biosciences Stock (NASDAQ: APTO) stock price, news, charts, stock research, profile.</p></div><div class="top-area-and-sidebar-container w-full flex mx-auto max-w-[1280px] gap-8 md:gap-4"><div class="w-full lg:w-8/12 flex flex-col gap-8 md:gap-4"><div class=""><div class="w-full flex flex-col gap-8"><div class="w-full flex flex-col lg:flex-row gap-8 md:gap-4"><div class="w-full flex flex-col"><div class="flex flex-col gap-8 md:gap-4"><div class="card flex-grow flex flex-col justify-center min-h-[400px] md:min-h-[500px]"><div class="tradingview-widget-container"><div id="tradingview_f52f1"></div></div></div><div class="metrics-mobile w-full"><table class="w-full h-full"><tbody class="flex flex-col h-full divide-y divide-bzblue-300 px-4 py-2 rounded border border-bzblue-400"><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Open</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Close</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Volume / Avg.</td><td class="value font-bold">112.00 / 755.46K</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Day Range</td><td class="value font-bold">- - -</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">52 Wk Range</td><td class="value font-bold">0.13 - 2.91</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Market Cap</td><td class="value font-bold">$3.71M</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">P/E Ratio</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Dividend Yield</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Exchange</td><td class="value font-bold">NASDAQ</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">RSI</td><td class="value font-bold"><div class="flex items-center gap-4">22<div class="sc-iWHcIr kQRHRb down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div></td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Short Interest</td><td class="value font-bold"><div class="flex items-center gap-4">0.75% <div class="sc-iWHcIr kQRHRb up"><div style="color:#30bf60"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 34.8c-38.2-10.9-78.1 11.2-89 49.4l-5.7 20c-3.7 13-10.4 25-19.5 35l-51.3 56.4c-8.9 9.8-8.2 25 1.6 33.9s25 8.2 33.9-1.6l51.3-56.4c14.1-15.5 24.4-34 30.1-54.1l5.7-20c3.6-12.7 16.9-20.1 29.7-16.5s20.1 16.9 16.5 29.7l-5.7 20c-5.7 19.9-14.7 38.7-26.6 55.5c-5.2 7.3-5.8 16.9-1.7 24.9s12.3 13 21.3 13L448 224c8.8 0 16 7.2 16 16c0 6.8-4.3 12.7-10.4 15c-7.4 2.8-13 9-14.9 16.7s.1 15.8 5.3 21.7c2.5 2.8 4 6.5 4 10.6c0 7.8-5.6 14.3-13 15.7c-8.2 1.6-15.1 7.3-18 15.2s-1.6 16.7 3.6 23.3c2.1 2.7 3.4 6.1 3.4 9.9c0 6.7-4.2 12.6-10.2 14.9c-11.5 4.5-17.7 16.9-14.4 28.8c.4 1.3 .6 2.8 .6 4.3c0 8.8-7.2 16-16 16H286.5c-12.6 0-25-3.7-35.5-10.7l-61.7-41.1c-11-7.4-25.9-4.4-33.3 6.7s-4.4 25.9 6.7 33.3l61.7 41.1c18.4 12.3 40 18.8 62.1 18.8H384c34.7 0 62.9-27.6 64-62c14.6-11.7 24-29.7 24-50c0-4.5-.5-8.8-1.3-13c15.4-11.7 25.3-30.2 25.3-51c0-6.5-1-12.8-2.8-18.7C504.8 273.7 512 257.7 512 240c0-35.3-28.6-64-64-64l-92.3 0c4.7-10.4 8.7-21.2 11.8-32.2l5.7-20c10.9-38.2-11.2-78.1-49.4-89zM32 192c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32H96c17.7 0 32-14.3 32-32V224c0-17.7-14.3-32-32-32H32z" fill="currentColor"></path></svg></div></div></div></td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Days to Cover</td><td class="value font-bold">1.56</td></tr></tbody></table></div></div></div></div><div class="w-full"><div class="flex flex-col"><div class="sc-dIQvSy eAJogp news-tab-and-ads-wrapper w-full flex flex-col lg:flex-row gap-8 md:gap-4"><div class="sc-jGeVcH kgFmXr w-full"><div class="sc-gopctv kqzvuv tabs-container pill-variant"><div class="tab-list-wrapper"><div class="flex items-center whitespace-nowrap mr-4 recent-news-title"><div class="sc-fgisPL iMnyge section-title leading-none"><h3>Recent News</h3></div></div><div class="tab-list"><button class="tab active" name="News">News</button><button class="tab" name="Partners">Partners</button><button class="tab" name="Press Releases">Press Releases</button></div></div><div class="tabs-content"><div class="tab-content selected"><div class="sc-gkFsFt fyUiDy flex flex-col"><div class="quote-news-list"><div class="sc-emhixo bRJFnU content-feed "><div class="content-feed-container"><div class="content-feed-list"><div class="quote-news-item bg-[#F2F8FF66] border border-bzblue-400 rounded p-4"><div class="sc-hwDNbq djKghV news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42158698/why-uxin-shares-are-trading-higher-here-are-20-stocks-moving-premarket"><div class="sc-nqTvk jzrfof article-title"><span>Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket</span></div><div class="sc-nqTvk jzrfof article-teaser"><span> </span></div></a><div><span class="article-author text-sm font-semibold mr-2">Avi Kapoor</span><div class="flex items-center"><div class="sc-gfCqec hQVzmp"></div></div></div></div></div></div></div><div class="absolute" style="height:1px;width:1px"></div></div><div class="quote-news-item bg-[#F2F8FF66] border border-bzblue-400 rounded p-4"><div class="sc-hwDNbq djKghV news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42145950/s-intuit-shares-fall-following-q1-results"><div class="sc-nqTvk jzrfof article-title"><span>S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results</span></div><div class="sc-nqTvk jzrfof article-teaser"><span> </span></div></a><div><span class="article-author text-sm font-semibold mr-2">Avi Kapoor</span><div class="flex items-center"><div class="sc-gfCqec hQVzmp"></div></div></div></div></div></div></div><div class="absolute" style="height:1px;width:1px"></div></div><div class="quote-news-item bg-[#F2F8FF66] border border-bzblue-400 rounded p-4"><div class="sc-hwDNbq djKghV news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42144711/crude-oil-gains-over-1-ross-stores-earnings-top-views"><div class="sc-nqTvk jzrfof article-title"><span>Crude Oil Gains Over 1%; Ross Stores Earnings Top Views</span></div><div class="sc-nqTvk jzrfof article-teaser"><span> </span></div></a><div><span class="article-author text-sm font-semibold mr-2">Avi Kapoor</span><div class="flex items-center"><div class="sc-gfCqec hQVzmp"></div></div></div></div></div></div></div><div class="absolute" style="height:1px;width:1px"></div></div></div><div class="mt-8"><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div></div></div></div></div></div></div><div class="tab-content"><div class="lazyload-wrapper "><div style="height:400px" class="lazyload-placeholder"></div></div></div><div class="tab-content"><div class="lazyload-wrapper "><div style="height:400px" class="lazyload-placeholder"></div></div></div></div></div></div></div></div></div></div></div><div class="main-div"><div class="flex gap-2 items-center mb-3"><div class="sc-fgisPL iMnyge section-title"><h3>Financials</h3></div></div><div class="flex flex-col gap-8 md:gap-4 lg:flex-row"><div class="w-full flex flex-col gap-8 md:gap-4"><div class="sc-jIOndm jzzteW"><div class="card"><div class="flex justify-between items-center"><div class="simple-tab-wrapper"></div><div class="simple-tab-wrapper"><div class="simple-tab active"><div class="simple-tab-text">Quarterly</div></div><div class="simple-tab "><div class="simple-tab-text">Annual</div></div></div></div><div style="height:325px;overflow:hidden;width:100%" class="echarts-for-react chart-body mt-4 z-[1]"></div><div class="divider my-4"></div><table class="w-full"><thead><tr class="table-row"><th class="table-title">Name</th></tr></thead><tbody class="mt-2"><tr><td><div class="mt-2 divider"></div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">Revenue</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">Gross</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">EBITDA</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">EBIT</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">Earnings</div><div class="table-cell-subtitle">Change</div></td></tr></tbody></table></div></div><div class="flex flex-col md:flex-row gap-8 md:gap-4 w-full"><div class="analyst-rating-bar-chart card flex flex-col flex-1"><h6 class="font-bold mb-4">Analyst Trends and Forecast</h6><div class="flex gap-5 md:gap-8 mt-auto mx-auto"><div class="flex h-[200px]"><div class="sc-iBpinA sc-cNGRH ilZWRW kEZlwm flex flex-col items-center h-full w-full w-[48px] md:w-[50px] rounded overflow-hidden"><div class="color-box buy" style="height:100%"><span class="leading-none">1</span></div><div class="color-box hold" style="height:0"><span class="leading-none"> </span></div><div class="color-box sell" style="height:0"><span class="leading-none"> </span></div><div class="color-box strong_sell" style="height:0"><span class="leading-none"> </span></div><div class="font-normal whitespace-nowrap text-center text-sm p-2 text-gray-700 mt-auto">Jun</div></div></div><div class="flex h-[200px]"><div class="sc-iBpinA sc-cNGRH ilZWRW kEZlwm flex flex-col items-center h-full w-full w-[48px] md:w-[50px] rounded overflow-hidden"><div class="color-box buy" style="height:100%"><span class="leading-none">1</span></div><div class="color-box hold" style="height:0"><span class="leading-none"> </span></div><div class="color-box sell" style="height:0"><span class="leading-none"> </span></div><div class="color-box strong_sell" style="height:0"><span class="leading-none"> </span></div><div class="font-normal whitespace-nowrap text-center text-sm p-2 text-gray-700 mt-auto">Nov</div></div></div></div><div class="mt-2 lg:ml-0"><div class="sc-czPwHC ktMpoo flex items-center justify-center gap-4 lg:gap-2 p-1 flex-wrap"><div class="flex items-center gap-2"><div class="color-key-box" style="background:#30BF60"></div><div class="text-sm">Buy</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FFD644"></div><div class="text-sm">Hold</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF9244"></div><div class="text-sm">Sell</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF4050"></div><div class="text-sm">Strong Sell</div></div></div></div></div><div class="sc-kqpPGb dVtUSe analyst-rating-semi-circle-chart card flex-1"><div class="flex items-center gap-2 mb-4"><h6 class="font-bold">Analyst Rating and Forecast</h6><div class="sc-glxhRN knMeVD tooltip-container hover" id="tooltip-container"><div class="info-circle-icon text-sm flex items-center justify-center"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M256 512A256 256 0 1 0 256 0a256 256 0 1 0 0 512zM216 336h24V272H216c-13.3 0-24-10.7-24-24s10.7-24 24-24h48c13.3 0 24 10.7 24 24v88h8c13.3 0 24 10.7 24 24s-10.7 24-24 24H216c-13.3 0-24-10.7-24-24s10.7-24 24-24zm40-208a32 32 0 1 1 0 64 32 32 0 1 1 0-64z" fill="currentColor"></path></svg></div></div></div><div class="w-full max-w-[420px] mx-auto"><div class="box gauge--3 relative"><div class="container gauge-background"><div><svg viewBox="0 0 100 55" xmlns="http://www.w3.org/2000/svg"><defs><linearGradient id="linear" x1="0%" x2="100%" y1="0%" y2="0%"><stop offset="0%" stop-color="#EF4444"></stop><stop offset="25%" stop-color="#F97316"></stop><stop offset="50%" stop-color="#FFD644"></stop><stop offset="75%" stop-color="#84CC16"></stop><stop offset="100%" stop-color="#30BF60"></stop></linearGradient></defs><path d="M10,50 A40,40 0 1,1 90,50" fill="none" stroke="#E1EAF9" stroke-dasharray="0" stroke-dashoffset="0" stroke-linecap="round" stroke-width="8"></path><path d="M10,50 A40,40 0 1,1 90,50" fill="none" stroke="url(#linear)" stroke-dasharray="128.4911395318225" stroke-linecap="round" stroke-width="8" style="stroke-dashoffset:21.10925863737082"></path><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="10" cy="50" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="10" y="50.25">1</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="20.25" cy="23" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="20.25" y="23.25">2</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="50" cy="10" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="50" y="10.25">3</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="80" cy="23" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="80" y="23.25">4</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="90" cy="50" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="90" y="50.25">5</text></g></svg></div></div><div class="analyst-rating-score buy flex flex-col items-center justify-center absolute bottom-[-30px] left-1/2 -translate-y-2/4 -translate-x-2/4 z-[2]"><div class="analyst-rating-score-circle text-white font-bold rounded-full w-12 h-12 text-center flex items-center justify-center">4.3</div><span class="analyst-rating-label rounded-full font-bold text-sm z-[2] -mt-2 py-0.5 px-2 min-w-[60px] text-center">Buy</span></div></div></div><div class="mt-2 lg:ml-0"><div class="sc-czPwHC ktMpoo flex items-center justify-center gap-4 lg:gap-2 p-1 flex-wrap"><div class="flex items-center gap-2"><div class="color-key-box" style="background:#30BF60"></div><div class="text-sm">Strong Buy</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#91DBB0"></div><div class="text-sm">Buy</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FFD644"></div><div class="text-sm">Hold</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF9244"></div><div class="text-sm">Sell</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF4050"></div><div class="text-sm">Strong Sell</div></div></div></div></div></div></div></div></div></div><div class="w-full lg:w-4/12 flex flex-col items-center gap-8 md:gap-4"><div class="metrics-desktop w-full"><table class="w-full h-full"><tbody class="flex flex-col h-full divide-y divide-bzblue-300 px-4 py-2 rounded border border-bzblue-400"><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Open</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Close</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Volume / Avg.</td><td class="value font-bold">112.00 / 755.46K</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Day Range</td><td class="value font-bold">- - -</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">52 Wk Range</td><td class="value font-bold">0.13 - 2.91</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Market Cap</td><td class="value font-bold">$3.71M</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">P/E Ratio</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Dividend Yield</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Exchange</td><td class="value font-bold">NASDAQ</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">RSI</td><td class="value font-bold"><div class="flex items-center gap-4">22<div class="sc-iWHcIr kQRHRb down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div></td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Short Interest</td><td class="value font-bold"><div class="flex items-center gap-4">0.75% <div class="sc-iWHcIr kQRHRb up"><div style="color:#30bf60"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 34.8c-38.2-10.9-78.1 11.2-89 49.4l-5.7 20c-3.7 13-10.4 25-19.5 35l-51.3 56.4c-8.9 9.8-8.2 25 1.6 33.9s25 8.2 33.9-1.6l51.3-56.4c14.1-15.5 24.4-34 30.1-54.1l5.7-20c3.6-12.7 16.9-20.1 29.7-16.5s20.1 16.9 16.5 29.7l-5.7 20c-5.7 19.9-14.7 38.7-26.6 55.5c-5.2 7.3-5.8 16.9-1.7 24.9s12.3 13 21.3 13L448 224c8.8 0 16 7.2 16 16c0 6.8-4.3 12.7-10.4 15c-7.4 2.8-13 9-14.9 16.7s.1 15.8 5.3 21.7c2.5 2.8 4 6.5 4 10.6c0 7.8-5.6 14.3-13 15.7c-8.2 1.6-15.1 7.3-18 15.2s-1.6 16.7 3.6 23.3c2.1 2.7 3.4 6.1 3.4 9.9c0 6.7-4.2 12.6-10.2 14.9c-11.5 4.5-17.7 16.9-14.4 28.8c.4 1.3 .6 2.8 .6 4.3c0 8.8-7.2 16-16 16H286.5c-12.6 0-25-3.7-35.5-10.7l-61.7-41.1c-11-7.4-25.9-4.4-33.3 6.7s-4.4 25.9 6.7 33.3l61.7 41.1c18.4 12.3 40 18.8 62.1 18.8H384c34.7 0 62.9-27.6 64-62c14.6-11.7 24-29.7 24-50c0-4.5-.5-8.8-1.3-13c15.4-11.7 25.3-30.2 25.3-51c0-6.5-1-12.8-2.8-18.7C504.8 273.7 512 257.7 512 240c0-35.3-28.6-64-64-64l-92.3 0c4.7-10.4 8.7-21.2 11.8-32.2l5.7-20c10.9-38.2-11.2-78.1-49.4-89zM32 192c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32H96c17.7 0 32-14.3 32-32V224c0-17.7-14.3-32-32-32H32z" fill="currentColor"></path></svg></div></div></div></td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Days to Cover</td><td class="value font-bold">1.56</td></tr></tbody></table></div><div class="flex flex-col gap-8 md:gap-4 px-4 md:mt-4"><div class="min-h-[220px] w-full"></div></div></div></div><div class="main-div"><div class="flex gap-2 items-center mb-4"><div class="sc-fgisPL iMnyge section-title"><h3>Compare</h3></div></div><div class="sc-bdoPik kJGCHJ"><div class="flex flex-col gap-8 md:gap-4 w-full md:hidden"><div><button class="compare-tab active"><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="sc-iWHcIr kQRHRb down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div><div class="compare-tab__label font-bold">EPS</div><div class="compare-tab__value inverse">$-0.37</div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 111c9.4-9.4 24.6-9.4 33.9 0L465 303c9.4 9.4 9.4 24.6 0 33.9s-24.6 9.4-33.9 0l-175-175L81 337c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9L239 111z" fill="currentColor"></path></svg></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE dWAhon"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button><div class="tab-content w-full"><div class="flex flex-col items-start w-full gap-2"><div class="flex items-center gap-2"><div class="rounded-lg p-2 red-chip"><div class="text-xs whitespace-nowrap label-text">EPS worse than industry</div></div><div class="sc-iWHcIr kQRHRb down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div><div><div class="font-bold text-lg text-gray-600 mb-2 tab-title">Earnings Per Share</div><div class="text-gray-600 text-md tab-description">EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.</div></div></div><div class="sc-iTPigJ izTmBY flex flex-col-reverse md:flex-row w-full mt-4"><div class="w-full lg:w-9/12 z-[1]"><div style="height:375px;width:100%" class="echarts-for-react chart-body"></div></div><div class="w-full lg:w-3/12"><div class="symbol-menu h-full border border-b-0 md:border-b-1 md:border-l-0"><div class="searchbar border-b"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M248 72c0-13.3-10.7-24-24-24s-24 10.7-24 24V232H40c-13.3 0-24 10.7-24 24s10.7 24 24 24H200V440c0 13.3 10.7 24 24 24s24-10.7 24-24V280H408c13.3 0 24-10.7 24-24s-10.7-24-24-24H248V72z" fill="currentColor"></path></svg></div><div class="sc-cieYuS cfstRH searchbar-wrapper searchbar-box"><div class="sc-vZZzB eZXymS searchbar-container"><div class="sc-ifVVRW kOhchH search-input-container"><div class="sc-gUDIDV fcPNlb search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Compare" role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div><div class="flex flex-col overflow-y-auto max-h-[310px]"><div class="symbol-entry justify-between"><div class="flex items-center gap-2"><div class="symbol-pill-dot" style="background-color:#1060FF"></div><div class="symbol-pill">APTO</div></div></div></div></div></div></div></div></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">P/E</div><div class="compare-tab__value "></div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE iaCkFP"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">P/B</div><div class="compare-tab__value "></div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE iaCkFP"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">ROE</div><div class="compare-tab__value inverse"></div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE dWAhon"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">D/E</div><div class="compare-tab__value "></div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE iaCkFP"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button></div></div><div class="hidden md:block"><div class="tabs-row flex items-center gap-4 wrap"><button class="compare-tab active"><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">EPS</div><div class="compare-tab__value inverse">$-0.37</div></div><div class="sc-iWHcIr kQRHRb down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE dWAhon"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">P/E</div><div class="compare-tab__value "></div></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE iaCkFP"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">P/B</div><div class="compare-tab__value "></div></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE iaCkFP"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">ROE</div><div class="compare-tab__value inverse"></div></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE dWAhon"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">D/E</div><div class="compare-tab__value "></div></div></div><div class="sc-dXIwAT dDpTqW"><div class="sc-jFWsBE iaCkFP"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button></div><div class="tab-content w-full"><div class="flex items-center justify-between w-full"><div><div class="font-bold text-lg text-gray-600 mb-2 tab-title">Earnings Per Share</div><div class="text-gray-600 text-md tab-description">EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.</div></div><div class="flex items-center gap-2"><div class="rounded p-2 red-chip"><div class="text-xs whitespace-nowrap label-text">EPS worse than industry</div></div><div class="sc-iWHcIr kQRHRb down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div></div><div class="sc-iTPigJ izTmBY flex flex-col-reverse md:flex-row w-full mt-4"><div class="w-full lg:w-9/12 z-[1]"><div style="height:375px;width:100%" class="echarts-for-react chart-body"></div></div><div class="w-full lg:w-3/12"><div class="symbol-menu h-full border border-b-0 md:border-b-1 md:border-l-0"><div class="searchbar border-b"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M248 72c0-13.3-10.7-24-24-24s-24 10.7-24 24V232H40c-13.3 0-24 10.7-24 24s10.7 24 24 24H200V440c0 13.3 10.7 24 24 24s24-10.7 24-24V280H408c13.3 0 24-10.7 24-24s-10.7-24-24-24H248V72z" fill="currentColor"></path></svg></div><div class="sc-cieYuS cfstRH searchbar-wrapper searchbar-box"><div class="sc-vZZzB eZXymS searchbar-container"><div class="sc-ifVVRW kOhchH search-input-container"><div class="sc-gUDIDV fcPNlb search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Compare" role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div><div class="flex flex-col overflow-y-auto max-h-[310px]"><div class="symbol-entry justify-between"><div class="flex items-center gap-2"><div class="symbol-pill-dot" style="background-color:#1060FF"></div><div class="symbol-pill">APTO</div></div></div></div></div></div></div></div></div></div></div><div class="main-div"><div class="flex flex-col gap-8 md:gap-4 lg:flex-row"><div class="w-full lg:w-9/12"><div class="sc-fgisPL iTzbfE section-title text-2xl"><h3>FAQ</h3></div><div class="mt-6 mb-1"><div class="sc-dXGmlw cvbRHX faq-container"><div class="sc-jUULvF dOUStP faq-block"><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">How do I buy Aptose Biosciences (APTO) stock?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>You can purchase shares of Aptose Biosciences (NASDAQ:APTO) through any online brokerage.</p><p><a href="https://www.benzinga.com/money/online-stock-trading/" rel="noreferrer" target="_blank">View our list of the best stock brokerages</a></p></div></div></div><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">Who are Aptose Biosciences (APTO) competitors?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>There are no as such competitors for Aptose Biosciences.</p></div></div></div><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">What is the forecast, or price target, for Aptose Biosciences (APTO) stock?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>Aptose Biosciences has a consensus price target of $13.14.</p></div></div></div><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">What is the current price for Aptose Biosciences (APTO)?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>The stock price for Aptose Biosciences (NASDAQ: APTO) is $0.19 last updated November 27, 2024 at 4:00 AM EST.</p></div></div></div><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">Does Aptose Biosciences (APTO) pay a dividend?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>There are no upcoming dividends for Aptose Biosciences.</p></div></div></div><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">When is Aptose Biosciences (NASDAQ:APTO) reporting earnings?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>Aptose Biosciences’s Q3 earnings are confirmed for Friday, November 8, 2024.</p></div></div></div><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">Is Aptose Biosciences (APTO) going to split?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>There is no upcoming split for Aptose Biosciences.</p></div></div></div><div class="sc-jKBaTn iDWzoL qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">What sector and industry does Aptose Biosciences (APTO) operate in?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>Aptose Biosciences is in the <b>Healthcare</b> sector and <b>Biotechnology</b> industry. They are listed on the NASDAQ.</p></div></div></div></div></div></div></div></div></div><div class="main-div px-50"><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div></div></div></div></div></div><div class="footer"><div class="footer-top-section"><div class="benzinga-links-section"><div class="logo-and-socials-wrapper"><span class="sc-eRxdlV jnspZt benzinga-logo light presentation"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span><div class="social-sites-list"><a aria-label="Click to check out Benzinga's facebook" class="sc-iFEMmm fgxyIy facebook" color="#3b5998" href="https://web.facebook.com/Benzinga/?_rdc=1&_rdr" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64h98.2V334.2H109.4V256h52.8V222.3c0-87.1 39.4-127.5 125-127.5c16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1c-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H255V480H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's instagram" class="sc-iFEMmm XrAQw instagram" color="#e1306c" href="https://www.instagram.com/benzinga/?hl=en" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's linkedin" class="sc-iFEMmm cjvdFo linkedin" color="#0072b1" href="https://www.linkedin.com/company/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's soundcloud" class="sc-iFEMmm jlbEXg soundcloud" color="#fe5000" href="https://soundcloud.com/bztv" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 640 512" xmlns="http://www.w3.org/2000/svg"><path d="M111.4 256.3l5.8 65-5.8 68.3c-.3 2.5-2.2 4.4-4.4 4.4s-4.2-1.9-4.2-4.4l-5.6-68.3 5.6-65c0-2.2 1.9-4.2 4.2-4.2 2.2 0 4.1 2 4.4 4.2zm21.4-45.6c-2.8 0-4.7 2.2-5 5l-5 105.6 5 68.3c.3 2.8 2.2 5 5 5 2.5 0 4.7-2.2 4.7-5l5.8-68.3-5.8-105.6c0-2.8-2.2-5-4.7-5zm25.5-24.1c-3.1 0-5.3 2.2-5.6 5.3l-4.4 130 4.4 67.8c.3 3.1 2.5 5.3 5.6 5.3 2.8 0 5.3-2.2 5.3-5.3l5.3-67.8-5.3-130c0-3.1-2.5-5.3-5.3-5.3zM7.2 283.2c-1.4 0-2.2 1.1-2.5 2.5L0 321.3l4.7 35c.3 1.4 1.1 2.5 2.5 2.5s2.2-1.1 2.5-2.5l5.6-35-5.6-35.6c-.3-1.4-1.1-2.5-2.5-2.5zm23.6-21.9c-1.4 0-2.5 1.1-2.5 2.5l-6.4 57.5 6.4 56.1c0 1.7 1.1 2.8 2.5 2.8s2.5-1.1 2.8-2.5l7.2-56.4-7.2-57.5c-.3-1.4-1.4-2.5-2.8-2.5zm25.3-11.4c-1.7 0-3.1 1.4-3.3 3.3L47 321.3l5.8 65.8c.3 1.7 1.7 3.1 3.3 3.1 1.7 0 3.1-1.4 3.1-3.1l6.9-65.8-6.9-68.1c0-1.9-1.4-3.3-3.1-3.3zm25.3-2.2c-1.9 0-3.6 1.4-3.6 3.6l-5.8 70 5.8 67.8c0 2.2 1.7 3.6 3.6 3.6s3.6-1.4 3.9-3.6l6.4-67.8-6.4-70c-.3-2.2-2-3.6-3.9-3.6zm241.4-110.9c-1.1-.8-2.8-1.4-4.2-1.4-2.2 0-4.2.8-5.6 1.9-1.9 1.7-3.1 4.2-3.3 6.7v.8l-3.3 176.7 1.7 32.5 1.7 31.7c.3 4.7 4.2 8.6 8.9 8.6s8.6-3.9 8.6-8.6l3.9-64.2-3.9-177.5c-.4-3-2-5.8-4.5-7.2zm-26.7 15.3c-1.4-.8-2.8-1.4-4.4-1.4s-3.1.6-4.4 1.4c-2.2 1.4-3.6 3.9-3.6 6.7l-.3 1.7-2.8 160.8s0 .3 3.1 65.6v.3c0 1.7.6 3.3 1.7 4.7 1.7 1.9 3.9 3.1 6.4 3.1 2.2 0 4.2-1.1 5.6-2.5 1.7-1.4 2.5-3.3 2.5-5.6l.3-6.7 3.1-58.6-3.3-162.8c-.3-2.8-1.7-5.3-3.9-6.7zm-111.4 22.5c-3.1 0-5.8 2.8-5.8 6.1l-4.4 140.6 4.4 67.2c.3 3.3 2.8 5.8 5.8 5.8 3.3 0 5.8-2.5 6.1-5.8l5-67.2-5-140.6c-.2-3.3-2.7-6.1-6.1-6.1zm376.7 62.8c-10.8 0-21.1 2.2-30.6 6.1-6.4-70.8-65.8-126.4-138.3-126.4-17.8 0-35 3.3-50.3 9.4-6.1 2.2-7.8 4.4-7.8 9.2v249.7c0 5 3.9 8.6 8.6 9.2h218.3c43.3 0 78.6-35 78.6-78.3.1-43.6-35.2-78.9-78.5-78.9zm-296.7-60.3c-4.2 0-7.5 3.3-7.8 7.8l-3.3 136.7 3.3 65.6c.3 4.2 3.6 7.5 7.8 7.5 4.2 0 7.5-3.3 7.5-7.5l3.9-65.6-3.9-136.7c-.3-4.5-3.3-7.8-7.5-7.8zm-53.6-7.8c-3.3 0-6.4 3.1-6.4 6.7l-3.9 145.3 3.9 66.9c.3 3.6 3.1 6.4 6.4 6.4 3.6 0 6.4-2.8 6.7-6.4l4.4-66.9-4.4-145.3c-.3-3.6-3.1-6.7-6.7-6.7zm26.7 3.4c-3.9 0-6.9 3.1-6.9 6.9L227 321.3l3.9 66.4c.3 3.9 3.1 6.9 6.9 6.9s6.9-3.1 6.9-6.9l4.2-66.4-4.2-141.7c0-3.9-3-6.9-6.9-6.9z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's twitter" class="sc-iFEMmm jldMrO twitter" color="#000000" href="https://twitter.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64zm297.1 84L257.3 234.6 379.4 396H283.8L209 298.1 123.3 396H75.8l111-126.9L69.7 116h98l67.7 89.5L313.6 116h47.5zM323.3 367.6L153.4 142.9H125.1L296.9 367.6h26.3z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's youtube" class="sc-iFEMmm gXlNji youtube" color="red" href="https://www.youtube.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M549.655 124.083c-6.281-23.65-24.787-42.276-48.284-48.597C458.781 64 288 64 288 64S117.22 64 74.629 75.486c-23.497 6.322-42.003 24.947-48.284 48.597-11.412 42.867-11.412 132.305-11.412 132.305s0 89.438 11.412 132.305c6.281 23.65 24.787 41.5 48.284 47.821C117.22 448 288 448 288 448s170.78 0 213.371-11.486c23.497-6.321 42.003-24.171 48.284-47.821 11.412-42.867 11.412-132.305 11.412-132.305s0-89.438-11.412-132.305zm-317.51 213.508V175.185l142.739 81.205-142.739 81.201z" fill="currentColor"></path></svg></div></a></div></div><div class="app-store-wrapper"><a aria-label="Click to download the Benzinga app" class="sc-dnxBXz brbZLb google-play-store-button-wrapper button-wrapper" data-action="Download on Google Play Store Click" href="https://play.google.com/store/apps/details?id=com.benzinga.app&hl=en_NZ&gl=US"><svg clip-rule="evenodd" fill-rule="evenodd" height="39px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 36" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M2863.6 530.6c-36.3 0-66.9-12.7-91.1-37.7-24-24.3-37.4-57.8-36.8-92 0-36.5 12.4-67.4 36.8-91.9 24.1-25 54.7-37.7 91-37.7 35.9 0 66.5 12.7 91.1 37.7 24.4 25.3 36.8 56.2 36.8 91.9-.4 36.6-12.8 67.5-36.8 91.9-24.1 25.2-54.7 37.8-91 37.8zm-1080.1 0c-35.5 0-66.3-12.5-91.5-37.2-25-24.6-37.7-55.7-37.7-92.4s12.7-67.8 37.7-92.4c24.7-24.7 55.5-37.2 91.5-37.2a127.533 127.533 0 0151.1 10.6c16.1 6.9 29.2 16.3 38.9 27.8l2.4 2.9-27.1 26.6-2.8-3.3c-15.3-18.2-35.8-27.1-62.9-27.1-24.2 0-45.3 8.6-62.7 25.6-17.5 17.1-26.4 39.5-26.4 66.6 0 27.1 8.9 49.5 26.4 66.6 17.4 17 38.5 25.6 62.7 25.6 25.8 0 47.5-8.6 64.4-25.6 10-10 16.2-24 18.4-41.7H1779v-37.4h124.2l.5 3.4c.9 6.3 1.8 12.8 1.8 18.8 0 34.5-10.4 62.4-31 83-23.4 24.4-54 36.8-91 36.8zm1436.1-5.3h-38.3L3064 337.6l1 33.8v153.8h-38.3V276.7h43.7l1.2 1.9 110.3 176.8-1-33.7v-145h38.7v248.6zm-643.8 0H2537V314.1h-67.3v-37.4H2643v37.4h-67.3v211.2h.1zm-137.7 0h-38.7V276.7h38.7v248.6zm-217.5 0h-38.7V314.1h-67.3v-37.4h173.3v37.4h-67.3v211.2zm-130.5-.4h-148.4V276.7h148.4v37.4h-109.6v68.2h98.9v37h-98.9v68.2h109.6v37.4zm710.8-57.7c17.3 17.3 38.3 26 62.7 26 25.1 0 45.6-8.5 62.7-26 17-17 25.6-39.3 25.6-66.2 0-26.9-8.6-49.3-25.5-66.2-17.3-17.3-38.4-26-62.7-26-25.1 0-45.6 8.5-62.6 26-17 17-25.6 39.3-25.6 66.2 0 26.9 8.5 49.3 25.4 66.2zM2732.1 872.4c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.6-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4.1 61-44.5 103.4-96.2 103.4zm-373.3-273.6c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.7-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4 0 61-44.5 103.4-96.2 103.4zm-444.2-221.5v72.2h173.3c-5.3 40.5-18.7 70.4-39.2 90.9-25.4 25.4-64.6 53-133.7 53-106.5 0-189.8-86-189.8-192.5s83.3-192.5 189.8-192.5c57.5 0 99.4 22.7 130.5 51.7l51.2-51.2c-43.2-41.4-100.7-73.1-181.3-73.1-146.1 0-268.7 119-268.7 264.7 0 146.1 122.5 264.7 268.7 264.7 78.9 0 138.1-25.8 184.9-74.4 47.7-47.7 62.8-115 62.8-169.3 0-16.9-1.3-32.1-4-45h-244.6c.1-.1.1.8.1.8zm1816.9 56.2C3717.2 942.4 3674 872 3585.4 872c-87.8 0-160.8 69.1-160.8 170.6 0 95.8 72.2 170.6 169.3 170.6 78 0 123.4-47.7 142.1-75.7l-57.9-38.8c-19.2 28.5-45.9 47.2-83.8 47.2-38.3 0-65.1-17.4-82.9-51.7l228.1-94.5c0 .1-8-19-8-19zm-232.6 57c-1.8-65.9 51.2-99.4 89.1-99.4 29.9 0 54.8 14.7 63.3 36.1l-152.4 63.3zM3313.6 1203h74.9V701.8h-74.9V1203zm-123-292.7h-2.7c-16.9-20.1-49-38.3-90-38.3-85.1 0-163.5 74.9-163.5 171.1 0 95.8 78 169.8 163.5 169.8 40.5 0 73.1-18.3 90-38.8h2.7v24.5c0 65.1-34.8 100.2-90.9 100.2-45.9 0-74.4-33-86-60.6l-65.1 27.2c18.7 45 68.6 100.7 151 100.7 87.8 0 162.2-51.7 162.2-177.8V882.2H3191v28.1h-.4zm-86 235.7c-51.7 0-94.9-43.2-94.9-102.9 0-60.2 43.2-103.8 94.9-103.8 51.2 0 90.9 44.1 90.9 103.8.5 59.7-39.6 102.9-90.9 102.9zm977.6-444.2h-179.1V1203h74.9v-189.8h104.3c82.9 0 164.4-60.1 164.4-155.5s-81.2-155.9-164.5-155.9zm2.2 241.4h-106.5v-172h106.5c56.1 0 87.8 46.3 87.8 86 0 39.3-32.1 86-87.8 86zm462.5-71.7c-54.4 0-110.5 24.1-133.7 76.6l66.4 27.6c14.3-27.6 40.5-37 68.2-37 38.8 0 78 23.2 78.9 64.6v5.3c-13.4-7.6-42.8-19.2-78-19.2-71.7 0-144.4 39.2-144.4 112.7 0 67.3 58.8 110.5 124.3 110.5 50.3 0 78-22.7 95.3-49h2.7v38.8h72.2v-192c0-89.4-66.4-138.9-151.9-138.9zm-9.4 274.5c-24.5 0-58.8-12-58.8-42.8 0-38.8 42.8-53.5 79.3-53.5 33 0 48.6 7.1 68.2 16.9-5.4 45-43.4 79-88.7 79.4zm424.7-263.8l-86 217.4h-2.7l-89.1-217.4h-80.6l133.7 303.9-76.2 168.9h78L5045 882.2h-82.8zM4288 1203h74.9V701.8H4288V1203zM418.4 302.1c-11.6 12.5-18.3 31.6-18.3 56.6v886.7c0 25 6.7 44.1 18.7 56.1l3.1 2.7 496.8-496.8v-11.1L421.5 299.4l-3.1 2.7z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1084 973.5L918.3 807.8v-11.6L1084 630.5l3.6 2.2 196 111.4c56.1 31.6 56.1 83.8 0 115.8l-196 111.4-3.6 2.2z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1087.6 971.3L918.3 802l-499.9 499.9c18.3 19.6 49 21.8 83.3 2.7l585.9-333.3M1087.6 632.7L501.7 299.9c-34.3-19.6-65.1-16.9-83.3 2.7L918.3 802l169.3-169.3z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path></svg></a><a aria-label="Click to download the Benzinga app" class="sc-dnxBXz brbZLb apple-app-store-button-wrapper button-wrapper" data-action="Download on Apple App Store Click" href="https://apps.apple.com/us/app/benzinga-stock-news-tracker/id688949481"><svg fill="#0c2140" height="43.3px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 40" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M24.997 19.889a5.15 5.15 0 012.45-4.317 5.27 5.27 0 00-4.15-2.244c-1.746-.183-3.439 1.045-4.329 1.045-.907 0-2.277-1.027-3.753-.997a5.534 5.534 0 00-4.651 2.837c-2.011 3.482-.511 8.6 1.416 11.414.963 1.378 2.09 2.918 3.564 2.863 1.442-.06 1.981-.919 3.722-.919 1.725 0 2.231.919 3.734.885 1.548-.026 2.523-1.385 3.453-2.776a11.366 11.366 0 001.579-3.216 4.98 4.98 0 01-3.035-4.575zm-2.841-8.412a5.066 5.066 0 001.159-3.63 5.153 5.153 0 00-3.335 1.726 4.82 4.82 0 00-1.19 3.495 4.265 4.265 0 003.366-1.591zM42.302 27.14h-4.734l-1.136 3.356h-2.005l4.483-12.418h2.083l4.484 12.418h-2.039l-1.136-3.356zm-4.243-1.549h3.752l-1.85-5.447h-.052l-1.85 5.447zm17.1.379c0 2.813-1.506 4.621-3.778 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.298 0 3.812 1.816 3.812 4.622zm-1.91 0c0-1.833-.947-3.038-2.393-3.038-1.419 0-2.375 1.23-2.375 3.038 0 1.824.956 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm11.876 0c0 2.813-1.507 4.621-3.779 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.297 0 3.813 1.816 3.813 4.622zm-1.911 0c0-1.833-.947-3.038-2.393-3.038-1.42 0-2.375 1.23-2.375 3.038 0 1.824.955 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm8.495 1.066c.138 1.232 1.334 2.04 2.969 2.04 1.567 0 2.694-.808 2.694-1.919 0-.964-.68-1.541-2.289-1.936l-1.61-.388c-2.28-.551-3.339-1.617-3.339-3.348 0-2.142 1.867-3.614 4.518-3.614 2.625 0 4.424 1.472 4.484 3.614H77.26c-.112-1.239-1.136-1.987-2.634-1.987s-2.521.757-2.521 1.858c0 .878.654 1.395 2.255 1.79l1.368.336c2.548.603 3.605 1.626 3.605 3.443 0 2.323-1.849 3.778-4.793 3.778-2.753 0-4.613-1.421-4.733-3.667h1.902zM83.346 19.3v2.142h1.722v1.472h-1.722v4.991c0 .776.345 1.137 1.102 1.137.204-.004.408-.018.611-.043v1.463c-.34.063-.686.092-1.032.086-1.833 0-2.548-.689-2.548-2.445v-5.189h-1.316v-1.472h1.316V19.3h1.867zm2.718 6.67c0-2.849 1.678-4.639 4.294-4.639 2.625 0 4.295 1.79 4.295 4.639 0 2.856-1.661 4.638-4.295 4.638s-4.294-1.782-4.294-4.638zm6.695 0c0-1.954-.895-3.108-2.401-3.108s-2.401 1.162-2.401 3.108c0 1.962.895 3.106 2.401 3.106s2.401-1.144 2.401-3.106zm3.426-4.528h1.773v1.541h.043a2.164 2.164 0 012.177-1.635c.214-.001.428.022.637.069v1.738a2.62 2.62 0 00-.835-.112l-.076-.002a1.883 1.883 0 00-1.873 1.873 1.87 1.87 0 00.012.212v5.37h-1.858v-9.054zm13.198 6.395c-.25 1.643-1.85 2.771-3.898 2.771-2.634 0-4.269-1.764-4.269-4.595 0-2.84 1.644-4.682 4.191-4.682 2.505 0 4.08 1.721 4.08 4.466v.637h-6.395v.112l-.009.208a2.37 2.37 0 002.358 2.358l.087-.002a2.05 2.05 0 002.091-1.273h1.764zm-6.282-2.702h4.526l.004-.121a2.19 2.19 0 00-2.177-2.178l-.047.001a2.306 2.306 0 00-2.306 2.292v.006zM37.826 8.731l.189-.007a2.653 2.653 0 012.64 2.64 2.63 2.63 0 01-.021.332c0 1.906-1.03 3.002-2.808 3.002h-2.155V8.731h2.155zm-1.228 5.123h1.125l.112.003a1.884 1.884 0 001.875-1.876 1.79 1.79 0 00-.02-.273c.012-.085.018-.17.018-.256a1.89 1.89 0 00-1.881-1.881l-.104.003h-1.125v4.28zm5.083-1.41a2.143 2.143 0 012.123-2.336c1.17 0 2.133.963 2.133 2.133l-.009.203.01.207c0 1.171-.963 2.134-2.134 2.134s-2.133-.963-2.133-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm6.559 2.254h-.922l-.93-3.317h-.071l-.926 3.317h-.913l-1.242-4.503h.902l.806 3.436h.067l.926-3.436h.852l.926 3.436h.07l.803-3.436h.889l-1.237 4.503zm2.281-4.503h.855v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.472 1.472 0 011.449 1.679v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.888v-4.503zm5.24-1.758h.889v6.261h-.889zm2.124 4.007a2.144 2.144 0 012.124-2.336c1.171 0 2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.17-.963 2.134-2.133 2.134s-2.134-.964-2.134-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm1.85.98c0-.81.603-1.278 1.675-1.344l1.219-.07v-.389c0-.475-.314-.744-.921-.744-.497 0-.84.182-.939.5h-.86c.091-.773.818-1.269 1.84-1.269 1.128 0 1.765.562 1.765 1.513v3.077h-.855v-.633h-.071a1.52 1.52 0 01-1.352.707 1.33 1.33 0 01-.141.007c-.744 0-1.357-.61-1.36-1.355zm2.894-.384v-.377l-1.099.07c-.62.042-.902.253-.902.65 0 .405.352.641.835.641a.97.97 0 00.107.005c.556 0 1.022-.435 1.059-.989zm2.053-.596c0-1.423.732-2.324 1.869-2.324a1.486 1.486 0 011.381.79h.067V8.437h.888v6.261h-.851v-.712h-.071a1.565 1.565 0 01-1.414.786c-1.145 0-1.869-.901-1.869-2.328zm.918 0c0 .955.45 1.53 1.203 1.53s1.212-.583 1.212-1.526-.468-1.53-1.212-1.53-1.203.579-1.203 1.526zm6.964 0l-.01-.203c0-1.17.963-2.133 2.134-2.133s2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.171-.963 2.134-2.133 2.134s-2.134-.963-2.134-2.134l.01-.207zm3.333 0c0-.976-.438-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.435 1.551 1.207 1.551s1.208-.571 1.208-1.551zm2.106-2.249h.856v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.47 1.47 0 011.464 1.464c0 .072-.005.144-.015.215v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.889v-4.503zm8.846-1.121v1.141h.976v.749h-.976v2.315c0 .472.194.679.637.679.113-.001.226-.008.339-.021v.74c-.16.029-.322.044-.484.046-.988 0-1.381-.348-1.381-1.216v-2.543h-.715v-.749h.715V9.074h.889zm2.19-.637h.88v2.481h.071c.241-.53.792-.853 1.373-.806l.08-.002a1.49 1.49 0 011.484 1.483c0 .066-.005.132-.013.198v2.907h-.89V12.01c0-.719-.335-1.084-.963-1.084l-.086-.003a1.06 1.06 0 00-1.052 1.052l.004.093v2.63h-.888V8.437zm9.056 5.045a1.833 1.833 0 01-1.951 1.303h-.054a2.055 2.055 0 01-2.026-2.325 2.086 2.086 0 012.058-2.352c1.271 0 2.027.856 2.027 2.27v.31h-3.18v.05a1.1 1.1 0 00-.004.1c0 .653.537 1.19 1.19 1.19a1.09 1.09 0 001.085-.546h.855zm-3.126-1.451h2.275l.003-.081c0-.596-.491-1.086-1.087-1.086h-.025a1.16 1.16 0 00-1.166 1.152v.015z"></path></svg></a></div></div><div class="sc-dxRmzR bnEqKR footer-row"><div class="sc-hPnoVK dfdtYF"><h3>Popular Channels</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/premarket-prep/" class="sc-bnRclF KOtsp">PreMarket Prep</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/pressreleases" class="sc-bnRclF KOtsp">Press Releases</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/analyst-stock-ratings" class="sc-bnRclF KOtsp">Analyst Ratings</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/news" class="sc-bnRclF KOtsp">News</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/markets/options" class="sc-bnRclF KOtsp">Options</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/etfs" class="sc-bnRclF KOtsp">ETFs</a></li></ul></div><div class="sc-hPnoVK dfdtYF"><h3>Tools & Features</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://pro.benzinga.com/" class="sc-bnRclF KOtsp">Real Time Feed</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/feeds/list" class="sc-bnRclF KOtsp">Public RSS Feeds</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/contact" class="sc-bnRclF KOtsp">Submit News Tips</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://pro.benzinga.com/blog/" class="sc-bnRclF KOtsp">Blog</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/widgets" class="sc-bnRclF KOtsp">Embeddable Finance Widgets & Tools</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/catalyst" class="sc-bnRclF KOtsp">Benzinga Catalyst</a></li></ul></div><div class="sc-hPnoVK dfdtYF"><h3>Partners & Contributors</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://app.impact.com/campaign-promo-signup/Benzinga1659111587301.brand?execution=e1s1" class="sc-bnRclF KOtsp">Affiliate Program</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://contributor.benzinga.com/contributor-onboarding" class="sc-bnRclF KOtsp">Contributor Portal</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/apis/" class="sc-bnRclF KOtsp">Licensing & Syndication</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/reach/" class="sc-bnRclF KOtsp">Sponsored Content</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://advertise.benzinga.com/" class="sc-bnRclF KOtsp">Advertise With Us</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/contact/" class="sc-bnRclF KOtsp">Lead Generation & SEO</a></li></ul></div><div class="sc-hPnoVK dfdtYF"><h3>About Benzinga</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/about" class="sc-bnRclF KOtsp">About Us</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://jobs.benzinga.com/" class="sc-bnRclF KOtsp">Careers</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/inthenews" class="sc-bnRclF KOtsp">In The News</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/events/" class="sc-bnRclF KOtsp">Events</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/contact" class="sc-bnRclF KOtsp">Contact Us</a></li></ul></div></div></div><div class="footer-bottom-section"><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/terms-and-conditions" class="sc-bnRclF KOtsp">Terms & Conditions </a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/page/privacy" class="sc-bnRclF KOtsp"> Do Not Sell My Personal Data/Privacy Policy</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/disclaimer" class="sc-bnRclF KOtsp">Disclaimer </a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="http://www.benzingastatus.com" class="sc-bnRclF KOtsp">Service Status</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/sitemap" class="sc-bnRclF KOtsp">Sitemap</a></li></ul><div class="copyright-section text-center w-full whitespace-nowrap mt-2">© 2024 Benzinga | All Rights Reserved</div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"activeTab":"profile","advertiserProfile":null,"headerProps":{},"includeAGGridStyles":false,"isAdvertiser":false,"isETF":false,"metaProps":{"author":"Benzinga","canonical":"https://www.benzinga.com/quote/APTO","dateCreated":"2019-01-01T01:01:01","dateUpdated":"2024-11-26T22:58:22.887-05:00","description":"Aptose Biosciences Stock (NASDAQ: APTO) stock price, news, charts, stock research, profile.","image":"https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60\u0026max_width=\u0026width=60\u0026x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv\u0026x-bz-exp=1732786269\u0026x-bz-security-isin=CA03835T3091\u0026x-bz-security-symbol=APTO\u0026x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69","language":"en","pageType":"ticker","structuredData":{"keywords":["\"symbol: APTO\"","\"section: profile\""]},"title":"Aptose Biosciences (NASDAQ:APTO) Stock Quotes, Forecast and News Summary","translations":{"auth":{"Auth":{"AuthModal":{"login":{"join-over":"Join over \u003cstrong\u003e6000 investors\u003c/strong\u003e who joined this week!","login-label":"Welcome Back","toggle-box":{"text1":"New to Benzinga?","text2":"Create Account"},"forgot-text":"Forgot Password?","get-unlimited-access":"Get Unlimited Access","come-see":"Come see why nearly \u003cspan class=\"font-black\"\u003e10,000 INVESTORS\u003c/span\u003e joined us THIS WEEK ALONE! Also get the Benzinga Research bonus report \u003cspan class=\"font-black\"\u003eBuy These 3 Stocks Before the Election\u003c/span\u003e emailed to you free when you create a new account with a valid email."},"register":{"auth-action-text":"Account Creation","toggle-box":{"text1":"Already have an account?","text2":"Login"}},"cta-label":"Please enter your email \u0026 password","continue-row":"or continue with","Benefits":{"institutional-research-reports":"Institutional Research Reports","actionable-trading-ideas":"Actionable Trading Ideas","professional-level-stock":"Professional Level Stock \u0026 Options Data","comment-on-articles":"Comment on Articles \u0026 Engage with Community Boards","in-depth-reports":"In Depth Reports","analyst-ratings":"Analyst Ratings","earnings":"Earnings","trade-ideas-more":"Trade Ideas, and more!","or-return-to":"Or return to"}},"Login":{"button":"Login","email":"Email","password":"Password","logged-in-success":"Logged in successfully"},"Register":{"button":"Register","email":"Email","password":"Password","thank-you":"Thank you for choosing Benzinga","completed":"Your registration process has been successfully completed","return-to-app":"Return to App"},"Meta":{"login-to-benzinga":"Login to Benzinga","login-to-access-features":"Login to Benzinga to access advanced features","logout-from-benzinga":"Logout from Benzinga","register-to-benzinga":"Register to Benzinga","register-to-access-features":"Register to Benzinga to access advanced features"},"Logout":{"logout-successful":"Logout Successful","returning-to-prev-page":"Returning to previous page..."}}},"common":{"Sidebars":{"Widgets":{"WatchlistSidebarWidget":{"title":"Your Watchlist","watchListBox":{"actionText":"Get Alerts","subtitle":"Create a Benzinga.com account for news on the stocks and cryptocurrencies you care about!","title":"Get News and Alerts"},"signUpBox":{"action":"Click to Get Started","subtitle":"FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.","title":"Create a Watchlist"}},"WatchListMovers":{"button":"Customize Watchlists"}}},"CompanyWatchlist":{"addToWatchlist":"Add To Watchlist +"},"AddToWatchlist":{"manageWatchListsLink":"Manage watchlists"},"Navigation":{"AccountMenu":{"my-account-text":"My Account","login":"Log In","logout":"Logout","reset-password":"Reset Password","forgot-password":"Forgot Password"},"TopBar":{"contributor":"Contribute","sign-in":"Sign in","login":"Login","register":"Register","DataAndAPIs":"Data \u0026 APIs","Events":"Events","Marketfy":"Marketfy","Premarket":"Premarket","Boost":"Boost"}},"Buttons":{"get-report":"Get Report","perks":"Perks","buy":"Buy","sell":"Sell","compare-brokers":"Compare Brokers","watchlist":"Watchlist","show-more":"Show More","see-more":"See More","show-less":"Show Less","browse":"Browse","skip":"Skip","back":"Back","close-window":"Close Window","allow":"Allow","deny":"Deny"},"Inputs":{"phone-number":"Phone Number","first-name":"First Name","email":"Email","password":"Password","Error":{"is-required":"{{field}} is required"}},"Date":{"Days":{"tomorrow":"tomorrow","today":"today","today-at":"Today at {{time}}"},"Periods":{"quarterly":"Quarterly","annual":"Annual","monthly":"Monthly","semi-annually":"Semi-Annually","other-regular":"Other Regular"}},"Table":{"name":"Name"},"Market":{"Actions":{"buy":"Buy","hold":"Hold","sell":"Sell","strong-sell":"Strong Sell","strong-buy":"Strong Buy"},"Direction":{"higher":"higher","lower":"lower","stagnant":"stagnant","positive":"positive","negative":"negative"}},"Fields":{"n-a":"N/A"},"Helpers":{"and":"and","as-of":"as of","the":"The","but":"but","yes":"Yes","no":"No","a-good":"a good","not-a-good":"not a good","above":"above","below":"below","is":"is","not":"not","is-not":"is not"},"Channels":{"general":"General","contracts":"Contracts","dividends":"Dividends","events":"Events","fda":"FDA","m-a":"M\u0026A","offerings":"Offerings","stock-split":"Stock Split","media":"Media","buybacks":"Buybacks","insider-trades":"Insider Trades","earnings":"Earnings","guidance":"Guidance","analyst-ratings":"Analyst Ratings","trading-ideas":"Trading Ideas"},"Sponsored":{"sponsored":"Sponsored"},"Watchlist":{"my-first-watchlist":"My First Watchlist","what-stocks-you-interested":"Which Stocks are you interested in?","select-stocks-you-are-interested":"Select stocks you are interested in below or in the search bar","search-stocks-to-add":"Search stocks to add","recommended-tickers":"Recommended Tickers","watchlist-tickers":"Watchlist Tickers"},"Notifications":{"dont-miss-alerts":"Don't miss out on alerts!","get-email-notifications":"Get Email Notifications","get-the-most-out-of-benzinga":"Get the most out of Benzinga by staying up to date with what's happening. Get Emails with updates on the the news you want.","get-sms-notifications":"Get SMS Notifications","allow-us-to-send-news":"Allow us to send you the news that matters most to you.","i-agree-to-receive-alerts":"I agree to receive alerts, educational, and promotional messages sent via an autodialer, and this agreement isn't a condition of any purchase. I also agree to the","data-rates-may-apply":"9 Msgs/Week. Msg \u0026 Data rates may apply.","get-push-notifications-prompt":"Would you like to be notified of the latest news and updates on the stock market?","disable-notifications-through-browser":"You can disable these notifications through your browser settings.","disabled-settings-alert":"Notifications are not enabled. Please reset your browser settings to allow notifications.","unable-to-subscribe-alert":"Unable to subscribe to notifications. Please try again later."},"Policy":{"terms-of-service":"Terms of Service","privacy-policy":"Privacy Policy"},"Comments":{"leave-a-comment":"Leave a Comment"}},"welcome":{"Welcome":{"meta":{"title":"Get started with your account","description":"Welcome to Benzinga"},"welcome-to":"Welcome to Benzinga!","choose-type-of-profile":"Choose the type of profile that suits you best","trader":"Trader","trader-description":"I actively buy and sell securities in financial markets to make short-term profits.","investor":"Investor","investor-description":"I seek long-term wealth accumulation by allocating capital to assets I believe will grow over time.","steps":{"profile-info":"Profile Info","watchlist":"Watchlist","alerts":"Alerts"},"before-you-leave":"Before you leave! Please answer the type of profile that suits you. This will help us create content you want.","view-dashboard":"View Dashboard","continue":"Continue","return-to-benzinga":"Return to Benzinga.com","before-you-go":"Before you go...","we-would-love-know-you-better":"We would love to know you better. What should we call you?"}},"quote":{"Quote":{"Nav":{"overview":"Overview","news":"News","holdings":"Holdings","dividends":"Dividends","short-interest":"Short Interest","guidance":"Guidance","earnings":"Earnings","option":"{{company}} ({{symbol}}) Options","analyst-ratings":"Analyst Ratings","insider-trades":"Insider Trades","government-trades":"Government Trades","forecast":"{{company}} ({{symbol}}) Forecast"},"Market":{"minutes-delayed":"{{minutes}} minutes delayed","after-hours":"After Hours","pre-market":"Pre-Market","intraday":"Intraday","high":"high","low":"low"},"WIIM":{"why-is-it-moving":"Why is it moving?"},"Headers":{"stock":"Stock","quotes-and-news-summary":"Quotes, Forecast and News Summary","analyst-ratings-rice-predictions":"Analyst Ratings, Price Targets, Forecasts","crypto":"{{name}} ({{symbol}}) Crypto Price, News and Market Data","earnings-estimates-eps-revenue":"Earnings Estimates, EPS, And Revenue","dividends":"Dividends","insider-trading-activity":"Insider Trading Activity","short-interest-report":"Short Interest Report","guidance-and-forecast":"Guidance And Forecast","latest-news-for":"Latest news for","holdings":"Top Holdings","option-chain":"Option Chain"},"Descriptions":{"profile":"stock price, news, charts, stock research, profile","dividend":"{{companyName}} issues dividends to shareholders from excess cash {{companyName}} generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular intervals","crypto-description":"{{name}} crypto price, news, charts, data, profile.","earnings":"{{companyName}} reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results","insider-trades":"{{companyName}}: Insider buying and selling updated today.","short-interest":"Short interest for {{companyName}} gives investors a sense of the degree to which investors are betting on the decline of {{companyName}}'s stock. Short interest data is updated every two weeks.","guidance":"Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period","option-chain":"Option chain shows key data for {{companyName}}'s stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for {{companyName}}"},"Metrics":{"open":"Open","close":"Close","high":"High","low":"Low","volume":"Volume","beta":"Beta","volume-avg":"Volume / Avg.","day-range":"Day Range","52wkrange":"52 Wk Range","52wklow":"52 Wk Low","52wkhigh":"52 Wk High","market-cap":"Market Cap","pe-ratio":"P/E Ratio","pb-ratio":"P/B Ratio","previous-close":"Prev. Close","dividend-yield":"Dividend Yield","dividend":"Dividend","ex-div-date":"Ex-Div Date","rsi":"RSI","short-interest":"Short Interest","days-to-cover":"Days to Cover","shares-out":"Shares Out","yield":"Yield","div-freq":"Div. Freq","price":"Price","24hr-price-change":"24 Hr Price Change","24hr-change":"24 Hr Change %","fully-diluted-valuation":"Fully Diluted Valuation","total-volume":"Total Volume","all-time-high":"All Time High (ATH)","ath-change":"ATH Change %","24-hr-high-low":"24 Hr High/Low","circulating-supply":"Circulating Supply","total-supply":"Total Supply","max-supply":"Max Supply","assets-under-management":"AUM","management-fee":"Mgmt Fee","average-daily-volume":"Avg. Volume Daily","average-expense-ratio":"Avg. Expense Ratio","implied-volatility":"Implied Volatility","put-call-volume-ratio":"Put/Call Vol Ratio","exchange":"Exchange"},"Reports":{"the-dividend-ex-date-was":"The dividend Ex-Date was {{date}}","the-dividend-ex-date-is":"The dividend Ex-Date is {{date}}","DuringPeriod":{"after-market":"after the market close","pre-market":"before the market open","regular":"during market hours"},"Earnings":{"earnings-were-released-today":"{{period}} earnings were released today {{duringPeriod}}","earnings-announcement":"{{period}} earnings announcement {{duringPeriod}} today","earnings-tomorrow-on":"{{period}} earnings tomorrow on {{formattedDate}} {{duringPeriod}}","earnings-from-now-on":"{{period}} Earnings {{timeFromNow}} from now on {{formattedDate}}, {{duringPeriod}}","earnings-were-released-on":"{{period}} Earnings were released on {{formattedDate}}, {{duringPeriod}}"},"ConferenceCall":{"scheduled-at-today":"Conference call scheduled today at {{callTime}}","in-progress":"Conference call in progress","ended-over":"Today's conference call ended over {{hoursAgo}}","scheduled-at-tomorrow":"Conference call scheduled tomorrow at {{callTime}}","recent":"The most recent conference call was at {{callTime}}, {{timeFromNow}}","scheduled-at":"Conference call scheduled {{timeFromNow}} at {{callTime}}","click-to-view-past-webcast":"Click to view past webcast","click-to-view-the-webcast":"Click to view the webcast"},"StockSplits":{"is-expected-to-split":"{{companyName}} is expected to split","recently-split-on":"{{companyName}} is expected to split","with-a-ratio-of":"with a ratio of"}},"News":{"all-news":"All News","recent-news":"Recent News","news":"News","partners":"Partners","press-release":"Press Releases","press-release-full-archive":"Full archive of press releases available on Benzinga Pro","no-news-found":"No news found"},"Financials":{"title":"Financials","revenue":"Revenue","change":"Change","gross":"Gross","earnings":"Earnings","profit-margin":"Profit Margin","analyst-trend":"Analyst Trends and Forecast","analyst-rating":"Analyst Rating and Forecast","analyst-rating-score":"This score is based on {{ratingsLength}} analyst{{s}} from the past {{timeBetween}}","no-rating":"No rating"},"About":{"about":"About {{company}}","sector":"Sector","industry":"Industry","team":"Team","executives":"Executives","board":"Board","other-members":"Other Members","contact-info":"Contact Info","address":"Address","logo-brought":"Logo brought to you by Benzinga Data"},"Compare":{"compare":"Compare","earnings-per-share":"Earnings Per Share","earnings-per-share-description":"EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.","price-to-earnings":"Price to Earnings","price-to-earnings-description":"The price-to-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings (EPS).","price-to-book":"Price to Book","price-to-book-description":"The price-to-book ratio (P/B ratio) is a financial ratio used to compare a company's current market price to its book value.","return-on-equity":"Return on Equity","return-on-equity-description":"Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders' equity.","debt-to-equity":"Debt to Equity","debt-to-equity-description":"The debt-to-equity (D/E) ratio is calculated by dividing a company’s total liabilities by its shareholder equity.","better":"better","worse":"worse","than-industry":"than industry"},"Peers":{"people-also-watch":"People Also Watch","show-all-related-companies":"Show all {{companiesLength}} related companies"},"FAQ":{"faq":"FAQ","Questions":{"how-do-i-buy-stock":"How do I buy {{quoteName}} ({{symbol}}) stock?","who-are-competitors":"Who are {{quoteName}} ({{symbol}}) competitors?","what-is-the-target-price-for":"What is the target price for {{quoteName}} ({{symbol}}) stock?","current-stock-price":"What is the current price for {{quoteName}} ({{symbol}})?","what-is-the-forecast-or-price-target-for":"What is the forecast, or price target, for {{quoteName}} ({{symbol}}) stock?","does-pay-dividend":"Does {{quoteName}} ({{symbol}}) pay a dividend?","when-is-reporting-earnings":"When is {{quoteName}} ({{exchange}}:{{symbol}}) reporting earnings?","is-going-to-split":"Is {{quoteName}} ({{symbol}}) going to split?","what-sector-industry-does-operate-in":"What sector and industry does {{quoteName}} ({{symbol}}) operate in?","what-were-the-latest-earnings":"What were the latest earnings per share (EPS) for {{quoteName}} ({{exchange}}:{{symbol}})?","what-were-revenues":"What were {{quoteName}}’s ({{exchange}}:{{symbol}}) revenues?","Dividends":{"when-does-pay-its-next-dividend":"When does {{quoteName}} ({{quoteSymbol}}) pay its next dividend?","what-date-did-i-need-to-own":"What date did I need to own {{quoteName}} ({{quoteSymbol}}) stock to get the latest dividend?","how-much-per-share-is-the-next":"How much per share is the next {{quoteName}} ({{quoteSymbol}}) dividend?","what-is-the-dividend-yield-for":"What is the dividend yield for {{quoteName}} ({{exchange}}:{{quoteSymbol}})?","what-was-the-announcement-date":"What was the announcement date for the next {{quoteName}} ({{quoteSymbol}}) dividend?","why-is-dividend-considered":"Why is {{quoteName}} ({{quoteSymbol}}) dividend considered {{status}}?","is-a-good-dividend":"Is {{quoteName}} ({{quoteSymbol}}) a good dividend?","is-the-dividend-sustainable":"Is the {{quoteName}} ({{quoteSymbol}}) dividend sustainable?"},"AnalystRatings":{"what-is-the-most-recent":"What is the most recent analyst rating for {{quoteName}} ({{quoteSymbol}})?","when-was-the-last-upgrade":"When was the last upgrade for {{quoteName}} ({{quoteSymbol}})?","when-was-the-last-downgrade":"When was the last downgrade for {{quoteName}} ({{quoteSymbol}})?","when-is-the-next-analyst-rating-update":"When is the next analyst rating going to be posted or updated for {{quoteName}} ({{quoteSymbol}})?","is-the-analyst-rating-correct":"Is the Analyst Rating {{quoteName}} ({{quoteSymbol}}) correct?"},"InsiderTrades":{"is-insider-trading-legal":"Is insider trading legal?","what-market-manipulation":"What are some examples of market manipulation?"},"Guidance":{"what-is-the-most-recent-guidance":"What is the most recent guidance for {{quoteName}} ({{quoteSymbol}})?"},"ETFs":{"how-has-etf-performed":"How has {{symbol}} ETF performed?","what-is-the-expense-ratio":"What is the expense ratio for {{symbol}}?","what-is-aum":"What is the Assets Under Management (AUM) for {{symbol}}?","what-is-investment-style":"What is the investment style for {{symbol}}?","what-are-top-holdings":"What are the top holdings for {{symbol}}?","what-is-the-avg-daily-volume":"What is the average daily trading volume for {{symbol}}?"}},"Answers":{"no-upcoming-slits-for":"There is no upcoming split for {{quoteName}}.","stock-slits-today":"The stock split for {{quoteSymbol}} was announced on {{date}}. The important ex-date for split is today. Holding the stock on the end of this date will include the value of the split.","stock-splits":"The stock split for {{quoteSymbol}} was announced on {{date}}. The date this stock split will start trading, also known as the ex-date, will be on {{dateEx}}.","stock-splits-date":"{{date}} with a ratio of","recently-split":"{{quoteName}} ({{symbol}}) recently split on {{date}} {{ratio}}","you-can-purchase-shares":"You can purchase shares of {{quoteName}} ({{exchange}}:{{symbol}}) through any online brokerage.","view-our-list-best-stock-brokerages":"View our list of the best stock brokerages","there-are-no-as-such-competitors":"There are no as such competitors for {{quoteName}}.","other-companies-in-space-includes":"Other companies in {{quoteName}}’s space includes","there-is-no-analysis-for":"There is no analysis for {{quoteName}}.","analyst-choice-answer":"The latest price target for {{quoteName}} ({{exchange}}:{{symbol}}) was reported by {{analyst}} on {{date}}. The analyst firm set a price target for {{ptCurrent}} expecting {{symbol}} to {{tickerTrend}} to within 12 months (a possible {{priceChange}}% {{tickerDirection}}). {{ratingsLength}} analyst firms have reported ratings in the last year.","the-stock-price-is":"The stock price for {{quoteName}} ({{exchange}}: {{symbol}}) is ${{lastTradePrice}} last updated {{lastUpdatedDate}}.","there-are-no-upcoming-dividends-for":"There are no upcoming dividends for {{quoteName}}.","there-is-no-dividend-information-for":"There is no dividend information for {{quoteName}}.","quarterly-cash-dividend":"A quarterly cash dividend of {{dividend}} per share of Class A Common Stock. The quarterly cash dividend was payable on {{payDate}} to stockholders of record on {{exDate}}.","the-next-dividend-date-is":"The next {{quoteName}} ({{symbol}}) dividend date is projected to be {{exDividendDate}}.","we-are-an-FPI-and-not-obliged":"We are an FPI and not obliged to release the earnings quarterly for the first two years. Thus, our interim earnings release for FY2021 is planned to be released in the end of October.","does-not-have-any":"{{quoteName}} does not have any upcoming earnings scheduled.","period-earnings-are-confirmed":"{{quoteName}}’s {{nextEarningPeriod}} earnings are confirmed for {{date}}.","industry-info":"{{quoteName}} is in the \u003cb\u003e{{sector}}\u003c/b\u003e sector and \u003cb\u003e{{industry}}\u003c/b\u003e industry. They are listed on the {{exchange}}.","there-are-no-earnings-for":"There are no earnings for {{quoteName}}","future-earning":"{{quoteName}} ({{quoteSymbol}}) is scheduled to report earnings on {{futureDate}}. The last reported earnings were for reported on {{pastDate}} for {{period}}.","earnings-not-scheduled":"{{quoteName}} ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on {{pastDate}} for {{period}}.","the-actual-eps-was":"The Actual EPS was {{actualEPS}}, which {{type}} the estimate of {{estEPS}}.","does-not-have-any-upcoming-earnings":"{{quoteName}} ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on {{date}} for {{period}} and the Actual EPS was {{actualEPS}}, which {{type}} the estimate of {{estEPS}}.","will-be-reporting-earnings-on":"{{quoteName}} ({{quoteSymbol}}) will be reporting earnings on {{date}}.","the-actual-revenue-was":"The Actual Revenue was {{actualREV}}, which {{type}} the estimate of {{estREV}}.","does-not-have-any-upcoming-earnings-revenue":"{{quoteName}} ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on {{date}} for {{period}} and the Actual Revenue was {{actualREV}}, which {{type}} the estimate of {{estREV}}.","the-last-reported-revenue":"The last reported revenues were from {{period}} and were {{actualREV}}.","no-analysis-for-consensus-price-target":"There is no analysis for {{quoteName}} to provide a consensus price target.","consensus-price-target":"{{quoteName}} has a consensus price target of ${{consensusPriceTarget}}.","has-a-consensus-price-target-of":"{{quoteName}} has a consensus price target of ${{consensusPriceTarget}}.","Dividends":{"the-out-to-investors-was":"out to investors was {{formattedDividendYield}} on {{date}}","next-dividend-was-announced-on":"{{quoteName}} next dividend was announced on {{announcedDate}} and will have an ex-dividend date of {{futureDate}}.","last-dividend-payout":"last dividend payout","and-was":"{{date}} and was {{formattedDividend}}.","the-next-dividend-payout-for":"The next dividend payout for {{quoteName}} ({{quoteSymbol}}) will be on {{payableDate}}. Investors need to be owners of {{quoteName}} ({{quoteSymbol}}) shares by {{recordDate}}.","the-next-dividend-for":"The next dividend for {{quoteName}} ({{quoteSymbol}}) will be on {{payableDate}} and will be {{formattedDividend}}.","was-paid-out":"was paid out","will-be-paid-out-next":"will be paid out next","has-no-upcoming-dividends-reported":"{{quoteName}} has no upcoming dividends reported. The last reported dividend for {{quoteName}} ({{quoteSymbol}}) was {{formattedDividendYield}} and {{hasDividendBeenPaid}} on {{payableDate}}.","the-most-current-yield-for":"The most current yield for {{quoteName}} ({{quoteSymbol}}) is {{futureFormattedYield}} and is payable next on {{futurePayableDate}}.","there-are-no-upcoming-dividends-announced-for":"There are no upcoming dividends announced for {{quoteName}}","the-last-dividend-was-announced-on":"$t(Quote.FAQ.Answers.Dividends.there-are-no-upcoming-dividends-announced-for, {\"quoteName\": {{quoteName}}). The last dividend was announced on {{announcedDate}}","the-next-dividend-was-announced-on":"The next dividend for {{quoteName}} ({{quoteSymbol}}) was announced on {{announcedDate}}.","not-enough-data-to-provide-evaluation":"There is not enough data to provide an evaluation.","dividend-decisions":"Dividend decisions can be influenced by what other companies in the same industry are doing. {{quoteName}}'s dividend yield is {{direction}} than the average dividend yield of its peers.","dividend-considered":"{{positive}} {{quoteName}} is considered {{good}} dividend. The dividend is {{position}} their peers {{conjunction}}, based on the TTM, the year-over-year dividend growth is {{marketDirection}}","based-on-historical":"{{positive}}. Based on historical data, {{quoteName}} dividend {{good}} considered sustainable. The company is {{dividendConsistency}} paying dividends consistently {{conjunction}} is {{earningsAvg}} make a profit."},"AnalystRatings":{"no-price-target":"There is no price target for {{quoteName}}","no-analyst-for":"There is no analyst for {{quoteName}}","no-last-upgrade":"There is no last upgrade for {{quoteName}}","the-latest-analyst-rating-for":"The latest analyst rating for {{quoteName}} ({{exchange}}:{{symbol}}) was provided by {{analyst}}, and {{quoteName}} {{actionCompany}} their {{currentRating}} rating.","no-next-analyst":"There is no next analyst rating for {{quoteName}}.","analysis-arrive":"Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of {{companyName}}, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for {{companyName}} was filed on {{lastRatingDate}} so you should expect the next rating to be made available sometime around {{nextRatingDateFormatted}}.","subjective":"While ratings are subjective and will change, the latest {{companyName}} ({{symbol}}) rating was a {{actionCompany}} with a price target of {{priceTargetPrior}} to {{priceTargetCurrent}}. The current price {{companyName}} ({{symbol}}) is trading at is {{lastTradePriceValue}}, which is {{typeValue}} the analyst’s predicted range.","last-upgrade-happened":"The last upgrade for {{companyName}} happened on {{upgradeDate}} when {{analyst}} raised their price target to {{priceTargetCurrent}}. {{analyst}} previously had {{ratingPrior}} for {{companyName}}.","no-last-downgrade":"There is no last downgrade for {{quoteName}}.","last-downgrade":"The last downgrade for {{companyName}} happened on {{downgradeDate}} when {{analyst}} changed their price target from {{priceTargetPrior}} to {{priceTargetCurrent}} for {{companyName}}.","initiated":"initiated","upgraded":"upgraded","downgraded":"downgraded","maintained":"maintained","reiterated":"reiterated"},"InsiderTrades":{"insider-trading-legal":"Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.","insider-trading-pump":"Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward."},"Guidance":{"no-specific-guidance":"There have been no specific sales or earnings guidance reported for {{quoteName}} in recent months.","there-have-been-no-specific-sales":"There have been no specific sales or earnings guidance reported for {{quoteName}} in recent months.","the-full-year":"the full year","the-last-reported":"The most recent guidance for {{name}} ({{ticker}}) was reported on {{date}} for {{period}} {{periodYear}}. The company provided earnings per share guidance in the range of {{formattedMin}} to {{formattedMax}}, compared to the estimated EPS of {{formattedEst}}. Additionally, {{name}} forecasted revenue between {{formattedRevenueMin}} and {{formattedRevenueMax}} for the quarter."},"ETFs":{"etf-performance":"The {{symbol}} ETF is currently trading at ${{currentPrice}}, which represents a {{changePercent}}% change. Over the past 52 weeks, the ETF has traded as high as ${{fiftyTwoWeekHigh}} and as low as ${{fiftyTwoWeekLow}}.","expense-ratio":"The expense ratio of {{symbol}} is {{expenseRatio}}. This represents the annual fee that all funds or ETFs charge their shareholders.","aum":"The total Assets Under Management (AUM) for {{symbol}} is {{aum}}. This represents the total market value of the assets managed by the ETF.","investment-style":"{{symbol}} follows a {{style}} investment style.","top-holdings":"The top holdings of {{symbol}} include: {{holdings}}. These represent the largest positions in the ETF's portfolio.","avg-daily-volume":"The average daily trading volume for {{symbol}} is {{volume}} shares.","no-performance-data-available":"Performance data for {{symbol}} is currently not available.","no-expense-ratio-data":"Expense ratio data for {{symbol}} is currently not available.","no-aum-data":"Assets Under Management (AUM) data for {{symbol}} is currently not available.","no-investment-style-data":"Investment style data for {{symbol}} is currently not available.","no-top-holdings-data":"Top holdings data for {{symbol}} is currently not available.","no-avg-daily-volume-data":"Average daily volume data for {{symbol}} is currently not available."}}},"Earnings":{"analyze-earnings":"Analyze the earnings history of {{companyName}} using advanced sorting and filters.","earnings-estimates-eps":"earnings estimates, EPS, and revenue","earnings-date":"Earnings Date","eps-estimate":"EPS Estimate","quarterly-revenue-estimate":"Quarterly Revenue Estimate","eps":"EPS","quarterly-revenue":"Quarterly Revenue","annual-revenue":"Annual Revenue","revenue":"Revenue","Charts":{"company-earnings-per-share":"{{companyName}} ({{symbol}}) Earnings Per Share","company-revenue":"{{companyName}} ({{symbol}}) Revenue","quarterly-eps-surprise":"Quarterly Earnings Surprise Amount","quarterly-revenue-surprise":"Quarterly Revenue Surprise Amount","legend":{"reported-eps":"Reported Earnings","estimated-eps":"Estimated Earnings","reported-revenue":"Reported Revenue","estimated-revenue":"Estimated Revenue","eps-surprise":"EPS Surprise %","revenue-surprise":"Revenue Surprise %"},"table":{"fiscal-quarter-end":"Fiscal Quarter End","date-reported":"Date Reported","actual-eps":"Actual EPS","estimate-eps":"Estimated EPS","actual-revenue":"Actual Revenue","estimate-revenue":"Estimated Revenue","surprise-percent":"Surprise %","no-data-available":"no data available to display"}}},"EPS":{"Type":{"beat":"beat","missed":"missed","hit":"hit"}},"Dividend":{"dividend-yield":"Dividend Yield","forward":"Forward","annual-dividend":"Annual Dividend","last-dividend":"Last Dividend","next-dividend":"Next Dividend","dividends-for":"Dividends for {{companyName}}","dividend-overview-title":"{{companyName}} Dividend Overview","dividend-overview-description":"{{companyName}} currently pays a {{dividendFrequency}} dividend of \u003cb\u003e{{annualDividend}}\u003c/b\u003e per year for a yield of \u003cb\u003e{{dividendYield}}%\u003c/b\u003e.","dividend-overview-description-no-dividend":"{{companyName}} does not currently pay a dividend or dividend information is unavailable.","dividend-overview-description-2":"{{companyName}} last traded ex-dividend on \u003cb\u003e{{lastDividendDate}}\u003c/b\u003e and the next ex-dividend date is scheduled for \u003cb\u003e{{nextDividendDate}}\u003c/b\u003e.","dividend-overview-description-2-next-date-unknown":"{{companyName}} last traded ex-dividend on \u003cb\u003e{{lastDividendDate}}\u003c/b\u003e and the next ex-dividend date is unknown.","dividend-overview-description-2-last-date-unknown":"{{companyName}} last traded ex-dividend is unknown and the next ex-dividend date is \u003cb\u003e{{nextDividendDate}}\u003c/b\u003e.","dividend-overview-description-2-both-dates-unknown":"{{companyName}}'s last ex-dividend date and next ex-dividend date are both unknown.","key-highlights-title":"Key Highlights","KeyHighlights":{"annual-payout":"Annual Payout","current-yield":"Current Yield","next-ex-dividend-date":"Next Ex-Dividend Date","last-ex-dividend-date":"Last Ex-Dividend Date","payments-per-year":"Payments per Year"}},"AnalystRatings":{"description":"{{companyName}} has a consensus price target of \u003cb\u003e{{consensusPriceTarget}}\u003c/b\u003e based on the ratings of \u003cb\u003e{{numRatings}}\u003c/b\u003e analysts. The high is \u003cb\u003e{{highestPriceTarget}}\u003c/b\u003e issued by \u003cb\u003e{{highestPriceTargetFirm}}\u003c/b\u003e on \u003cb\u003e{{highestPriceTargetDate}}\u003c/b\u003e. The low is \u003cb\u003e{{lowestPriceTarget}}\u003c/b\u003e issued by \u003cb\u003e{{lowestPriceTargetFirm}}\u003c/b\u003e on \u003cb\u003e{{lowestPriceTargetDate}}\u003c/b\u003e. The \u003cb\u003e{{numLastThreeRatings}}\u003c/b\u003e most-recent analyst ratings were released by \u003cb\u003e{{ratingsCompanies}}\u003c/b\u003e on \u003cb\u003e{{ratingsDate}}\u003c/b\u003e, respectively. With an average price target of \u003cb\u003e{{averagePriceTarget}}\u003c/b\u003e between \u003cb\u003e{{ratingsCompanies}}\u003c/b\u003e, there's an implied \u003cb\u003e{{averagePercentageChange}}%\u003c/b\u003e {{tickerDirection}} for {{companyName}} from these most-recent analyst ratings.","analyst-ratings-for":"Analyst Ratings for {{name}}","analyst-firms-making-recommendations":"Analyst Firms Making Recommendations","calculated-from-analyst-ratings":"calculated from analyst ratings","consensus-rating":"Consensus Rating","highest-price":"Highest Price Target","lowest-price-target":"Lowest Price Target","consensus-price-target":"Consensus Price Target","analyst-ratings-and-price-targets":"analyst ratings and price targets"},"InsiderTrades":{"what-is-insider-activity":"What is Insider Activity?","what-is-insider-activity-description":"Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.","what-are-company-insiders-doing":"What are {{companyName}} Insiders Doing?","what-are-company-insiders-doing-description":"At {{companyName}}, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of \u003cb\u003e{{totalSharesSold}}\u003c/b\u003e shares worth \u003cb\u003e{{totalSharesSoldValue}}\u003c/b\u003e, meanwhile, insiders have reported buying a total of \u003cb\u003e{{totalSharesPurchased}}\u003c/b\u003e shares for a total value of \u003cb\u003e{{totalSharesPurchasedValue}}\u003c/b\u003e.","what-are-company-insiders-doing-description-no-sold":"At {{companyName}}, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of \u003cb\u003e{{totalSharesPurchased}}\u003c/b\u003e shares for a total value of \u003cb\u003e{{totalSharesPurchasedValue}}\u003c/b\u003e.","what-are-company-insiders-doing-description-no-purchases":"At {{companyName}}, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of \u003cb\u003e{{totalSharesSold}}\u003c/b\u003e shares worth \u003cb\u003e{{totalSharesSoldValue}}\u003c/b\u003e, meanwhile, insiders have report no purchases in the last 30 days.","what-are-company-insiders-doing-no-data":"Insiders have report no purchases/sales in the last 30 days.","notable-recent-insider-trades-no-data":"There has been no Insider buying or selling in the last 90 days.","notable-recent-insider-trades-title":"Notable Recent Insider Buys and Sales","notable-recent-insider-trades-item":"On \u003cb\u003e{{date}}\u003c/b\u003e, {{name}}, the company's \u003cb\u003e{{title}}\u003c/b\u003e {{tradeType}} \u003cb\u003e{{shareCount}}\u003c/b\u003e shares for \u003cb\u003e{{shareValue}}\u003c/b\u003e each.","insider-summary-box-title":"Ownership Statistics for {{companyName}}","shares-outstanding":"Shares Outstanding","shares-float":"Shares Float","insider-shares-owned":"Insider Shares Owned","insider-percentage-owned":"Insider Percentage Owned","institutional-shared-held":"Institutional Shares Held","institutional-percentage-held":"Institutional Percentage Held","insider-trading-news":"{{symbol}} Insider Trading News","insider-trades":"insider trades"},"ShortInterest":{"short-interest":"Short Interest","days-to-cover":"Days to Cover","looking-for-the":"Looking for the","most-shorted-stocks":"most shorted stocks","short-interest-volume":"Based on the recent average volume of \u003cb\u003e{{volume}}\u003c/b\u003e shares traded per day, it would take \u003cb\u003e{{daysToCover}}\u003c/b\u003e day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.","short-interest-performance":"Short interest in {{companyName}} ({{ticker}}) {{trend}} during the last reporting period, {{rise}} from \u003cb\u003e{{shortInterestPriorMonth}}\u003c/b\u003e to \u003cb\u003e{{shortInterest}}\u003c/b\u003e. This put \u003cb\u003e{{shortPercentOfFloat}}%\u003c/b\u003e of the company's publicly available shares short.","increased":"increased","decreased":"decreased","rising":"rising","falling":"falling"},"Guidance":{"guidance-and-forecast":"guidance and forecast"},"Holdings":{"number-of-bond-holding-net":"Number of Bond Holdings","number-of-stock-holding-net":"Number of Stock Holdings","number-of-other-holding-net":"Number of Other Holdings","number-of-etfs":"Number of ETFs","total-number-of-holdings":"Total Holdings"},"Helpers":{"on-all-stocks":"on all stocks."},"Analysis":{"overview-rating":"Overview Rating","technicals-analysis":"Technicals Analysis","technicals-analysis-content":"Scores stock's market momentum out of 100, using buy/sell ratings, RSI, and price trends.","financials-analysis":"Financials Analysis","financials-analysis-content":"Rates stock's financial health out of 100, based on EPS, PE, PB ratios, ROE, and debt equity ratio.","status":{"good":"Good","promising":"Promising","speculative":"Speculative","very-promising":"Very Promising"}},"Price":{"last-update":"Last update","at-close":"At close"},"OptionChain":{"all":"All","expiration-date":"Expiration Date","moneyness":"Moneyness","strike-range":"Strike Range","in-the-money":"In The Money","near-the-money":"Near The Money","last-price":"Last price","change":"Change","bid":"Bid","ask":"Ask","volume":"Volume","open-interest":"Open Interest","options-news-education":" Options News and Education","unusual-options-activity":"Unusual Options Activity for {{companyStandardName}} ({{symbol}})"}}},"profile":{"Profile":{"profile-information":"Personal Information","profile-info":"Profile Info","first-name":"First Name","last-name":"Last Name","email-address":"Email Address","phone-no":"Phone No.","password":"Password","verified":"Verify Now","change-your-password":"Change your password","add-first-name":"Add First Name","add-last-name":"Add Last Name","add-email-address":"Add Email Address","add-phone-number":"Add Phone Number","unverified":"Unverified -","edit":"Edit","save":"Save","cancel":"Cancel","verification-email-sent":"Verification Email Sent!"},"Billing":{"label":"Billing","invalid-card":"Invalid card","subscription-info":"Subscription Info","noactive-subscription":"You have no active subscriptions.","billing-info":"Billing Info","click-or-drag":" Click or drag and drop image to change your avatar. Accepted file formats:{' '}","format":"JPG, PNG, GIF"},"Chat":{"label":"Chat","chat-username":"Chat Username","name":"JohnSmith1990","update":"Update","muted-users":"Muted User","muted":"You have no muted users","success":"Nickname updated successfully","error":"Nickname update failed. Please contact admin to change the name.'"},"NewsAlerts":{"label":"News Alerts"}}}},"overviewValues":{"bullSayBearSay":{"bear_case":"Aptose Biosciences Inc faces significant challenges that contribute to a negative outlook on its stock, including a reported net loss of ($1.76) per share, driven by ongoing research and development (R\u0026D) expenses totaling $8.3 million. The company's financial health is further pressured by its reliance on the success of its drug candidates, tuspetinib and luxeptinib, which exhibit mixed clinical data and potential safety concerns, leaving the company vulnerable to setbacks. Additionally, the long timeline required for early-stage programs to achieve sustained revenue generation, coupled with increasing competition in the oncology sector, suggests that Aptose may struggle to secure the necessary resources for continued development.","bull_case":"Aptose Biosciences Inc. demonstrates a promising outlook due to its innovative oncology pipeline, particularly the targeted drug candidates tuspetinib and luxeptinib, which are advancing through clinical trials and showing encouraging efficacy in treating complex cancers like AML and B-cell malignancies. The company has reported impressive clinical results, with tuspetinib achieving a 21% complete response rate in ven-refractory patients and a 43% response rate in ven-naive patients, contributing to a projected $500 million in potential revenue for relapsed/refractory AML at a 25% likelihood of success. Additionally, luxeptinib's broad applicability across different clinical scenarios presents further commercial potential, estimated at $800 million across AML and B-cell malignancies, supporting a positive long-term valuation perspective for the company.","id":"673e9d44ace794512d2490f0","securities":[{"cik":"882361","exchange":"NASDAQ","isin":"AU0000198525","name":"Aptose Biosciences","symbol":"APTO"}],"ticker":"APTO","updated":1732156740},"financials":{"down":0,"up":0},"ratingsByMonthWithCounts":[{"date":"Jun/2024","ratingBuyCount":1,"ratingCountTotal":1,"ratingHoldCount":0,"ratingSellCount":0,"ratingStrongBuyCount":0,"ratingStrongSellCount":0},{"date":"Nov/2024","ratingBuyCount":1,"ratingCountTotal":1,"ratingHoldCount":0,"ratingSellCount":0,"ratingStrongBuyCount":0,"ratingStrongSellCount":0}],"technicals":{"down":1,"up":2}},"pageTargeting":{"BZ_PTYPE":"ticker","BZ_TICKER":"APTO"},"peersChartData":{},"profile":{"conferenceCallsSummary":{"conferenceCalls":[],"last":null,"next":null},"dividendSummary":{"avgAnnualizedDividendGrowth":null,"dividends":[],"largestDividendYield":null,"last":null,"next":null,"yearOverYearGrowth":null},"fundamentals":{"valuationRatios":[{"id":{"shareClassId":"0P000003C6","date":"2024-11-26"},"payoutRatio":0,"salesPerShare":0,"bookValuePerShare":-0.4679,"cfoPerShare":-2.6475,"fcfPerShare":-2.6475,"earningYield":-16.4045,"salesYield":0,"bookValueYield":-2.6287,"cfYield":-14.8735,"fcfYield":-14.8735,"tangibleBookValuePerShare":-0.4679,"tangibleBvPerShare3YrAvg":7.6688,"tangibleBvPerShare5YrAvg":10.0418,"workingCapitalPerShare":0.0244,"workingCapitalPerShare3YrAvg":7.5843,"workingCapitalPerShare5YrAvg":9.9403,"priceChange1M":0.4676}],"company":{"primarySymbol":"APS","primaryExchange":"TSE","cik":"882361","isin":"AU0000198525","standardName":"Aptose Biosciences","countryId":"CAN","isReit":false,"industryTemplateCode":"N","businessCountryId":"CAN","isLimitedPartnership":false,"yearofEstablishment":2006,"isLimitedLiabilityCompany":false},"companyProfile":{"companyStatus":"U","countryId":"CAN","fiscalYearEnd":"12","shortName":"Aptose Biosciences","standardName":"Aptose Biosciences Inc","address1":"251 Consumers Road","address2":"Suite 1105","city":"Toronto","country":"CAN","homepage":"https://www.aptose.com","phone":"+1 647 479-9828","postalCode":"M2J 4R3","province":"ON","totalEmployees":36,"legalName":"Aptose Biosciences Inc","longDescription":"Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities."},"shareClass":{"shareClassId":"0P000003C6","companyId":"0C0000085F","symbol":"APTO","exchangeId":"NAS","currencyId":"USD","ipoDate":"1992-07-30","isDepositaryReceipt":false,"securityType":"ST00000001","shareClassStatus":"A","isPrimaryShare":false,"isDividendReinvest":false,"isDirectInvest":false,"investmentId":"E0CAN0087F","mic":"XNAS"},"earningReports":[{"id":{"shareClassId":"0P000003C6","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","periodEndingDate":"2024-09-30","fileDate":"2024-11-12","accessionNumber":"0000950170-24-124343","formType":"10-Q","basicContinuousOperations":-0.37,"basicEps":-0.37,"dilutedContinuousOperations":-0.37,"dilutedEps":-0.37,"basicAverageShares":18560000,"dilutedAverageShares":18560000,"continuingAndDiscontinuedBasicEps":-0.37,"continuingAndDiscontinuedDilutedEps":-0.37,"normalizedBasicEps":-0.37,"normalizedDilutedEps":-0.37}],"earningRatios":[{"id":{"shareClassId":"0P000003C6","asOf":"2023-09-30","reportType":"A","period":"3M","aorOrRestate":"AOR"},"fiscalYearEnd":12,"equityPerShareGrowth":-0.523202}],"financials":[{"asOf":"2024-09-30","period":"3M","reportType":"R","aorOrRestate":"RESTATE","balanceSheet":{"id":{"companyId":"0C0000085F","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","fileDate":"2024-11-12","accessionNumber":"0000950170-24-124343","formType":"10-Q","accountsPayable":1830000,"currentAccruedExpenses":7512000,"accumulatedDepreciation":-2460000,"totalLiabilitiesAsReported":20063000,"totalEquityAsReported":-9134000,"gainsLossesNotAffectingRetainedEarnings":-4316000,"additionalPaidInCapital":82262000,"capitalStock":452302000,"commonStock":452302000,"currentAssets":10235000,"currentDebtAndCapitalLeaseObligation":416000,"currentLiabilities":9758000,"currentCapitalLeaseObligation":416000,"grossPpe":3154000,"longTermDebt":10000000,"longTermDebtAndCapitalLeaseObligation":10305000,"longTermCapitalLeaseObligation":305000,"netPpe":694000,"payables":1830000,"payablesAndAccruedExpenses":9342000,"prepaidAssets":912000,"retainedEarnings":-539382000,"stockholdersEquity":-9134000,"totalAssets":10929000,"totalLiabilities":20063000,"totalNonCurrentAssets":694000,"investedCapital":866000,"totalLiabilitiesNetMinorityInterest":20063000,"totalNonCurrentLiabilitiesNetMinorityInterest":10305000,"totalEquityGrossMinorityInterest":-9134000,"commonStockEquity":-9134000,"otherCurrentAssets":1361000,"otherEquityAdjustments":-4316000,"otherProperties":3154000,"restrictedCash":7962000,"totalCapitalization":866000,"capitalLeaseObligations":721000,"tangibleBookValue":-9134000,"totalEquity":-9134000,"workingCapital":477000,"totalDebt":10721000,"ordinarySharesNumber":19521183,"netTangibleAssets":-9134000,"netDebt":10000000,"shareIssued":19521183},"cashFlowStatement":{"id":{"companyId":"0C0000085F","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","fileDate":"2024-11-12","accessionNumber":"0000950170-24-124343","formType":"10-Q","changeinCashSupplementalAsReported":-368000,"cashFlowFromContinuingFinancingActivities":10008000,"cashFlowFromContinuingInvestingActivities":0,"cashFlowFromContinuingOperatingActivities":-10376000,"financingCashFlow":10008000,"investingCashFlow":0,"operatingCashFlow":-10376000,"beginningCashPosition":8330000,"endCashPosition":7962000,"changeInAccountPayable":-5281000,"changeInAccruedExpense":2316000,"changesInCash":-368000,"changeInPayable":-5281000,"changeInPayablesAndAccruedExpense":-2965000,"changeInPrepaidAssets":324000,"changeInWorkingCapital":-3521000,"depreciation":96000,"depreciationAndAmortization":96000,"depreciationAmortizationDepletion":96000,"effectOfExchangeRateChanges":0,"netCommonStockIssuance":0,"netIssuancePaymentsOfDebt":10000000,"netLongTermDebtIssuance":10000000,"netIncomeFromContinuingOperations":-6953000,"proceedsFromStockOptionExercised":8000,"commonStockIssuance":0,"longTermDebtIssuance":10000000,"netInvestmentPurchaseAndSale":0,"netPpePurchaseAndSale":0,"changeInOtherCurrentAssets":-768000,"changeInOtherCurrentLiabilities":-112000,"gainLossOnSaleOfPpe":0,"otherNonCashItems":15000,"stockBasedCompensation":-13000,"unrealizedGainLossOnInvestmentSecurities":0,"issuanceOfCapitalStock":0,"issuanceOfDebt":10000000,"freeCashFlow":-10376000},"incomeStatement":{"id":{"companyId":"0C0000085F","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","fileDate":"2024-11-12","accessionNumber":"0000950170-24-124343","formType":"10-Q","depreciation":4000,"depreciationAndAmortization":4000,"depreciationAmortizationDepletion":4000,"generalAndAdministrativeExpense":2259000,"interestIncomeNonOperating":12000,"netNonOperatingInterestIncomeExpense":12000,"netIncome":-6953000,"netIncomeCommonStockholders":-6953000,"netIncomeContinuousOperations":-6953000,"netInterestIncome":12000,"totalRevenue":0,"operatingExpense":6965000,"operatingIncome":-6965000,"operatingRevenue":0,"pretaxIncome":-6953000,"researchAndDevelopment":4702000,"sellingGeneralAndAdministration":2259000,"totalExpenses":6965000,"interestIncome":12000,"ebit":-6965000,"ebitda":-6869000,"salariesAndWages":68000,"netIncomeFromContinuingAndDiscontinuedOperation":-6953000,"reconciledDepreciation":96000,"normalizedIncome":-6953000,"netIncomeFromContinuingOperationNetMinorityInterest":-6953000,"netIncomeIncludingNoncontrollingInterests":-6953000,"taxRateForCalcs":0,"taxEffectOfUnusualItems":0,"normalizedEbitda":-6869000,"totalRevenueAsReported":0,"operatingExpenseAsReported":6965000}}],"operationRatios":[{"id":{"companyId":"0C0000085F","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"isCalculated":false,"revenueGrowth":0,"operationRevenueGrowth3MonthAvg":0,"currentRatio":1.048883,"roa":-0.635616,"debttoAssets":0.980968,"commonEquityToAssets":-0.835758}],"alphaBeta":[],"ownership":[{"id":{"shareClassId":"0P000003C6","asOf":"2024-11-08"},"period":"","sharesOutstanding":19521183,"institutionHolderNumber":3,"institutionPercentHeld":0.0001500421,"institutionPercentHeld13f":0.1440380432,"institutionSharesHeld":2929,"institutionSharesSold":742,"numberOfInsiderBuys":10,"insiderSharesBought":190998,"insiderPercentOwned":0.095972,"insiderSharesOwned":1737988,"shareFloat":16429344,"shareClassLevelSharesOutstandingBalanceSheet":15717701,"shareClassLevelSharesOutstandingInterim":19521183,"sharesOutstandingWithBalanceSheetEndingDate":15717701}],"assetClassification":{"sic":"3741","sicName":"Pharmaceutical and Medicine Industry","naics":"325412","msSuperSectorCode":2,"msSuperSectorName":"Defensive","msSectorCode":206,"msSectorName":"Healthcare","msGroupCode":20610,"msGroupName":"Biotechnology","msIndustryCode":20610010,"msIndustryName":"Biotechnology"},"shareClassProfile":{"asOf":"2024-11-08","marketCap":3474770,"enterpriseValue":-4120071,"sharesOutstanding":19521183},"symbol":"APTO","idType":"SYMBOL","id":"APTO"},"fundamentalsAnnual":{"valuationRatios":[{"id":{"shareClassId":"0P000003C6","date":"2024-11-26"},"payoutRatio":0,"salesPerShare":0,"bookValuePerShare":-0.4679,"cfoPerShare":-2.6475,"fcfPerShare":-2.6475,"earningYield":-16.4045,"salesYield":0,"bookValueYield":-2.6287,"cfYield":-14.8735,"fcfYield":-14.8735,"tangibleBookValuePerShare":-0.4679,"tangibleBvPerShare3YrAvg":7.6688,"tangibleBvPerShare5YrAvg":10.0418,"workingCapitalPerShare":0.0244,"workingCapitalPerShare3YrAvg":7.5843,"workingCapitalPerShare5YrAvg":9.9403,"priceChange1M":0.4676}],"company":{"primarySymbol":"APS","primaryExchange":"TSE","cik":"882361","isin":"AU0000198525","standardName":"Aptose Biosciences","countryId":"CAN","isReit":false,"industryTemplateCode":"N","businessCountryId":"CAN","isLimitedPartnership":false,"yearofEstablishment":2006,"isLimitedLiabilityCompany":false},"companyProfile":{"companyStatus":"U","countryId":"CAN","fiscalYearEnd":"12","shortName":"Aptose Biosciences","standardName":"Aptose Biosciences Inc","address1":"251 Consumers Road","address2":"Suite 1105","city":"Toronto","country":"CAN","homepage":"https://www.aptose.com","phone":"+1 647 479-9828","postalCode":"M2J 4R3","province":"ON","totalEmployees":36,"legalName":"Aptose Biosciences Inc","longDescription":"Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities."},"shareClass":{"shareClassId":"0P000003C6","companyId":"0C0000085F","symbol":"APTO","exchangeId":"NAS","currencyId":"USD","ipoDate":"1992-07-30","isDepositaryReceipt":false,"securityType":"ST00000001","shareClassStatus":"A","isPrimaryShare":false,"isDividendReinvest":false,"isDirectInvest":false,"investmentId":"E0CAN0087F","mic":"XNAS"},"earningReports":[{"id":{"shareClassId":"0P000003C6","asOf":"2024-09-30","reportType":"TTM","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","periodEndingDate":"2024-09-30","basicContinuousOperations":-2.92,"basicEps":-2.92,"dilutedContinuousOperations":-2.92,"dilutedEps":-2.92,"basicAverageShares":14042000,"dilutedAverageShares":14042000,"continuingAndDiscontinuedBasicEps":-2.92,"continuingAndDiscontinuedDilutedEps":-2.92,"normalizedBasicEps":-2.92,"normalizedDilutedEps":-2.92}],"earningRatios":[],"financials":[{"asOf":"2024-09-30","period":"12M","reportType":"R","aorOrRestate":"RESTATE","balanceSheet":{"id":{"companyId":"0C0000085F","asOf":"2024-09-30","reportType":"R","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30"},"cashFlowStatement":{"id":{"companyId":"0C0000085F","asOf":"2024-09-30","reportType":"R","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","changeinCashSupplementalAsReported":-7758000,"cashFlowFromContinuingFinancingActivities":27463000,"cashFlowFromContinuingInvestingActivities":1956000,"cashFlowFromContinuingOperatingActivities":-37176000,"financingCashFlow":27463000,"investingCashFlow":1956000,"operatingCashFlow":-37176000,"beginningCashPosition":15720000,"endCashPosition":7963000,"changeInAccountPayable":-981000,"changeInAccruedExpense":-1617000,"changesInCash":-7757000,"changeInPayable":-981000,"changeInPayablesAndAccruedExpense":-2598000,"changeInPrepaidAssets":745000,"changeInWorkingCapital":-3009000,"depreciation":417000,"depreciationAndAmortization":417000,"depreciationAmortizationDepletion":417000,"effectOfExchangeRateChanges":-1000,"netCommonStockIssuance":17654000,"netIncomeFromContinuingOperations":-35800000,"proceedsFromStockOptionExercised":26000,"commonStockIssuance":17654000,"netInvestmentPurchaseAndSale":1938000,"netPpePurchaseAndSale":18000,"changeInOtherCurrentAssets":-1100000,"gainLossOnSaleOfPpe":76000,"otherNonCashItems":-277000,"stockBasedCompensation":1414000,"issuanceOfCapitalStock":17654000,"freeCashFlow":-37176000},"incomeStatement":{"id":{"companyId":"0C0000085F","asOf":"2024-09-30","reportType":"R","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","depreciation":23000,"depreciationAndAmortization":23000,"depreciationAmortizationDepletion":23000,"generalAndAdministrativeExpense":11498000,"interestIncomeNonOperating":397000,"netNonOperatingInterestIncomeExpense":397000,"netIncome":-35800000,"netIncomeCommonStockholders":-35800000,"netIncomeContinuousOperations":-35800000,"netInterestIncome":397000,"totalRevenue":0,"operatingExpense":36197000,"operatingIncome":-36197000,"operatingRevenue":0,"otherIncomeExpense":0,"pretaxIncome":-35800000,"researchAndDevelopment":24676000,"sellingGeneralAndAdministration":11498000,"totalExpenses":36197000,"interestIncome":397000,"ebit":-36197000,"ebitda":-35780000,"gainOnSaleOfSecurity":0,"salariesAndWages":906000,"netIncomeFromContinuingAndDiscontinuedOperation":-35800000,"reconciledDepreciation":417000,"normalizedIncome":-35800000,"netIncomeFromContinuingOperationNetMinorityInterest":-35800000,"netIncomeIncludingNoncontrollingInterests":-35800000,"totalUnusualItems":0,"totalUnusualItemsExcludingGoodwill":0,"taxRateForCalcs":0,"taxEffectOfUnusualItems":0,"normalizedEbitda":-35780000,"totalRevenueAsReported":0,"operatingExpenseAsReported":36197000}}],"operationRatios":[],"alphaBeta":[],"ownership":[{"id":{"shareClassId":"0P000003C6","asOf":"2024-11-08"},"period":"","sharesOutstanding":19521183,"institutionHolderNumber":3,"institutionPercentHeld":0.0001500421,"institutionPercentHeld13f":0.1440380432,"institutionSharesHeld":2929,"institutionSharesSold":742,"numberOfInsiderBuys":10,"insiderSharesBought":190998,"insiderPercentOwned":0.095972,"insiderSharesOwned":1737988,"shareFloat":16429344,"shareClassLevelSharesOutstandingBalanceSheet":15717701,"shareClassLevelSharesOutstandingInterim":19521183,"sharesOutstandingWithBalanceSheetEndingDate":15717701}],"assetClassification":{"sic":"3741","sicName":"Pharmaceutical and Medicine Industry","naics":"325412","msSuperSectorCode":2,"msSuperSectorName":"Defensive","msSectorCode":206,"msSectorName":"Healthcare","msGroupCode":20610,"msGroupName":"Biotechnology","msIndustryCode":20610010,"msIndustryName":"Biotechnology"},"shareClassProfile":{"asOf":"2024-11-08","marketCap":3474770,"enterpriseValue":-4120071,"sharesOutstanding":19521183},"symbol":"APTO","idType":"SYMBOL","id":"APTO"},"isStockReportSupported":false,"logoUrl":"https://image-util.benzinga.com/api/v2/logos/file/image/882361/mark_composite_light__25c5addb729aa382052f03b61c12839e.png?height=60\u0026max_width=\u0026width=60\u0026x-bz-cred=sb~JMiQKXau3YP857VHQmODD9Jcqqh4paohhZZjOc7hzF5ZPZG982pm5nCxhQ6kNFPIWwm-r97zyeNAeZOO8GsCySpSRnniTbq7hNE0Lgo7woLSKGQA2EaNCicEpq2PsXoNI7rG6VQnujIdZgIBwSCs_VQt-Irv\u0026x-bz-exp=1732786269\u0026x-bz-security-isin=CA03835T3091\u0026x-bz-security-symbol=APTO\u0026x-bz-signature=d58d135628bc98b58af99e9215ed4fd0dada4ac17c0b554eb3957d8d2db73c69","maSummary":{"last":null,"ma":[],"next":null},"quotes":{"APTO":{"symbol":"APTO","dxSymbol":"APTO","exchange":"XNAS","isoExchange":"XNAS","bzExchange":"NASDAQ","otcMarket":"","otcTier":"","type":"STOCK","name":"Aptose Biosciences","companyStandardName":"Aptose Biosciences Inc","description":"Aptose Biosciences, Inc. - Common Shares","bidPrice":0.187,"askPrice":0.2147,"askSize":1,"bidSize":51,"size":2649,"bidTime":1732698910000,"askTime":1732698001000,"lastTradePrice":0.19,"lastTradeTime":1732698001596,"volume":112,"change":0.012,"changePercent":6.74,"previousClosePrice":0.178,"previousCloseDate":"2024-11-26T16:00:00.000-05:00","fiftyDayAveragePrice":0.37,"hundredDayAveragePrice":0.43,"twoHundredDayAveragePrice":0.86,"averageVolume":755463,"fiftyTwoWeekHigh":2.9077,"fiftyTwoWeekLow":0.13,"marketCap":3709024,"sharesOutstanding":19521183,"sharesFloat":16429344,"ethPrice":0.19,"ethVolume":112,"ethTime":1732698001596,"currency":"USD","primary":false,"issuerShortName":"Aptose Biosciences"}},"richQuoteData":{"symbol":"APTO","dxSymbol":"APTO","exchange":"XNAS","isoExchange":"XNAS","bzExchange":"NASDAQ","otcMarket":"","otcTier":"","type":"STOCK","name":"Aptose Biosciences","companyStandardName":"Aptose Biosciences Inc","description":"Aptose Biosciences, Inc. - Common Shares","bidPrice":0.187,"askPrice":0.2147,"askSize":1,"bidSize":51,"size":2649,"bidTime":1732698910000,"askTime":1732698001000,"lastTradePrice":0.19,"lastTradeTime":1732698001596,"volume":112,"change":0.012,"changePercent":6.74,"previousClosePrice":0.178,"previousCloseDate":"2024-11-26T16:00:00.000-05:00","fiftyDayAveragePrice":0.37,"hundredDayAveragePrice":0.43,"twoHundredDayAveragePrice":0.86,"averageVolume":755463,"fiftyTwoWeekHigh":2.9077,"fiftyTwoWeekLow":0.13,"marketCap":3709024,"sharesOutstanding":19521183,"sharesFloat":16429344,"ethPrice":0.19,"ethVolume":112,"ethTime":1732698001596,"currency":"USD","primary":false,"issuerShortName":"Aptose Biosciences"},"schedule":{"schedule":{"trading":true,"shortDay":false,"resetTime":1732694400000,"localResetDate":"2024-11-27T03:00:00.000-05:00","dayId":20054,"startTime":1732683600000,"endTime":1732770000000,"timeZoneId":"America/New_York","sessions":[{"startTime":1732683600000,"endTime":1732698000000,"type":"NO_TRADING","localStartDate":"2024-11-27T00:00:00.000-05:00","localEndDate":"2024-11-27T04:00:00.000-05:00"},{"startTime":1732698000000,"endTime":1732717800000,"type":"PRE_MARKET","localStartDate":"2024-11-27T04:00:00.000-05:00","localEndDate":"2024-11-27T09:30:00.000-05:00"},{"startTime":1732717800000,"endTime":1732741200000,"type":"REGULAR","localStartDate":"2024-11-27T09:30:00.000-05:00","localEndDate":"2024-11-27T16:00:00.000-05:00"},{"startTime":1732741200000,"endTime":1732755600000,"type":"AFTER_MARKET","localStartDate":"2024-11-27T16:00:00.000-05:00","localEndDate":"2024-11-27T20:00:00.000-05:00"},{"startTime":1732755600000,"endTime":1732770000000,"type":"NO_TRADING","localStartDate":"2024-11-27T20:00:00.000-05:00","localEndDate":"2024-11-28T00:00:00.000-05:00"}]},"type":"PRE_MARKET"},"shortInterest":[{"recordDate":"2024-11-11","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"123222","daysToCover":1.56,"shortPercentOfFloat":0.82,"shortPriorMo":"192682","percentChangeMoMo":-36.05,"sharesFloat":"15017554","averageDailyVolume":"79059","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-11-04","settlementDate":"2024-10-31"},{"recordDate":"2024-10-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"192682","daysToCover":3.48,"shortPercentOfFloat":1.28,"shortPriorMo":"205871","percentChangeMoMo":-6.41,"sharesFloat":"15017554","averageDailyVolume":"55441","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-10-17","settlementDate":"2024-10-15"},{"recordDate":"2024-10-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"205871","daysToCover":1.77,"shortPercentOfFloat":1.37,"shortPriorMo":"818679","percentChangeMoMo":-74.85,"sharesFloat":"15017554","averageDailyVolume":"116561","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-10-02","settlementDate":"2024-09-30"},{"recordDate":"2024-09-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"818679","daysToCover":1,"shortPercentOfFloat":5.45,"shortPriorMo":"132009","percentChangeMoMo":520.17,"sharesFloat":"15017554","averageDailyVolume":"2466674","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-09-17","settlementDate":"2024-09-13"},{"recordDate":"2024-09-11","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"132009","daysToCover":1,"shortPercentOfFloat":0.88,"shortPriorMo":"49359","percentChangeMoMo":167.45,"sharesFloat":"15017554","averageDailyVolume":"754281","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-09-04","settlementDate":"2024-08-30"},{"recordDate":"2024-08-26","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"49359","daysToCover":1,"shortPercentOfFloat":0.33,"shortPriorMo":"91202","percentChangeMoMo":-45.88,"sharesFloat":"15017554","averageDailyVolume":"81814","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-08-19","settlementDate":"2024-08-15"},{"recordDate":"2024-08-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"91202","daysToCover":1,"shortPercentOfFloat":0.61,"shortPriorMo":"80801","percentChangeMoMo":12.87,"sharesFloat":"15017554","averageDailyVolume":"105755","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-08-02","settlementDate":"2024-07-31"},{"recordDate":"2024-07-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"80801","daysToCover":1.79,"shortPercentOfFloat":0.54,"shortPriorMo":"93021","percentChangeMoMo":-13.14,"sharesFloat":"15017554","averageDailyVolume":"45057","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-07-17","settlementDate":"2024-07-15"},{"recordDate":"2024-07-10","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"93021","daysToCover":1.79,"shortPercentOfFloat":0.62,"shortPriorMo":"112773","percentChangeMoMo":-17.51,"sharesFloat":"15009253","averageDailyVolume":"51970","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-07-02","settlementDate":"2024-06-28"},{"recordDate":"2024-06-26","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"112773","daysToCover":1.39,"shortPercentOfFloat":0.75,"shortPriorMo":"76968","percentChangeMoMo":46.52,"sharesFloat":"15009253","averageDailyVolume":"80944","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-06-18","settlementDate":"2024-06-14"},{"recordDate":"2024-06-11","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"76968","daysToCover":1.08,"shortPercentOfFloat":0.51,"shortPriorMo":"68075","percentChangeMoMo":13.06,"sharesFloat":"15009253","averageDailyVolume":"70963","sharesOutstanding":"18109393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-06-04","settlementDate":"2024-05-31"},{"recordDate":"2024-05-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"68075","daysToCover":1.34,"shortPercentOfFloat":0.52,"shortPriorMo":"83501","percentChangeMoMo":-18.47,"sharesFloat":"13209253","averageDailyVolume":"50882","sharesOutstanding":"16309393","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-05-17","settlementDate":"2024-05-15"},{"recordDate":"2024-05-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"83501","daysToCover":1.73,"shortPercentOfFloat":0.63,"shortPriorMo":"54928","percentChangeMoMo":52.02,"sharesFloat":"13151974","averageDailyVolume":"48172","sharesOutstanding":"16252114","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-05-02","settlementDate":"2024-04-30"},{"recordDate":"2024-04-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"54928","daysToCover":1,"shortPercentOfFloat":0.35,"shortPriorMo":"85573","percentChangeMoMo":-35.81,"sharesFloat":"15625575","averageDailyVolume":"92450","sharesOutstanding":"15717701","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-04-17","settlementDate":"2024-04-15"},{"recordDate":"2024-04-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"85573","daysToCover":1.15,"shortPercentOfFloat":0.55,"shortPriorMo":"50176","percentChangeMoMo":70.55,"sharesFloat":"15625575","averageDailyVolume":"74391","sharesOutstanding":"15717701","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-04-02","settlementDate":"2024-03-28"},{"recordDate":"2024-03-26","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"50176","daysToCover":1,"shortPercentOfFloat":0.32,"shortPriorMo":"70366","percentChangeMoMo":-28.69,"sharesFloat":"15614684","averageDailyVolume":"78381","sharesOutstanding":"15706810","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-03-19","settlementDate":"2024-03-15"},{"recordDate":"2024-03-11","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"70366","daysToCover":1,"shortPercentOfFloat":0.45,"shortPriorMo":"90552","percentChangeMoMo":-22.29,"sharesFloat":"15614684","averageDailyVolume":"86933","sharesOutstanding":"15706810","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-03-04","settlementDate":"2024-02-29"},{"recordDate":"2024-02-27","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"90552","daysToCover":1,"shortPercentOfFloat":0.58,"shortPriorMo":"192552","percentChangeMoMo":-52.97,"sharesFloat":"15614684","averageDailyVolume":"91834","sharesOutstanding":"15706810","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-02-20","settlementDate":"2024-02-15"},{"recordDate":"2024-02-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"192552","daysToCover":1.26,"shortPercentOfFloat":1.23,"shortPriorMo":"145976","percentChangeMoMo":31.91,"sharesFloat":"15614684","averageDailyVolume":"152352","sharesOutstanding":"15706810","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-02-02","settlementDate":"2024-01-31"},{"recordDate":"2024-01-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"145976","daysToCover":2.96,"shortPercentOfFloat":1.86,"shortPriorMo":"87715","percentChangeMoMo":66.42,"sharesFloat":"7850237","averageDailyVolume":"49316","sharesOutstanding":"7942363","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-01-17","settlementDate":"2024-01-12"},{"recordDate":"2024-01-10","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"87715","daysToCover":1,"shortPercentOfFloat":1.12,"shortPriorMo":"66260","percentChangeMoMo":32.38,"sharesFloat":"7850237","averageDailyVolume":"98246","sharesOutstanding":"7942363","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2024-01-03","settlementDate":"2023-12-29"},{"recordDate":"2023-12-27","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"66260","daysToCover":1.13,"shortPercentOfFloat":0.84,"shortPriorMo":"22601","percentChangeMoMo":193.17,"sharesFloat":"7850237","averageDailyVolume":"58464","sharesOutstanding":"7942363","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-12-19","settlementDate":"2023-12-15"},{"recordDate":"2023-12-11","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"22601","daysToCover":1,"shortPercentOfFloat":0.29,"shortPriorMo":"30472","percentChangeMoMo":-25.83,"sharesFloat":"7850237","averageDailyVolume":"36547","sharesOutstanding":"7942363","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-12-04","settlementDate":"2023-11-30"},{"recordDate":"2023-11-27","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"30472","daysToCover":1.02,"shortPercentOfFloat":0.39,"shortPriorMo":"41922","percentChangeMoMo":-27.31,"sharesFloat":"7724797","averageDailyVolume":"29927","sharesOutstanding":"7816923","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-11-17","settlementDate":"2023-11-15"},{"recordDate":"2023-11-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"41922","daysToCover":1,"shortPercentOfFloat":0.58,"shortPriorMo":"30429","percentChangeMoMo":37.77,"sharesFloat":"7233852","averageDailyVolume":"61292","sharesOutstanding":"7325978","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-11-02","settlementDate":"2023-10-31"},{"recordDate":"2023-10-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"30429","daysToCover":1,"shortPercentOfFloat":0.42,"shortPriorMo":"40229","percentChangeMoMo":-24.36,"sharesFloat":"7233852","averageDailyVolume":"32477","sharesOutstanding":"7325978","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-10-17","settlementDate":"2023-10-13"},{"recordDate":"2023-10-10","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"40229","daysToCover":1.16,"shortPercentOfFloat":0.56,"shortPriorMo":"29166","percentChangeMoMo":37.93,"sharesFloat":"7233852","averageDailyVolume":"34551","sharesOutstanding":"7325978","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-10-03","settlementDate":"2023-09-29"},{"recordDate":"2023-09-26","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"29166","daysToCover":1,"shortPercentOfFloat":0.4,"shortPriorMo":"37811","percentChangeMoMo":-22.86,"sharesFloat":"7233852","averageDailyVolume":"30541","sharesOutstanding":"7325978","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-09-19","settlementDate":"2023-09-15"},{"recordDate":"2023-09-12","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"37811","daysToCover":1,"shortPercentOfFloat":0.52,"shortPriorMo":"40677","percentChangeMoMo":-7.05,"sharesFloat":"7233852","averageDailyVolume":"39255","sharesOutstanding":"7325978","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-09-05","settlementDate":"2023-08-31"},{"recordDate":"2023-08-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"40677","daysToCover":1,"shortPercentOfFloat":0.63,"shortPriorMo":"46650","percentChangeMoMo":-12.8,"sharesFloat":"6427075","averageDailyVolume":"45247","sharesOutstanding":"6519201","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-08-17","settlementDate":"2023-08-15"},{"recordDate":"2023-08-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"46650","daysToCover":1,"shortPercentOfFloat":0.75,"shortPriorMo":"65210","percentChangeMoMo":-28.46,"sharesFloat":"6207419","averageDailyVolume":"53132","sharesOutstanding":"6299545","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-08-02","settlementDate":"2023-07-31"},{"recordDate":"2023-07-25","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"65210","daysToCover":2.65,"shortPercentOfFloat":1.05,"shortPriorMo":"79655","percentChangeMoMo":-18.13,"sharesFloat":"6207419","averageDailyVolume":"24592","sharesOutstanding":"6299545","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-07-18","settlementDate":"2023-07-14"},{"recordDate":"2023-07-12","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"79655","daysToCover":2.3,"shortPercentOfFloat":1.28,"shortPriorMo":"82524","percentChangeMoMo":-3.48,"sharesFloat":"6207419","averageDailyVolume":"34594","sharesOutstanding":"6299545","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-07-05","settlementDate":"2023-06-30"},{"recordDate":"2023-06-27","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"82524","daysToCover":1,"shortPercentOfFloat":1.33,"shortPriorMo":"463430","percentChangeMoMo":-82.19,"sharesFloat":"6207419","averageDailyVolume":"84556","sharesOutstanding":"6299545","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-06-20","settlementDate":"2023-06-15"},{"recordDate":"2023-06-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"463430","daysToCover":1.22,"shortPercentOfFloat":7.47,"shortPriorMo":"264121","percentChangeMoMo":75.46,"sharesFloat":"6207419","averageDailyVolume":"379854","sharesOutstanding":"6299545","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-06-02","settlementDate":"2023-05-31"},{"recordDate":"2023-05-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"264121","daysToCover":1.17,"shortPercentOfFloat":4.28,"shortPriorMo":"182658","percentChangeMoMo":44.6,"sharesFloat":"6171979","averageDailyVolume":"226681","sharesOutstanding":"6264105","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-05-17","settlementDate":"2023-05-15"},{"recordDate":"2023-05-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"182658","daysToCover":1.08,"shortPercentOfFloat":2.97,"shortPriorMo":"164114","percentChangeMoMo":11.3,"sharesFloat":"6151451","averageDailyVolume":"169606","sharesOutstanding":"6243577","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-05-02","settlementDate":"2023-04-28"},{"recordDate":"2023-04-25","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"164114","daysToCover":1,"shortPercentOfFloat":2.69,"shortPriorMo":"262232","percentChangeMoMo":-37.42,"sharesFloat":"6108226","averageDailyVolume":"227314","sharesOutstanding":"6200351","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-04-18","settlementDate":"2023-04-14"},{"recordDate":"2023-04-12","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"262232","daysToCover":1.54,"shortPercentOfFloat":4.29,"shortPriorMo":"170976","percentChangeMoMo":53.37,"sharesFloat":"6108226","averageDailyVolume":"169847","sharesOutstanding":"6200351","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-04-04","settlementDate":"2023-03-31"},{"recordDate":"2023-03-24","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"170976","daysToCover":1.74,"shortPercentOfFloat":2.8,"shortPriorMo":"176166","percentChangeMoMo":-2.95,"sharesFloat":"6116986","averageDailyVolume":"98228","sharesOutstanding":"6200351","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-03-17","settlementDate":"2023-03-15"},{"recordDate":"2023-03-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"176166","daysToCover":1.48,"shortPercentOfFloat":2.9,"shortPriorMo":"175029","percentChangeMoMo":0.65,"sharesFloat":"6074452","averageDailyVolume":"118822","sharesOutstanding":"6157818","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-03-02","settlementDate":"2023-02-28"},{"recordDate":"2023-02-27","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"175029","daysToCover":1.04,"shortPercentOfFloat":2.88,"shortPriorMo":"203305","percentChangeMoMo":-13.91,"sharesFloat":"6074452","averageDailyVolume":"167949","sharesOutstanding":"6157818","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-02-17","settlementDate":"2023-02-15"},{"recordDate":"2023-02-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"203305","daysToCover":1,"shortPercentOfFloat":3.35,"shortPriorMo":"782375","percentChangeMoMo":-74.01,"sharesFloat":"6074452","averageDailyVolume":"281042","sharesOutstanding":"6157818","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-02-02","settlementDate":"2023-01-31"},{"recordDate":"2023-01-25","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"782375","daysToCover":2.99,"shortPercentOfFloat":12.88,"shortPriorMo":"973492","percentChangeMoMo":-19.63,"sharesFloat":"6074452","averageDailyVolume":"261238","sharesOutstanding":"6157818","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-01-18","settlementDate":"2023-01-13"},{"recordDate":"2023-01-11","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"973492","daysToCover":2.41,"shortPercentOfFloat":16.03,"shortPriorMo":"1007371","percentChangeMoMo":-3.36,"sharesFloat":"6074452","averageDailyVolume":"403330","sharesOutstanding":"6157818","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2023-01-04","settlementDate":"2022-12-30"},{"recordDate":"2022-12-27","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"1007371","daysToCover":2.19,"shortPercentOfFloat":16.6,"shortPriorMo":"782303","percentChangeMoMo":28.77,"sharesFloat":"6069616","averageDailyVolume":"459882","sharesOutstanding":"6152982","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2022-12-19","settlementDate":"2022-12-15"},{"recordDate":"2022-12-09","symbol":"APTO","company":"Aptose Biosciences, Inc. Commo","totalShortInterest":"782303","daysToCover":5.4,"shortPercentOfFloat":12.89,"shortPriorMo":"692046","percentChangeMoMo":13.04,"sharesFloat":"6069616","averageDailyVolume":"144969","sharesOutstanding":"6152982","exchange":"SC","sector":"Healthcare","industry":"Biotechnology","exchangeReceiptDate":"2022-12-02","settlementDate":"2022-11-30"}],"splitsSummary":{"last":null,"next":null,"splits":[]},"symbol":"APTO","tickerDetails":{"symbol":"APTO","sharesOutstanding":19521183,"shareFloat":16429344,"sharesShort":123222,"sharesShortPercentOfFloat":0.75,"financialStats":{"operationRatiosAsOf1Y":"2023-12-31","revenueGrowth1Y":0},"company":{"exists":true,"fiscalYearEnd":12,"longDescription":"Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities."},"keyStatistics":{"revenueGrowth":0,"totalAssets":10929000,"longTermDebt":10000000,"currentRatio":1.048883,"tangibleBookValuePerShare":-0.4679},"peers":[],"percentiles":[]},"wiim":null,"earningsSummary":{"earnings":[{"currency":"USD","cusip":"03835T200","date":"2024-11-08","date_confirmed":1,"eps":"-0.370","eps_est":"-1.190","eps_prior":"-1.760","eps_surprise":"0.8200","eps_surprise_percent":"0.6891","eps_type":"GAAP","exchange":"NASDAQ","id":"654c893c336d940001b1cfb1","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","period":"Q3","period_year":2024,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1731099921},{"currency":"USD","cusip":"03835T200","date":"2024-08-08","date_confirmed":1,"eps":"-0.430","eps_est":"-0.860","eps_prior":"-2.270","eps_surprise":"0.4300","eps_surprise_percent":"0.5000","eps_type":"GAAP","exchange":"NASDAQ","id":"64d491403044f50001cb2434","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","period":"Q2","period_year":2024,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1723183215},{"currency":"USD","cusip":"03835T200","date":"2024-05-14","date_confirmed":1,"eps":"-0.730","eps_est":"-0.740","eps_prior":"-2.220","eps_surprise":"0.0100","eps_surprise_percent":"0.0135","eps_type":"GAAP","exchange":"NASDAQ","id":"6458a3e629cf91000117e2f2","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","period":"Q1","period_year":2024,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:02:00","updated":1715721192},{"currency":"USD","cusip":"03835T200","date":"2024-03-26","date_confirmed":1,"eps":"-1.440","eps_est":"-1.590","eps_prior":"-1.650","eps_surprise":"0.1500","eps_surprise_percent":"0.0943","eps_type":"GAAP","exchange":"NASDAQ","id":"642290a34a876f0001e6ce22","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Rev \u0026 EPS is calculated by deducting 12M - 9M Report","period":"Q4","period_year":2023,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:02:00","updated":1711483764},{"currency":"USD","cusip":"03835T200","date":"2023-11-09","date_confirmed":1,"eps":"-1.760","eps_est":"-2.050","eps_prior":"-1.650","eps_surprise":"0.2900","eps_surprise_percent":"0.1415","eps_type":"GAAP","exchange":"NASDAQ","id":"6360c40144a5cc00011e4df8","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","period":"Q3","period_year":2023,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:02:00","updated":1699564009},{"currency":"USD","cusip":"03835T200","date":"2023-08-10","date_confirmed":1,"eps":"-2.270","eps_est":"-2.010","eps_prior":"-1.650","eps_surprise":"-0.2600","eps_surprise_percent":"-0.1294","eps_type":"GAAP","exchange":"NASDAQ","id":"62e8cb86e8b34600012bfebc","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","period":"Q2","period_year":2023,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:02:00","updated":1691700137},{"currency":"USD","cusip":"03835T200","date":"2023-05-08","date_confirmed":1,"eps":"-2.250","eps_est":"-1.800","eps_prior":"-1.800","eps_surprise":"-0.4500","eps_surprise_percent":"-0.2500","eps_type":"GAAP","exchange":"NASDAQ","id":"6278bc0412d85100019fcb89","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q1","period_year":2023,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1686240539},{"currency":"USD","cusip":"03835T200","date":"2023-03-23","date_confirmed":1,"eps":"-1.650","eps_est":"-1.650","eps_prior":"-4.050","eps_surprise":"0.0000","eps_surprise_percent":"0.0000","eps_type":"GAAP","exchange":"NASDAQ","id":"623974014ab54b0001bff169","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q4","period_year":2022,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:44:00","updated":1686240538},{"currency":"USD","cusip":"03835T200","date":"2022-11-01","date_confirmed":1,"eps":"-1.650","eps_est":"-1.800","eps_prior":"-1.950","eps_surprise":"0.1500","eps_surprise_percent":"0.0833","eps_type":"GAAP","exchange":"NASDAQ","id":"618cbf7f9d47f700011bdecb","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q3","period_year":2022,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:01:00","updated":1686240542},{"currency":"USD","cusip":"03835T200","date":"2022-08-02","date_confirmed":1,"eps":"-1.650","eps_est":"-1.950","eps_prior":"-2.250","eps_surprise":"0.3000","eps_surprise_percent":"0.1538","eps_type":"GAAP","exchange":"NASDAQ","id":"6108e97bbf0b78000138730f","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q2","period_year":2022,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:01:00","updated":1686240537},{"currency":"USD","cusip":"03835T200","date":"2022-05-09","date_confirmed":1,"eps":"-1.800","eps_est":"-2.250","eps_prior":"-2.700","eps_surprise":"0.4500","eps_surprise_percent":"0.2000","eps_type":"GAAP","exchange":"NASDAQ","id":"6090f0fbdc107600019566d8","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q1","period_year":2022,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:01:00","updated":1686240537},{"currency":"USD","cusip":"03835T200","date":"2022-03-22","date_confirmed":1,"eps":"-4.050","eps_est":"-2.550","eps_prior":"-2.550","eps_surprise":"-1.5000","eps_surprise_percent":"-0.5882","eps_type":"GAAP","exchange":"NASDAQ","id":"605991ffb0ce0700013d13a5","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q4","period_year":2021,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:01:00","updated":1686240536},{"currency":"USD","cusip":"03835T200","date":"2021-11-11","date_confirmed":1,"eps":"-1.950","eps_est":"-2.550","eps_prior":"-2.250","eps_surprise":"0.6000","eps_surprise_percent":"0.2353","eps_type":"GAAP","exchange":"NASDAQ","id":"5fbf528395505d0001cd0338","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q3","period_year":2021,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1686240532},{"currency":"USD","cusip":"03835T200","date":"2021-08-03","date_confirmed":1,"eps":"-2.250","eps_est":"-2.100","eps_prior":"-3.150","eps_surprise":"-0.1500","eps_surprise_percent":"-0.0714","eps_type":"GAAP","exchange":"NASDAQ","id":"5f2907b32902dd0001f8552c","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q2","period_year":2021,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:01:00","updated":1686240531},{"currency":"USD","cusip":"03835T200","date":"2021-05-04","date_confirmed":1,"eps":"-2.700","eps_est":"-2.100","eps_prior":"-2.250","eps_surprise":"-0.6000","eps_surprise_percent":"-0.2857","eps_type":"GAAP","exchange":"NASDAQ","id":"5eb10f0113dffb0001540b3b","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q1","period_year":2021,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1686240533},{"currency":"USD","cusip":"03835T200","date":"2021-03-23","date_confirmed":1,"eps":"-2.550","eps_est":"-2.100","eps_prior":"-1.950","eps_surprise":"-0.4500","eps_surprise_percent":"-0.2143","eps_type":"GAAP","exchange":"NASDAQ","id":"5e673b02959da900019143af","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q4","period_year":2020,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1686240530},{"currency":"USD","cusip":"03835T200","date":"2020-11-10","date_confirmed":1,"eps":"-2.250","eps_est":"-2.250","eps_prior":"-1.800","eps_surprise":"0.0000","eps_surprise_percent":"0.0000","eps_type":"GAAP","exchange":"NASDAQ","id":"5dd2660acef4490001951968","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q3","period_year":2020,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1686240530},{"currency":"USD","cusip":"03835T200","date":"2020-08-04","date_confirmed":1,"eps":"-3.150","eps_est":"-2.250","eps_prior":"-1.950","eps_surprise":"-0.9000","eps_surprise_percent":"-0.4000","eps_type":"GAAP","exchange":"NASDAQ","id":"5d4918a224333a0001014264","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q2","period_year":2020,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1686240530},{"currency":"USD","cusip":"03835T200","date":"2020-05-05","date_confirmed":1,"eps":"-2.250","eps_est":"-2.250","eps_prior":"-2.100","eps_surprise":"0.0000","eps_surprise_percent":"0.0000","eps_type":"","exchange":"NASDAQ","id":"5cd7a892c4d51a927d3aa9de","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q1","period_year":2020,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"","ticker":"APTO","time":"16:00:00","updated":1686240529},{"currency":"USD","cusip":"03835T200","date":"2020-03-10","date_confirmed":1,"eps":"-1.950","eps_est":"-2.250","eps_prior":"-2.550","eps_surprise":"0.3000","eps_surprise_percent":"0.1333","eps_type":"","exchange":"NASDAQ","id":"5c8dd495c4d51af5064c2d7a","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"Split Adjusted EPS","period":"Q4","period_year":2019,"revenue":"0.000","revenue_est":"","revenue_prior":"0","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"","ticker":"APTO","time":"16:00:00","updated":1686240529}],"last":{"currency":"USD","cusip":"03835T200","date":"2024-11-08","date_confirmed":1,"eps":"-0.370","eps_est":"-1.190","eps_prior":"-1.760","eps_surprise":"0.8200","eps_surprise_percent":"0.6891","eps_type":"GAAP","exchange":"NASDAQ","id":"654c893c336d940001b1cfb1","importance":3,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","period":"Q3","period_year":2024,"revenue":"0.000","revenue_est":"","revenue_prior":"0.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"APTO","time":"16:00:00","updated":1731099921},"next":null,"year":null},"etfFund":null,"guidance":[],"guidanceSummary":{"guidance":[],"last":null,"next":null},"initialRecentNews":[{"assets":[{"type":"image","title":"Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today","alt":"ETF","source":"Image via Shutterstock","mime":"","primary":true,"attributes":{"fid":"901336","filename":"Netflix--TSMC--American-Express--Moderna.jpeg","filepath":"files/images/story/2024/11/25/Netflix--TSMC--American-Express--Moderna.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Avi Kapoor","channels":[{"tid":57,"vid":1,"name":"News"},{"tid":23,"vid":1,"name":"Pre-Market Outlook"},{"tid":2,"vid":1,"name":"Markets"},{"tid":24,"vid":1,"name":"Movers"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-25T10:27:33Z","createdAt":"2024-11-25T10:27:33Z","id":42158698,"image":"https://www.benzinga.com/files/images/story/2024/11/25/Netflix--TSMC--American-Express--Moderna.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3661,"Industry":"Telephone \u0026 Telegraph Apparatus","IndustryGroup":366,"MajorGroup":36,"Division":""},{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""},{"IndustryCode":2099,"Industry":"Food Preparations, N.E.C.","IndustryGroup":209,"MajorGroup":20,"Division":""},{"IndustryCode":2311,"Industry":"Men'S \u0026 Boys' Suits, Coats, \u0026 Overcoats","IndustryGroup":231,"MajorGroup":23,"Division":""},{"IndustryCode":2833,"Industry":"Medicinals \u0026 Botanicals","IndustryGroup":283,"MajorGroup":28,"Division":""},{"IndustryCode":1041,"Industry":"Gold Ores","IndustryGroup":104,"MajorGroup":10,"Division":""},{"IndustryCode":3355,"Industry":"Aluminum Rolling \u0026 Drawing, N.E.C.","IndustryGroup":335,"MajorGroup":33,"Division":""},{"IndustryCode":9612,"Industry":"Motion Picture \u0026 Video Distribution","IndustryGroup":961,"MajorGroup":96,"Division":""},{"IndustryCode":3572,"Industry":"Computer Storage Devices","IndustryGroup":357,"MajorGroup":35,"Division":""},{"IndustryCode":3571,"Industry":"Electronic Computers","IndustryGroup":357,"MajorGroup":35,"Division":""},{"IndustryCode":5045,"Industry":"Computers \u0026 Peripheral Equipment \u0026 Software","IndustryGroup":504,"MajorGroup":50,"Division":""},{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""}],"NAICS":[{"NationalIndustryCode":334290,"NationalIndustry":"Other Communications Equipment Manufacturing","IndustryCode":33429,"Industry":"Other Communications Equipment Manufacturing","IndustryGroupCode":3342,"IndustryGroup":"Communications Equipment Manufacturing","SubSectorCode":334,"SubSector":"Computer and Electronic Product Manufacturing","SectorCode":33,"Sector":"Manufacturing"},{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":311999,"NationalIndustry":"All Other Miscellaneous Food Manufacturing ","IndustryCode":31199,"Industry":"All Other Food Manufacturing","IndustryGroupCode":3119,"IndustryGroup":"Other Food Manufacturing","SubSectorCode":311,"SubSector":"Food Manufacturing","SectorCode":31,"Sector":"Manufacturing"},{"NationalIndustryCode":424330,"NationalIndustry":"Women's, Children's, and Infants' Clothing and Accessories Merchant Wholesalers ","IndustryCode":42433,"Industry":"Women's, Children's, and Infants' Clothing and Accessories Merchant Wholesalers ","IndustryGroupCode":4243,"IndustryGroup":"Apparel, Piece Goods, and Notions Merchant Wholesalers ","SubSectorCode":424,"SubSector":"Merchant Wholesalers, Nondurable Goods ","SectorCode":42,"Sector":"Wholesale Trade"},{"NationalIndustryCode":541715,"NationalIndustry":"Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) ","IndustryCode":54171,"Industry":"Research and Development in the Physical, Engineering, and Life Sciences","IndustryGroupCode":5417,"IndustryGroup":"Scientific Research and Development Services","SubSectorCode":541,"SubSector":"Professional, Scientific, and Technical Services","SectorCode":54,"Sector":"Professional, Scientific, and Technical Services"},{"NationalIndustryCode":212221,"NationalIndustry":"Gold Ore Mining ","IndustryCode":21222,"Industry":"Gold Ore and Silver Ore Mining","IndustryGroupCode":2122,"IndustryGroup":"Metal Ore Mining","SubSectorCode":212,"SubSector":"Mining (except Oil and Gas)","SectorCode":21,"Sector":"Mining, Quarrying, and Oil and Gas Extraction"},{"NationalIndustryCode":335929,"NationalIndustry":"Other Communication and Energy Wire Manufacturing ","IndustryCode":33592,"Industry":"Communication and Energy Wire and Cable Manufacturing","IndustryGroupCode":3359,"IndustryGroup":"Other Electrical Equipment and Component Manufacturing","SubSectorCode":335,"SubSector":"Electrical Equipment, Appliance, and Component Manufacturing","SectorCode":33,"Sector":"Manufacturing"},{"NationalIndustryCode":512110,"NationalIndustry":"Motion Picture and Video Production ","IndustryCode":51211,"Industry":"Motion Picture and Video Production","IndustryGroupCode":5121,"IndustryGroup":"Motion Picture and Video Industries","SubSectorCode":512,"SubSector":"Motion Picture and Sound Recording Industries","SectorCode":51,"Sector":"Information"},{"NationalIndustryCode":334112,"NationalIndustry":"Computer Storage Device Manufacturing ","IndustryCode":33411,"Industry":"Computer and Peripheral Equipment Manufacturing","IndustryGroupCode":3341,"IndustryGroup":"Computer and Peripheral Equipment Manufacturing","SubSectorCode":334,"SubSector":"Computer and Electronic Product Manufacturing","SectorCode":33,"Sector":"Manufacturing"},{"NationalIndustryCode":334111,"NationalIndustry":"Electronic Computer Manufacturing ","IndustryCode":33411,"Industry":"Computer and Peripheral Equipment Manufacturing","IndustryGroupCode":3341,"IndustryGroup":"Computer and Peripheral Equipment Manufacturing","SubSectorCode":334,"SubSector":"Computer and Electronic Product Manufacturing","SectorCode":33,"Sector":"Manufacturing"},{"NationalIndustryCode":334118,"NationalIndustry":"Computer Terminal and Other Computer Peripheral Equipment Manufacturing ","IndustryCode":33411,"Industry":"Computer and Peripheral Equipment Manufacturing","IndustryGroupCode":3341,"IndustryGroup":"Computer and Peripheral Equipment Manufacturing","SubSectorCode":334,"SubSector":"Computer and Electronic Product Manufacturing","SectorCode":33,"Sector":"Manufacturing"},{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":31120010,"Industry":"Communication Equipment","IndustryGroupCode":31120,"IndustryGroup":"Hardware","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":31110030,"Industry":"Software—Infrastructure","IndustryGroupCode":31110,"IndustryGroup":"Software","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":20610010,"Industry":"Biotechnology","IndustryGroupCode":20610,"IndustryGroup":"Biotechnology","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":20525040,"Industry":"Packaged Foods","IndustryGroupCode":20525,"IndustryGroup":"Consumer Packaged Goods","SectorCode":205,"Sector":"Consumer Defensive","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":10280010,"Industry":"Apparel Retail","IndustryGroupCode":10280,"IndustryGroup":"Retail—Cyclical","SectorCode":102,"Sector":"Consumer Cyclical","SuperSectorCode":1,"SuperSector":"Cyclical"},{"IndustryCode":10150040,"Industry":"Gold","IndustryGroupCode":10150,"IndustryGroup":"Metals \u0026 Mining","SectorCode":101,"Sector":"Basic Materials","SuperSectorCode":1,"SuperSector":"Cyclical"},{"IndustryCode":31110020,"Industry":"Software—Application","IndustryGroupCode":31110,"IndustryGroup":"Software","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":31120040,"Industry":"Electronic Components","IndustryGroupCode":31120,"IndustryGroup":"Hardware","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":30820040,"Industry":"Entertainment","IndustryGroupCode":30820,"IndustryGroup":"Media—Diversified","SectorCode":308,"Sector":"Communication Services","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":20645010,"Industry":"Medical Care Facilities","IndustryGroupCode":20645,"IndustryGroup":"Healthcare Providers \u0026 Services","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":31070060,"Industry":"Electrical Equipment \u0026 Parts","IndustryGroupCode":31070,"IndustryGroup":"Industrial Products","SectorCode":310,"Sector":"Industrials","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":31120020,"Industry":"Computer Hardware","IndustryGroupCode":31120,"IndustryGroup":"Hardware","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":10200010,"Industry":"Auto \u0026 Truck Dealerships","IndustryGroupCode":10200,"IndustryGroup":"Vehicles \u0026 Parts","SectorCode":102,"Sector":"Consumer Cyclical","SuperSectorCode":1,"SuperSector":"Cyclical"},{"IndustryCode":31080040,"Industry":"Marine Shipping","IndustryGroupCode":31080,"IndustryGroup":"Transportation","SectorCode":310,"Sector":"Industrials","SuperSectorCode":3,"SuperSector":"Sensitive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":662991,"post_path":"24/11/42158698/why-uxin-shares-are-trading-higher-here-are-20-stocks-moving-premarket","post_type":"post"}},"nodeId":42158698,"stocks":[{"tid":159820,"vid":2,"name":"AKTS"},{"tid":10504,"vid":2,"name":"ALLT","description":"Allotmmunication"},{"tid":146192,"vid":2,"name":"APTO","description":"Aptose Biosciences"},{"tid":816506,"vid":2,"name":"ARQQ","description":"ARQIT QUANTUM ORD"},{"tid":42956,"vid":2,"name":"CDXC"},{"tid":803537,"vid":2,"name":"DBGI"},{"tid":911107,"vid":2,"name":"ELAB"},{"tid":29183,"vid":2,"name":"GORO","description":"Gold Resource"},{"tid":69331,"vid":2,"name":"KC"},{"tid":752133,"vid":2,"name":"KULR","description":"KULR Technology Group, Inc."},{"tid":12001,"vid":2,"name":"LION","description":"Fidelity Sourthern"},{"tid":926289,"vid":2,"name":"NIVF","description":"NewGenIvf Group"},{"tid":9688,"vid":2,"name":"NVX","description":"Nuveen California Dividend Advantage Municipal Fund 2"},{"tid":737861,"vid":2,"name":"QMCO"},{"tid":725269,"vid":2,"name":"QUBT"},{"tid":834654,"vid":2,"name":"RGTI"},{"tid":722462,"vid":2,"name":"UXIN"},{"tid":721709,"vid":2,"name":"XCUR"},{"tid":920925,"vid":2,"name":"XTKG"},{"tid":790317,"vid":2,"name":"ZIM"}],"storyId":"67445111b6cb720001aa6391","tags":[{"tid":134703,"vid":3,"name":"Gainers"},{"tid":139492,"vid":3,"name":"Losers"},{"tid":753246,"vid":3,"name":"Premarket Movers"}],"teaser":" ","teaserText":" ","tickers":[{"tid":159820,"vid":2,"name":"AKTS"},{"tid":10504,"vid":2,"name":"ALLT","description":"Allotmmunication"},{"tid":146192,"vid":2,"name":"APTO","description":"Aptose Biosciences"},{"tid":816506,"vid":2,"name":"ARQQ","description":"ARQIT QUANTUM ORD"},{"tid":42956,"vid":2,"name":"CDXC"},{"tid":803537,"vid":2,"name":"DBGI"},{"tid":911107,"vid":2,"name":"ELAB"},{"tid":29183,"vid":2,"name":"GORO","description":"Gold Resource"},{"tid":69331,"vid":2,"name":"KC"},{"tid":752133,"vid":2,"name":"KULR","description":"KULR Technology Group, Inc."},{"tid":12001,"vid":2,"name":"LION","description":"Fidelity Sourthern"},{"tid":926289,"vid":2,"name":"NIVF","description":"NewGenIvf Group"},{"tid":9688,"vid":2,"name":"NVX","description":"Nuveen California Dividend Advantage Municipal Fund 2"},{"tid":737861,"vid":2,"name":"QMCO"},{"tid":725269,"vid":2,"name":"QUBT"},{"tid":834654,"vid":2,"name":"RGTI"},{"tid":722462,"vid":2,"name":"UXIN"},{"tid":721709,"vid":2,"name":"XCUR"},{"tid":920925,"vid":2,"name":"XTKG"},{"tid":790317,"vid":2,"name":"ZIM"}],"title":"Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket","updated":"2024-11-25T10:27:33Z","updatedAt":"2024-11-25T10:27:33Z","url":"https://www.benzinga.com/24/11/42158698/why-uxin-shares-are-trading-higher-here-are-20-stocks-moving-premarket"},{"assets":[{"type":"image","title":"Intuit,Sign,Is,Displayed,Near,Business,And,Financial,Software,Company","alt":"Intuit","source":"Intuit via Shutterstock","mime":"","primary":true,"attributes":{"fid":"901168","filename":"Intuit-Sign-Is-Displayed-Near-Business-A_1.jpeg","filepath":"files/images/story/2024/11/22/Intuit-Sign-Is-Displayed-Near-Business-A_1.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Avi Kapoor","channels":[{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"},{"tid":2,"vid":1,"name":"Markets"},{"tid":67,"vid":1,"name":"Analyst Ratings"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-22T19:18:42Z","createdAt":"2024-11-22T19:18:42Z","id":42145950,"image":"https://www.benzinga.com/files/images/story/2024/11/22/Intuit-Sign-Is-Displayed-Near-Business-A_1.jpeg","isBzPost":true,"isBzProPost":false,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3845,"Industry":"Electromedical \u0026 Electrotherapeutic Apparatus","IndustryGroup":384,"MajorGroup":38,"Division":""},{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""},{"IndustryCode":7379,"Industry":"Computer Related Services, N.E.C.","IndustryGroup":737,"MajorGroup":73,"Division":""},{"IndustryCode":7372,"Industry":"Prepackaged Software","IndustryGroup":737,"MajorGroup":73,"Division":""},{"IndustryCode":6719,"Industry":"Offices Of Holding Companies, N.E.C.","IndustryGroup":671,"MajorGroup":67,"Division":""},{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""}],"NAICS":[{"NationalIndustryCode":339112,"NationalIndustry":"Surgical and Medical Instrument Manufacturing ","IndustryCode":33911,"Industry":"Medical Equipment and Supplies Manufacturing","IndustryGroupCode":3391,"IndustryGroup":"Medical Equipment and Supplies Manufacturing","SubSectorCode":339,"SubSector":"Miscellaneous Manufacturing","SectorCode":33,"Sector":"Manufacturing"},{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":541519,"NationalIndustry":"Other Computer Related Services","IndustryCode":54151,"Industry":"Computer Systems Design and Related Services","IndustryGroupCode":5415,"IndustryGroup":"Computer Systems Design and Related Services","SubSectorCode":541,"SubSector":"Professional, Scientific, and Technical Services","SectorCode":54,"Sector":"Professional, Scientific, and Technical Services"},{"NationalIndustryCode":511210,"NationalIndustry":"Software Publishers","IndustryCode":51121,"Industry":"Software Publishers","IndustryGroupCode":5112,"IndustryGroup":"Software Publishers","SubSectorCode":511,"SubSector":"Publishing Industries (except Internet)","SectorCode":51,"Sector":"Information"},{"NationalIndustryCode":551112,"NationalIndustry":"Offices of Other Holding Companies ","IndustryCode":55111,"Industry":"Management of Companies and Enterprises","IndustryGroupCode":5511,"IndustryGroup":"Management of Companies and Enterprises","SubSectorCode":551,"SubSector":"Management of Companies and Enterprises","SectorCode":55,"Sector":"Management of Companies and Enterprises"}],"Morningstar":[{"IndustryCode":20650010,"Industry":"Medical Devices","IndustryGroupCode":20650,"IndustryGroup":"Medical Devices \u0026 Instruments","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":20610010,"Industry":"Biotechnology","IndustryGroupCode":20610,"IndustryGroup":"Biotechnology","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":31110030,"Industry":"Software—Infrastructure","IndustryGroupCode":31110,"IndustryGroup":"Software","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":31110020,"Industry":"Software—Application","IndustryGroupCode":31110,"IndustryGroup":"Software","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":31030010,"Industry":"Conglomerates","IndustryGroupCode":31030,"IndustryGroup":"Conglomerates","SectorCode":310,"Sector":"Industrials","SuperSectorCode":3,"SuperSector":"Sensitive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":false,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":false,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":661605,"post_path":"24/11/42145950/s-intuit-shares-fall-following-q1-results","post_type":"post"}},"nodeId":42145950,"stocks":[{"tid":920812,"vid":2,"name":"AMIX"},{"tid":146192,"vid":2,"name":"APTO","description":"Aptose Biosciences"},{"tid":160254,"vid":2,"name":"CETX"},{"tid":728907,"vid":2,"name":"ESTC"},{"tid":11830,"vid":2,"name":"INTU","description":"Intuit"},{"tid":12071,"vid":2,"name":"MATW","description":"Matthews International Corporation"},{"tid":90108,"vid":2,"name":"REPL","description":"REPL"}],"storyId":"6740d90fb6cb720001aa316a","tags":[{"tid":850735,"vid":3,"name":"PT Changes"}],"teaser":" ","teaserText":" ","tickers":[{"tid":920812,"vid":2,"name":"AMIX"},{"tid":146192,"vid":2,"name":"APTO","description":"Aptose Biosciences"},{"tid":160254,"vid":2,"name":"CETX"},{"tid":728907,"vid":2,"name":"ESTC"},{"tid":11830,"vid":2,"name":"INTU","description":"Intuit"},{"tid":12071,"vid":2,"name":"MATW","description":"Matthews International Corporation"},{"tid":90108,"vid":2,"name":"REPL","description":"REPL"}],"title":"S\u0026amp;P 500 Moves Higher; Intuit Shares Fall Following Q1 Results","updated":"2024-11-22T19:18:43Z","updatedAt":"2024-11-22T19:18:43Z","url":"https://www.benzinga.com/24/11/42145950/s-intuit-shares-fall-following-q1-results"},{"assets":[{"type":"image","title":"oil-prices-5079975","alt":"shell stock","source":"","mime":"","primary":true,"attributes":{"fid":"901144","filename":"oil-prices-5079975.jpeg","filepath":"files/images/story/2024/11/22/oil-prices-5079975.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Avi Kapoor","channels":[{"tid":16888,"vid":1,"name":"Earnings"},{"tid":24769,"vid":1,"name":"Equities"},{"tid":57,"vid":1,"name":"News"},{"tid":125557,"vid":1,"name":"Eurozone"},{"tid":36240,"vid":1,"name":"Commodities"},{"tid":25,"vid":1,"name":"Intraday Update"},{"tid":2,"vid":1,"name":"Markets"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-22T18:16:56Z","createdAt":"2024-11-22T18:16:56Z","id":42144711,"image":"https://www.benzinga.com/files/images/story/2024/11/22/oil-prices-5079975.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3845,"Industry":"Electromedical \u0026 Electrotherapeutic Apparatus","IndustryGroup":384,"MajorGroup":38,"Division":""},{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""},{"IndustryCode":7379,"Industry":"Computer Related Services, N.E.C.","IndustryGroup":737,"MajorGroup":73,"Division":""},{"IndustryCode":6719,"Industry":"Offices Of Holding Companies, N.E.C.","IndustryGroup":671,"MajorGroup":67,"Division":""},{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""},{"IndustryCode":5651,"Industry":"Family Clothing Stores","IndustryGroup":565,"MajorGroup":56,"Division":""}],"NAICS":[{"NationalIndustryCode":339112,"NationalIndustry":"Surgical and Medical Instrument Manufacturing ","IndustryCode":33911,"Industry":"Medical Equipment and Supplies Manufacturing","IndustryGroupCode":3391,"IndustryGroup":"Medical Equipment and Supplies Manufacturing","SubSectorCode":339,"SubSector":"Miscellaneous Manufacturing","SectorCode":33,"Sector":"Manufacturing"},{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":541519,"NationalIndustry":"Other Computer Related Services","IndustryCode":54151,"Industry":"Computer Systems Design and Related Services","IndustryGroupCode":5415,"IndustryGroup":"Computer Systems Design and Related Services","SubSectorCode":541,"SubSector":"Professional, Scientific, and Technical Services","SectorCode":54,"Sector":"Professional, Scientific, and Technical Services"},{"NationalIndustryCode":511210,"NationalIndustry":"Software Publishers","IndustryCode":51121,"Industry":"Software Publishers","IndustryGroupCode":5112,"IndustryGroup":"Software Publishers","SubSectorCode":511,"SubSector":"Publishing Industries (except Internet)","SectorCode":51,"Sector":"Information"},{"NationalIndustryCode":551112,"NationalIndustry":"Offices of Other Holding Companies ","IndustryCode":55111,"Industry":"Management of Companies and Enterprises","IndustryGroupCode":5511,"IndustryGroup":"Management of Companies and Enterprises","SubSectorCode":551,"SubSector":"Management of Companies and Enterprises","SectorCode":55,"Sector":"Management of Companies and Enterprises"},{"NationalIndustryCode":448140,"NationalIndustry":"Family Clothing Stores ","IndustryCode":44814,"Industry":"Family Clothing Stores ","IndustryGroupCode":4481,"IndustryGroup":"Clothing Stores ","SubSectorCode":448,"SubSector":"Clothing and Clothing Accessories Stores ","SectorCode":44,"Sector":"Retail Trade"}],"Morningstar":[{"IndustryCode":20650010,"Industry":"Medical Devices","IndustryGroupCode":20650,"IndustryGroup":"Medical Devices \u0026 Instruments","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":20610010,"Industry":"Biotechnology","IndustryGroupCode":20610,"IndustryGroup":"Biotechnology","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":31110030,"Industry":"Software—Infrastructure","IndustryGroupCode":31110,"IndustryGroup":"Software","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":31110020,"Industry":"Software—Application","IndustryGroupCode":31110,"IndustryGroup":"Software","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":31030010,"Industry":"Conglomerates","IndustryGroupCode":31030,"IndustryGroup":"Conglomerates","SectorCode":310,"Sector":"Industrials","SuperSectorCode":3,"SuperSector":"Sensitive"},{"IndustryCode":10280010,"Industry":"Apparel Retail","IndustryGroupCode":10280,"IndustryGroup":"Retail—Cyclical","SectorCode":102,"Sector":"Consumer Cyclical","SuperSectorCode":1,"SuperSector":"Cyclical"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":661251,"post_path":"24/11/42144711/crude-oil-gains-over-1-ross-stores-earnings-top-views","post_type":"post"}},"nodeId":42144711,"stocks":[{"tid":920812,"vid":2,"name":"AMIX"},{"tid":146192,"vid":2,"name":"APTO","description":"Aptose Biosciences"},{"tid":160254,"vid":2,"name":"CETX"},{"tid":728907,"vid":2,"name":"ESTC"},{"tid":12071,"vid":2,"name":"MATW","description":"Matthews International Corporation"},{"tid":90108,"vid":2,"name":"REPL","description":"REPL"},{"tid":12779,"vid":2,"name":"ROST","description":"Ross Stores"}],"storyId":"6740ca95b6cb720001aa2c45","tags":[{"tid":126586,"vid":3,"name":"Mid Day Market Update"}],"teaser":" ","teaserText":" ","tickers":[{"tid":920812,"vid":2,"name":"AMIX"},{"tid":146192,"vid":2,"name":"APTO","description":"Aptose Biosciences"},{"tid":160254,"vid":2,"name":"CETX"},{"tid":728907,"vid":2,"name":"ESTC"},{"tid":12071,"vid":2,"name":"MATW","description":"Matthews International Corporation"},{"tid":90108,"vid":2,"name":"REPL","description":"REPL"},{"tid":12779,"vid":2,"name":"ROST","description":"Ross Stores"}],"title":"Crude Oil Gains Over 1%; Ross Stores Earnings Top Views","updated":"2024-11-22T18:16:57Z","updatedAt":"2024-11-22T18:16:57Z","url":"https://www.benzinga.com/24/11/42144711/crude-oil-gains-over-1-ross-stores-earnings-top-views"}],"isPublicComSupported":false,"listings":[{"symbol":"APTO","type":"STOCK","cik":882361,"name":"Aptose Biosciences Inc","exchange":"NASDAQ","shortName":"Aptose Biosciences Inc","description":"Aptose Biosciences, Inc. - Common Shares","currency":"USD"},{"symbol":"APM","type":"STOCK","cik":1734005,"name":"Aptorum Group Ltd","exchange":"NASDAQ","shortName":"Aptorum Group Ltd","description":"Aptorum Group Limited - Class A Ordinary Shares","currency":"USD"},{"symbol":"APT/USD","type":"CRYPTO","cik":0,"name":"Aptos - United States Dollar","exchange":"CRYPTO","shortName":"Aptos - United States Dollar","description":"Aptos - United States Dollar","currency":"USD"}],"newsAll":[{"id":42162917,"author":"Benzinga Newsdesk","created":"Mon, 25 Nov 2024 08:36:57 -0500","updated":"Mon, 25 Nov 2024 08:36:57 -0500","title":"Aptose Biosciences shares are trading lower after the company announced the pricing of an $8M public offering.","teaser":"","body":"","url":"https://www.benzinga.com/wiim/24/11/42162917/aptose-biosciences-shares-are-trading-lower-after-the-company-announced-the-pricing-of-an-8m-public","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":726669,"name":"WIIM","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42162917\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42162917\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42158698,"author":"Avi Kapoor","created":"Mon, 25 Nov 2024 05:27:33 -0500","updated":"Mon, 25 Nov 2024 05:27:33 -0500","title":"Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket","teaser":" ","body":"\u003cp\u003eShares of \u003cstrong\u003eUxin Limited\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/UXIN#NYSE\"\u003eUXIN\u003c/a\u003e) rose sharply in today's pre-market trading after the company reported \u003ca href=\"https://www.benzinga.com/quote/UXIN/earnings\"\u003esecond-quarter financial results.\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eUxin posted quarterly sales of $70.85 million, up from $48.80 million in the year-ago period\u003c/p\u003e\n\u003cp\u003eUxin shares rose 3% to $6.50 in the pre-market trading session.\u003c/p\u003e\n\u003cp\u003eHere are some other stocks moving in pre-market trading.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eGainers\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRigetti Computing, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/RGTI#NASDAQ\"\u003eRGTI\u003c/a\u003e) gained 59.2% to $2.77 in pre-market trading after climbing around 18% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eQuantum Corporation\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/QMCO#NASDAQ\"\u003eQMCO\u003c/a\u003e) rose 40.4% to $12.84 in pre-market trading after jumping 127% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eKULR Technology Group, Inc\u003c/strong\u003e. (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/KULR#NYSE\"\u003eKULR\u003c/a\u003e) gained 29.8% to $0.5777 in pre-market trading after gaining around 7% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eExicure, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/XCUR#NASDAQ\"\u003eXCUR\u003c/a\u003e) gained 28.4% to $23.59 in pre-market trading after jumping around 69% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eArqit Quantum Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ARQQ#NASDAQ\"\u003eARQQ\u003c/a\u003e) gained 22% to $15.76 in pre-market trading after gaining 21% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eNOVONIX Limited\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/NVX#NASDAQ\"\u003eNVX\u003c/a\u003e) gained 19.1% to $2.31 in pre-market trading. Novonix secured a 32,000-tonne offtake agreement with Volkswagen\u0026#8217;s PowerCo for synthetic graphite supply.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eQuantum Computing Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/QUBT#NASDAQ\"\u003eQUBT\u003c/a\u003e) gained 16.9% to $7.13 in pre-market trading after jumping 28% on Friday. \u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAllot Ltd.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ALLT#NASDAQ\"\u003eALLT\u003c/a\u003e) climbed 16.7% to $4.94 in pre-market trading. Allot, last week, reported better-than-expected quarterly financial results.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eLionsgate Studios Corp\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/LION#NASDAQ\"\u003eLION\u003c/a\u003e) gained 11.2% to $7.89 in pre-market trading.\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eLosers\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAkoustis Technologies, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AKTS#NASDAQ\"\u003eAKTS\u003c/a\u003e) shares tumbled 37.5% to $0.0629 in pre-market trading\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAptose Biosciences Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) shares fell 17.8% to $0.1560 in pre-market trading. Aptose Biosciences shares dipped 22% on Friday after the company announced the pricing of an $8 million public offering.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eX3 Holdings Co., Ltd\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/XTKG#NASDAQ\"\u003eXTKG\u003c/a\u003e) declined 16.6% to $1.76 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eNewGenIvf Group Ltd\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/NIVF#NASDAQ\"\u003eNIVF\u003c/a\u003e) fell 16.1% to $0.43 in pre-market trading after declining 6% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eElevai Labs Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ELAB#NASDAQ\"\u003eELAB\u003c/a\u003e) fell 13.9% to $0.0173 in pre-market trading. Elevai Labs implemented a 1-for-200 reverse stock split to retain Nasdaq listing, reducing shares to 3.07 million.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eGold Resource Corporation\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GORO#NYSE\"\u003eGORO\u003c/a\u003e) shares fell 13.1% to $0.1368 in pre-market trading after gaining 6% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eDigital Brands Group, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DBGI#NASDAQ\"\u003eDBGI\u003c/a\u003e) dipped 12.4% to $0.1063 in pre-market trading after falling over 4% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eZIM Integrated Shipping Services Ltd\u003c/strong\u003e. (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ZIM#NYSE\"\u003eZIM\u003c/a\u003e) shares dipped 6.9% to $22.15 in pre-market trading. ZIM Integrated Shipping Services, last week, reported better-than-expected third-quarter financial results and raised its FY24 adjusted EBIT and EBITDA guidance.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eChromaDex Corporation\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CDXC#NASDAQ\"\u003eCDXC\u003c/a\u003e) fell 5.9% to $7.00 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eKingsoft Cloud Holdings Limited\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/KC#NASDAQ\"\u003eKC\u003c/a\u003e) fell 4.3% to $6.90 in today's pre-market trading after jumping around 25% on Friday. Kingsoft Cloud, last week, reported a fiscal third-quarter 2024 revenue of 1.89 billion Chinese yuan ($268.7 million), up by 16.0% year-on-year, beating the analyst consensus estimate of $247.46 million\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNow Read This: \u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin\"\u003eJim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n","url":"https://www.benzinga.com/24/11/42158698/why-uxin-shares-are-trading-higher-here-are-20-stocks-moving-premarket","image":"https://cdn.benzinga.com/files/images/story/2024/11/25/Netflix--TSMC--American-Express--Moderna.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/25/Netflix--TSMC--American-Express--Moderna.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/25/Netflix--TSMC--American-Express--Moderna.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":57,"name":"News","description":""},{"tid":23,"name":"Pre-Market Outlook","description":""},{"tid":2,"name":"Markets","description":""},{"tid":24,"name":"Movers","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":159820,"name":"AKTS","description":""},{"tid":10504,"name":"ALLT","description":"Allotmmunication"},{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":816506,"name":"ARQQ","description":"ARQIT QUANTUM ORD"},{"tid":42956,"name":"CDXC","description":""},{"tid":803537,"name":"DBGI","description":null},{"tid":911107,"name":"ELAB","description":""},{"tid":29183,"name":"GORO","description":"Gold Resource"},{"tid":69331,"name":"KC","description":""},{"tid":752133,"name":"KULR","description":"KULR Technology Group, Inc."},{"tid":12001,"name":"LION","description":"Fidelity Sourthern"},{"tid":926289,"name":"NIVF","description":"NewGenIvf Group"},{"tid":9688,"name":"NVX","description":"Nuveen California Dividend Advantage Municipal Fund 2"},{"tid":737861,"name":"QMCO","description":""},{"tid":725269,"name":"QUBT","description":null},{"tid":834654,"name":"RGTI","description":null},{"tid":722462,"name":"UXIN","description":""},{"tid":721709,"name":"XCUR","description":null},{"tid":920925,"name":"XTKG","description":null},{"tid":790317,"name":"ZIM","description":null}],"tags":[{"tid":134703,"name":"Gainers","description":""},{"tid":139492,"name":"Losers","description":""},{"tid":753246,"name":"Premarket Movers","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42158698\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42158698\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42145950,"author":"Avi Kapoor","created":"Fri, 22 Nov 2024 14:18:42 -0500","updated":"Fri, 22 Nov 2024 14:18:43 -0500","title":"S\u0026P 500 Moves Higher; Intuit Shares Fall Following Q1 Results","teaser":" ","body":"\u003cp\u003eU.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 350 points on Friday.\u003c/p\u003e\n\u003cp\u003eThe Dow traded up 0.82% to 44,228.50 while the NASDAQ rose 0.14% to 18,998.27. The S\u0026amp;P 500 also rose, gaining, 0.31% to 5,966.91.\u003c/p\u003e\n\u003cp\u003eCheck This Out: \u003ca href=\"https://www.benzinga.com/24/11/42135346/top-3-materials-stocks-that-could-blast-off-in-november\"\u003eTop 3 Materials Stocks That Could Blast Off In November\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLeading and Lagging Sectors\u003c/strong\u003e\u003cbr /\u003e\u003cbr /\u003eConsumer staples shares rose by 1.5% on Friday.\u003c/p\u003e\n\u003cp\u003eIn trading on Friday, communication services shares fell by 0.6%.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTop Headline\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eShares of \u003cstrong\u003eIntuit Inc\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/INTU#NASDAQ\"\u003eINTU\u003c/a\u003e) fell over 5% on Friday after the company reported upbeat results for its first-quarter results, but issued weak forecast for the current quarter.\u003c/p\u003e\n\u003cp\u003eThe company reported quarterly earnings of $2.50 per share, which beat the analyst consensus estimate of $2.35 per share. Quarterly revenue came in at $3.28 billion which beat the consensus estimate of $3.14 billion\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEquities Trading UP\u003c/strong\u003e\u003cbr /\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eElastic N.V. \u003c/strong\u003e(NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ESTC#NYSE\"\u003eESTC\u003c/a\u003e) shares shot up 16% to $109.17 after the company reported better-than-expected second-quarter financial results and issued FY25 guidance above estimates.\u003c/li\u003e\n\u003cli\u003eShares of \u003cstrong\u003eMatthews International Corporation \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MATW#NASDAQ\"\u003eMATW\u003c/a\u003e) got a boost, surging 19% to $30.26 following upbeat earnings.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eReplimune Group, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/REPL#NASDAQ\"\u003eREPL\u003c/a\u003e) shares were also up, gaining 45% to $16.00 after the company on Thursday announced it received breakthrough therapy designation status for RP1 and will submit an RP1 biologics license application to the FDA under an accelerated approval pathway.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eEquities Trading DOWN\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAutonomix Medical, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AMIX#NASDAQ\"\u003eAMIX\u003c/a\u003e) shares dropped 55% to $6.11 after the company announced the pricing of a $9 million underwritten public offering.\u003c/li\u003e\n\u003cli\u003eShares of \u003cstrong\u003eAptose Biosciences Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) were down 43% to $0.1390 after the company announced the pricing of an $8 million public offering.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCemtrex, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CETX#NASDAQ\"\u003eCETX\u003c/a\u003e) was down, falling 41% to $0.1164 after the company announced its board approved a 1-for-35 reverse stock split.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCommodities\u003c/strong\u003e\u003cbr /\u003e\u003cbr /\u003eIn commodity news, oil traded up 1.5% to $71.16 while gold traded up 1.1% at $2,704.00.\u003c/p\u003e\n\u003cp\u003eSilver traded up 1.1% to $31.275 on Friday, while copper fell 0.8% to $4.0940.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEuro zone\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eEuropean shares were higher today. The eurozone's STOXX 600 rose 1.12%, Germany's DAX gained 0.77% and France's CAC 40 rose 0.46%. Spain's IBEX 35 Index rose 0.16%, while London's FTSE 100 gained 1.35%.\u003c/p\u003e\n\u003cp\u003eThe S\u0026amp;P Global UK composite PMI declined to 49.9 in November versus 51.8 in the previous month, while Eurozone composite PMI dipped to 48.1 in November from 50 in the prior month.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAsia Pacific Markets\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAsian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.68%, Hong Kong's Hang Seng Index falling 1.89%, China's Shanghai Composite Index dipping 3.06% and India's BSE Sensex gaining 2.54%.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEconomics\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe S\u0026amp;P Global US Services PMI climbed to 57 in November versus 55 in the previous month, while manufacturing PMI increased to 48.8 in November from 48.5 in the previous month.\u003c/li\u003e\n\u003cli\u003eThe University of Michigan consumer sentiment for the US fell to 71.8 in November versus a preliminary reading of 73.\u003c/li\u003e\n\u003cli\u003eThe year-ahead inflation expectations in the U.S fell to 2.6% in November from 2.7% in October.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eNow Read This: \u003ca href=\"https://www.benzinga.com/24/11/42135946/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-with-over-3-dividend-yields-3\"\u003eWall Street\u0026#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields\u003c/a\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/24/11/42145950/s-intuit-shares-fall-following-q1-results","image":"https://cdn.benzinga.com/files/images/story/2024/11/22/Intuit-Sign-Is-Displayed-Near-Business-A_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/22/Intuit-Sign-Is-Displayed-Near-Business-A_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/22/Intuit-Sign-Is-Displayed-Near-Business-A_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":16888,"name":"Earnings","description":""},{"tid":57,"name":"News","description":""},{"tid":2,"name":"Markets","description":""},{"tid":67,"name":"Analyst Ratings","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":920812,"name":"AMIX","description":null},{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":160254,"name":"CETX","description":""},{"tid":728907,"name":"ESTC","description":""},{"tid":11830,"name":"INTU","description":"Intuit"},{"tid":12071,"name":"MATW","description":"Matthews International Corporation"},{"tid":90108,"name":"REPL","description":"REPL"}],"tags":[{"tid":850735,"name":"PT Changes","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42145950\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42145950\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42145950\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42144711,"author":"Avi Kapoor","created":"Fri, 22 Nov 2024 13:16:56 -0500","updated":"Fri, 22 Nov 2024 13:16:57 -0500","title":"Crude Oil Gains Over 1%; Ross Stores Earnings Top Views","teaser":" ","body":"\u003cp\u003eU.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining by more than 250 points on Friday.\u003c/p\u003e\n\u003cp\u003eThe Dow traded up 0.59% to 44,128.84 while the NASDAQ rose 0.08% to 18,986.80. The S\u0026amp;P 500 also rose, gaining, 0.28% to 5,965.15.\u003c/p\u003e\n\u003cp\u003eCheck This Out: \u003ca href=\"https://www.benzinga.com/24/11/42135346/top-3-materials-stocks-that-could-blast-off-in-november\"\u003eTop 3 Materials Stocks That Could Blast Off In November\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLeading and Lagging Sectors\u003c/strong\u003e\u003cbr /\u003e\u003cbr /\u003eConsumer staples shares rose by 1.5% on Friday.\u003c/p\u003e\n\u003cp\u003eIn trading on Friday, communication services shares fell by 0.6%.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTop Headline\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRoss Stores\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ROST#NASDAQ\"\u003eROST\u003c/a\u003e) reported better-than-expected third-quarter EPS results.\u003c/p\u003e\n\u003cp\u003eThe company said it sees FY25 earnings of $6.10 to $6.17 per share\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEquities Trading UP\u003c/strong\u003e\u003cbr /\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eElastic N.V. \u003c/strong\u003e(NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ESTC#NYSE\"\u003eESTC\u003c/a\u003e) shares shot up 16% to $109.17 after the company reported better-than-expected second-quarter financial results and issued FY25 guidance above estimates.\u003c/li\u003e\n\u003cli\u003eShares of \u003cstrong\u003eMatthews International Corporation \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MATW#NASDAQ\"\u003eMATW\u003c/a\u003e) got a boost, surging 19% to $30.26 following upbeat earnings.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eReplimune Group, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/REPL#NASDAQ\"\u003eREPL\u003c/a\u003e) shares were also up, gaining 45% to $16.00 after the company on Thursday announced it received breakthrough therapy designation status for RP1 and will submit an RP1 biologics license application to the FDA under an accelerated approval pathway.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eEquities Trading DOWN\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAutonomix Medical, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AMIX#NASDAQ\"\u003eAMIX\u003c/a\u003e) shares dropped 55% to $6.11 after the company announced the pricing of a $9 million underwritten public offering.\u003c/li\u003e\n\u003cli\u003eShares of \u003cstrong\u003eAptose Biosciences Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) were down 43% to $0.1390 after the company announced the pricing of an $8 million public offering.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCemtrex, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CETX#NASDAQ\"\u003eCETX\u003c/a\u003e) was down, falling 41% to $0.1164 after the company announced its board approved a 1-for-35 reverse stock split.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCommodities\u003c/strong\u003e\u003cbr /\u003e\u003cbr /\u003eIn commodity news, oil traded up 1.5% to $71.16 while gold traded up 1.1% at $2,704.00.\u003c/p\u003e\n\u003cp\u003eSilver traded up 1.1% to $31.275 on Friday, while copper fell 0.8% to $4.0940.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEuro zone\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eEuropean shares were higher today. The eurozone's STOXX 600 rose 1.12%, Germany's DAX gained 0.77% and France's CAC 40 rose 0.46%. Spain's IBEX 35 Index rose 0.16%, while London's FTSE 100 gained 1.35%.\u003c/p\u003e\n\u003cp\u003eThe S\u0026amp;P Global UK composite PMI declined to 49.9 in November versus 51.8 in the previous month, while Eurozone composite PMI dipped to 48.1 in November from 50 in the prior month.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAsia Pacific Markets\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAsian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.68%, Hong Kong's Hang Seng Index falling 1.89%, China's Shanghai Composite Index dipping 3.06% and India's BSE Sensex gaining 2.54%.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEconomics\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe S\u0026amp;P Global US Services PMI climbed to 57 in November versus 55 in the previous month, while manufacturing PMI increased to 48.8 in November from 48.5 in the previous month.\u003c/li\u003e\n\u003cli\u003eThe University of Michigan consumer sentiment for the US fell to 71.8 in November versus a preliminary reading of 73.\u003c/li\u003e\n\u003cli\u003eThe year-ahead inflation expectations in the U.S fell to 2.6% in November from 2.7% in October.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNow Read This: \u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/24/11/42135946/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-with-over-3-dividend-yields-3\"\u003eWall Street\u0026#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n","url":"https://www.benzinga.com/24/11/42144711/crude-oil-gains-over-1-ross-stores-earnings-top-views","image":"https://cdn.benzinga.com/files/images/story/2024/11/22/oil-prices-5079975.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/22/oil-prices-5079975.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/22/oil-prices-5079975.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":16888,"name":"Earnings","description":""},{"tid":24769,"name":"Equities","description":""},{"tid":57,"name":"News","description":""},{"tid":125557,"name":"Eurozone","description":""},{"tid":36240,"name":"Commodities","description":""},{"tid":25,"name":"Intraday Update","description":""},{"tid":2,"name":"Markets","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":920812,"name":"AMIX","description":null},{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":160254,"name":"CETX","description":""},{"tid":728907,"name":"ESTC","description":""},{"tid":12071,"name":"MATW","description":"Matthews International Corporation"},{"tid":90108,"name":"REPL","description":"REPL"},{"tid":12779,"name":"ROST","description":"Ross Stores"}],"tags":[{"tid":126586,"name":"Mid Day Market Update","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42144711\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42144711\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42144711\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42140418,"author":"Avi Kapoor","created":"Fri, 22 Nov 2024 10:23:20 -0500","updated":"Fri, 22 Nov 2024 10:23:20 -0500","title":"Dow Jumps 300 Points; Gap Posts Upbeat Earnings","teaser":" ","body":"\u003cp\u003eU.S. stocks traded higher this morning, with the Dow Jones index gaining by more than 300 points on Friday.\u003c/p\u003e\n\u003cp\u003eFollowing the market opening Friday, the Dow traded up 0.72% to 44,184.62 while the NASDAQ rose 0.07% to 18,985.33. The S\u0026amp;P 500 also rose, gaining, 0.35% to 5,969.29.\u003c/p\u003e\n\u003cp\u003eCheck This Out: \u003ca href=\"https://www.benzinga.com/24/11/42135346/top-3-materials-stocks-that-could-blast-off-in-november\"\u003eTop 3 Materials Stocks That Could Blast Off In November\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLeading and Lagging Sectors\u003c/strong\u003e\u003cbr /\u003e\u003cbr /\u003eConsumer staples shares rose by 1% on Friday.\u003c/p\u003e\n\u003cp\u003eIn trading on Friday, communication services shares fell by 0.4%.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTop Headline\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGap, Inc.\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GAP#NYSE\"\u003eGAP\u003c/a\u003e) reported better-than-expected earnings for its second quarter and raised its outlook for FY24 gross margin.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;The company reported quarterly earnings of 54 cents per share, which beat the analyst consensus estimate of 40 cents per share.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEquities Trading UP\u003c/strong\u003e\u003cbr /\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eSKK Holdings Limited \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SKK#NASDAQ\"\u003eSKK\u003c/a\u003e) shares shot up 76% to $1.95 after declining around 75% on Wednesday.\u003c/li\u003e\n\u003cli\u003eShares of \u003cstrong\u003eDevvStream Corp. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DEVS#NASDAQ\"\u003eDEVS\u003c/a\u003e) got a boost, surging 77% to $0.8931.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eReplimune Group, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/REPL#NASDAQ\"\u003eREPL\u003c/a\u003e) shares were also up, gaining 48% to $16.37 after the company on Thursday announced it received breakthrough therapy designation status for RP1 and will submit an RP1 biologics license application to the FDA under an accelerated approval pathway.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eEquities Trading DOWN\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAutonomix Medical, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AMIX#NASDAQ\"\u003eAMIX\u003c/a\u003e) shares dropped 52% to $6.53 after the company announced the pricing of a $9 million underwritten public offering.\u003c/li\u003e\n\u003cli\u003eShares of \u003cstrong\u003eAptose Biosciences Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) were down 44% to $0.1374 after the company announced the pricing of an $8 million public offering.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCemtrex, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CETX#NASDAQ\"\u003eCETX\u003c/a\u003e) was down, falling 42% to $0.1148 after the company announced its board approved a 1-for-35 reverse stock split.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCommodities\u003c/strong\u003e\u003cbr /\u003e\u003cbr /\u003eIn commodity news, oil traded up 0.8% to $70.67 while gold traded up 0.9% at $2,697.70.\u003c/p\u003e\n\u003cp\u003eSilver traded up 1.2% to $31.33 on Thursday, while copper fell 0.8% to $4.0910.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEuro zone\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eEuropean shares were higher today. The eurozone's STOXX 600 rose 1.2%, Germany's DAX gained 0.9% and France's CAC 40 rose 0.7%. Spain's IBEX 35 Index rose 0.2%, while London's FTSE 100 gained 1.4%.\u003c/p\u003e\n\u003cp\u003eThe S\u0026amp;P Global UK composite PMI declined to 49.9 in November versus 51.8 in the previous month, while Eurozone composite PMI dipped to 48.1 in November from 50 in the prior month.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAsia Pacific Markets\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAsian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.68%, Hong Kong's Hang Seng Index falling 1.89%, China's Shanghai Composite Index dipping 3.06% and India's BSE Sensex gaining 2.54%.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEconomics\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe S\u0026amp;P Global US Services PMI climbed to 57 in November versus 55 in the previous month, while manufacturing PMI increased to 48.8 in November from 48.5 in the previous month.\u003c/li\u003e\n\u003cli\u003eThe University of Michigan consumer sentiment for the US fell to 71.8 in November versus a preliminary reading of 73.\u003c/li\u003e\n\u003cli\u003eThe year-ahead inflation expectations in the U.S fell to 2.6% in November from 2.7% in October.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNow Read This: \u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/24/11/42135946/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-with-over-3-dividend-yields-3\"\u003eWall Street\u0026#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n","url":"https://www.benzinga.com/24/11/42140418/dow-jumps-300-points-gap-posts-upbeat-earnings","image":"https://cdn.benzinga.com/files/images/story/2024/11/22/Wall-Street-US-stocks.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/22/Wall-Street-US-stocks.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/22/Wall-Street-US-stocks.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":135733,"name":"Cryptocurrency","description":"Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies."},{"tid":16888,"name":"Earnings","description":""},{"tid":24769,"name":"Equities","description":""},{"tid":57,"name":"News","description":""},{"tid":125557,"name":"Eurozone","description":""},{"tid":25,"name":"Intraday Update","description":""},{"tid":2,"name":"Markets","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":920812,"name":"AMIX","description":null},{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":160254,"name":"CETX","description":""},{"tid":919569,"name":"DEVS","description":null},{"tid":14670,"name":"GAP","description":"PharmaGap"},{"tid":90108,"name":"REPL","description":"REPL"},{"tid":10072,"name":"SKK","description":"ProShares UltraShort Russell2000 Growth"}],"tags":[{"tid":126500,"name":"Mid Morning Market Update","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42140418\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42140418\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42140418\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42136326,"author":"Benzinga Newsdesk","created":"Fri, 22 Nov 2024 08:08:27 -0500","updated":"Fri, 22 Nov 2024 08:08:28 -0500","title":"Aptose Biosciences shares are trading lower after the company announced the pricing of an $8 million public offering.","teaser":"","body":"","url":"https://www.benzinga.com/wiim/24/11/42136326/aptose-biosciences-shares-are-trading-lower-after-the-company-announced-the-pricing-of-an-8-million","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":726669,"name":"WIIM","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42136326\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42136326\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42136326\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42136325,"author":"Benzinga Newsdesk","created":"Fri, 22 Nov 2024 08:08:16 -0500","updated":"Fri, 22 Nov 2024 08:08:16 -0500","title":"Aptose Biosciences Prices $8M Public Offering Of 40M Shares And 20M Warrants At $0.20 Per Unit; Warrants Priced At $0.25 Per Share And Expire In Five Years, With Closing Expected On November 25, 2024","teaser":"","body":"","url":"https://www.benzinga.com/news/24/11/42136325/aptose-biosciences-prices-8m-public-offering-of-40m-shares-and-20m-warrants-at-0-20-per-unit-warrant","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":57,"name":"News","description":""},{"tid":65,"name":"Offerings","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42136325\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42136325\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42136325\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42133339,"author":"Avi Kapoor","created":"Fri, 22 Nov 2024 05:29:01 -0500","updated":"Fri, 22 Nov 2024 05:29:02 -0500","title":"Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket","teaser":" ","body":"\u003cp\u003eShares of \u003cstrong\u003eElastic N.V\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ESTC#NYSE\"\u003eESTC\u003c/a\u003e) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results and issued FY25 guidance \u003ca href=\"https://www.benzinga.com/quote/ESTC/news\"\u003eabove estimates\u003c/a\u003e.\u003c/p\u003e\n\u003cp\u003eElastic reported quarterly earnings of 59 cents per share which beat the analyst consensus estimate of 38 cents per share. The company reported quarterly sales of $365.361 million which beat the analyst consensus estimate of $355.900 million.\u003c/p\u003e\n\u003cp\u003eElastic shares jumped 29.1% to $121.46 in the pre-market trading session.\u003c/p\u003e\n\u003cp\u003eHere are some other stocks moving in pre-market trading.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eGainers\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eVirpax Pharmaceuticals, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRPX#NASDAQ\"\u003eVRPX\u003c/a\u003e) gained 67.1% to $0.9855 in pre-market trading after the company announced an agreement with the US HHS department for an extension towards its cooperative research and development.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eWellchange Holdings Company Limited\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/WCT#NASDAQ\"\u003eWCT\u003c/a\u003e) rose 50.4% to $1.88 in pre-market trading after dipping 62% on Thursday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eBeneficient \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/BENF#NASDAQ\"\u003eBENF\u003c/a\u003e) gained 30.7% to $1.15 in pre-market trading after gaining around 7% on Thursday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eSKK Holdings Limited\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SKK#NASDAQ\"\u003eSKK\u003c/a\u003e) gained 25.4% to $1.38 in pre-market trading after declining around 75% on Wednesday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eExicure, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/XCUR#NASDAQ\"\u003eXCUR\u003c/a\u003e) gained 19.4% to $12.98 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eThe Gap, Inc\u003c/strong\u003e. (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GAP#NYSE\"\u003eGAP\u003c/a\u003e) gained 14.9% to $25.33 in pre-market trading after reporting better-than-expected third-quarter results.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eGlobal Blue Group Holding AG\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GB#NYSE\"\u003eGB\u003c/a\u003e) gained 10.4% to $6.90 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eKairos Pharma, Ltd\u003c/strong\u003e. (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/KAPA#NYSE\"\u003eKAPA\u003c/a\u003e) climbed 8.7% to $1.63 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eRoss Stores, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ROST#NASDAQ\"\u003eROST\u003c/a\u003e) gained 7% to $153.01 in pre-market trading after the company reported better-than-expected third-quarter EPS results..\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eLosers\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eKnightscope, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/KSCP#NASDAQ\"\u003eKSCP\u003c/a\u003e) shares tumbled 41.8% to $10.64 in pre-market trading after the company announced the pricing of $12.1 million public offering.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAutonomix Medical, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AMIX#NASDAQ\"\u003eAMIX\u003c/a\u003e) fell 33.3% to $9.01 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCemtrex, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CETX#NASDAQ\"\u003eCETX\u003c/a\u003e) shares fell 27.2% to $0.1430 in pre-market trading after the company announced its board approved a 1-for-35 reverse stock split.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eProcaps Group S.A.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/PROC#NASDAQ\"\u003ePROC\u003c/a\u003e) declined 18.7% to $0.90 in pre-market trading as the company said it faced Nasdaq delisting threat due to Form 20-F filing delay.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCarter Bankshares, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CARE#NASDAQ\"\u003eCARE\u003c/a\u003e) shares fell 10.6% to $16.86 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eReal Messenger Corporation\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/RMSG#NASDAQ\"\u003eRMSG\u003c/a\u003e) dipped 16.2% to $3.51 in pre-market trading after jumping over 10% on Thursday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAptose Biosciences Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) fell 13.9% to $0.21 in pre-market trading after dipping more than 10% on Thursday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eEnvoy Medical, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/COCH#NASDAQ\"\u003eCOCH\u003c/a\u003e) shares dipped 12.7% to $1.92 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eReddit, Inc\u003c/strong\u003e. (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/RDDT#NYSE\"\u003eRDDT\u003c/a\u003e) fell 7.3% to $146.50 in pre-market trading. Reddit's shareholder, Advance Magazine Publishers Inc. plans to sell as much as $1.2 billion of the company's stake, reported Bloomberg on Friday morning. The company is said to be offering 7.8 million shares in between the range of $145.38-$148.54 each.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eIntuit Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/INTU#NASDAQ\"\u003eINTU\u003c/a\u003e) fell 5.7% to $639.95 in today's pre-market trading. Intuit reported upbeat results for its first-quarter results, but issued weak forecast for the current quarter.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNow Read This: \u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/24/11/42131399/dow-surges-over-450-points-investor-sentiment-improves-fear-greed-index-moves-to-greed-zone\"\u003eDow Surges Over 450 Points As Nvidia Climbs Post-Earnings, Google, Amazon Slip: Fear Index Shifts To \u0026#8216;Greed\u0026#8217; Zone\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n","url":"https://www.benzinga.com/24/11/42133339/why-elastic-shares-are-trading-higher-by-29-here-are-20-stocks-moving-premarket","image":"https://cdn.benzinga.com/files/images/story/2024/11/22/Nvidia--Palantir--Clover-Health--Joby-Av.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/22/Nvidia--Palantir--Clover-Health--Joby-Av.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/22/Nvidia--Palantir--Clover-Health--Joby-Av.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[],"stocks":[{"tid":920812,"name":"AMIX","description":null},{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":899380,"name":"BENF","description":"BENEFICIENT CL A CMN"},{"tid":103847,"name":"CARE","description":"CARTER BANK\u0026TR (V"},{"tid":160254,"name":"CETX","description":""},{"tid":910476,"name":"COCH","description":"Envoy Medical, Inc. - Class A Common Stock"},{"tid":728907,"name":"ESTC","description":""},{"tid":14670,"name":"GAP","description":"PharmaGap"},{"tid":14674,"name":"GB","description":"Greatbatch"},{"tid":11830,"name":"INTU","description":"Intuit"},{"tid":910713,"name":"KAPA","description":null},{"tid":826393,"name":"KSCP","description":null},{"tid":812091,"name":"PROC","description":null},{"tid":923044,"name":"RDDT","description":null},{"tid":945283,"name":"RMSG","description":null},{"tid":12779,"name":"ROST","description":"Ross Stores"},{"tid":10072,"name":"SKK","description":"ProShares UltraShort Russell2000 Growth"},{"tid":793648,"name":"VRPX","description":null},{"tid":921986,"name":"WCT","description":null},{"tid":721709,"name":"XCUR","description":null}],"tags":[{"tid":134703,"name":"Gainers","description":""},{"tid":753246,"name":"Premarket Movers","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42133339\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42133339\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42133339\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42095887,"author":"Benzinga Newsdesk","created":"Wed, 20 Nov 2024 13:01:52 -0500","updated":"Wed, 20 Nov 2024 13:01:53 -0500","title":"HC Wainwright \u0026 Co. Maintains Buy on Aptose Biosciences, Lowers Price Target to $2","teaser":"HC Wainwright \u0026 Co. analyst Joseph Pantginis maintains Aptose Biosciences (NASDAQ:APTO) with a Buy and lowers the price target from $7 to $2.","body":"\u003cp\u003eHC Wainwright \u0026amp; Co. analyst Joseph Pantginis maintains Aptose Biosciences (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) with a Buy and lowers the price target from $7 to $2.\u003c/p\u003e\n","url":"https://www.benzinga.com/news/24/11/42095887/hc-wainwright-co-maintains-buy-on-aptose-biosciences-lowers-price-target-to-2","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":57,"name":"News","description":""},{"tid":72,"name":"Price Target","description":""},{"tid":67,"name":"Analyst Ratings","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42095887\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42095887\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42095887\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42086033,"author":"Benzinga Newsdesk","created":"Wed, 20 Nov 2024 07:45:33 -0500","updated":"Wed, 20 Nov 2024 07:45:34 -0500","title":"Aptose Biosciences Announced Initiation Of The TUSCANY Study, Tuspetinib In Combination Therapy With Azacitidine And Venetoclax As A Frontline Triplet Combination Therapy For Patients Newly Diagnosed With Acute Myeloid Leukemia","teaser":"","body":"","url":"https://www.benzinga.com/news/24/11/42086033/aptose-biosciences-announced-initiation-of-the-tuscany-study-tuspetinib-in-combination-therapy-with","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":57,"name":"News","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42086033\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42086033\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41857279,"author":"Benzinga Newsdesk","created":"Fri, 08 Nov 2024 16:04:16 -0500","updated":"Fri, 08 Nov 2024 16:04:17 -0500","title":"Aptose Biosciences Q3 2024 GAAP EPS $(0.37) Beats $(1.19) Estimate","teaser":"Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(1.19) by 68.91 percent.","body":"\u003cp\u003eAptose Biosciences (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(1.19) by 68.91 percent.\u003c/p\u003e\n","url":"https://www.benzinga.com/news/earnings/24/11/41857279/aptose-biosciences-q3-2024-gaap-eps-0-37-beats-1-19-estimate","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":16888,"name":"Earnings","description":""},{"tid":862672,"name":"Earnings Beats","description":"Coverage of Earnings Beats."},{"tid":57,"name":"News","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41857279\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41857279\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 41857279\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":40685074,"author":"Benzinga Newsdesk","created":"Tue, 03 Sep 2024 07:10:14 -0500","updated":"Tue, 03 Sep 2024 09:08:38 -0500","title":"Aptose shares are trading higher after the company announced a $10 million loan through a Facility Agreement with Hanmi Pharmaceutical Co.","teaser":"","body":"","url":"https://www.benzinga.com/wiim/24/09/40685074/aptose-shares-are-trading-higher-after-the-company-announced-a-10-million-loan-through-a-facility-ag","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":18467,"name":"General","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 40685074\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 40685074\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 40685074\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":40681382,"author":"Avi Kapoor","created":"Tue, 03 Sep 2024 04:13:36 -0500","updated":"Tue, 03 Sep 2024 04:13:37 -0500","title":"Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket","teaser":" ","body":"\u003cp\u003eShares of \u003cstrong\u003eZhibao Technology Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ZBAO#NASDAQ\"\u003eZBAO\u003c/a\u003e) rose sharply in today's pre-market trading after the company announced that it has won a tender to provide high-end medical third party administration services to the People\u0026#8217;s\u003ca href=\"https://www.benzinga.com/quote/ZBAO/news\"\u003e Insurance Company of China Limited.\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eZhibao Technology shares jumped 18.8% to $3.99 in the pre-market trading.\u003c/p\u003e\n\u003cp\u003eHere are some other stocks moving in pre-market trading.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eGainers\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eSify Technologies Limited \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SIFY#NASDAQ\"\u003eSIFY\u003c/a\u003e) gained 129.4% to $0.7599 in pre-market trading. Sify becomes first in India to achieve NVIDIA DGX-ready data center certification for liquid cooling to enable breakthrough AI performance.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAptose Biosciences Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) rose 48.1% to $0.6040 in today's pre-market trading after the company announced a $10 million loan through a Facility Agreement with Hanmi Pharmaceutical Co.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eConduit Pharmaceuticals Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CDT#NASDAQ\"\u003eCDT\u003c/a\u003e) gained 25.8% to $0.1549 in pre-market trading after declining over 5% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003ePerfect Moment Ltd\u003c/strong\u003e. (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/PMNT#NYSE\"\u003ePMNT\u003c/a\u003e) gained 25.2% to $1.29 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCyclacel Pharmaceuticals In\u003c/strong\u003ec (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CYCC#NASDAQ\"\u003eCYCC\u003c/a\u003e) gained 21.7% to $1.28 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003ePolar Power In\u003c/strong\u003ec (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/POLA#NASDAQ\"\u003ePOLA\u003c/a\u003e) gained 18.8% to $0.47 in the pre-market trading session. Polar Power, last month, posted a profit for the second quarter.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eQuantaSing Group Ltd- ADR\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/QSG#NASDAQ\"\u003eQSG\u003c/a\u003e) gained 13.2% to $1.97 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eShoals Technologies Group, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SHLS#NASDAQ\"\u003eSHLS\u003c/a\u003e) rose 11.5% to $6.01 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAutozi Internet Technology (Global) Ltd\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AZI#NASDAQ\"\u003eAZI\u003c/a\u003e) gained 5% to $3.15 in pre-market trading amid post-IPO volatility.\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eLosers\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eBluejay Diagnostics Inc\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/BJDX#NASDAQ\"\u003eBJDX\u003c/a\u003e) fell 13.3% to $0.16 in pre-market trading after declining around 6% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eFocus Universal Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/FCUV#NASDAQ\"\u003eFCUV\u003c/a\u003e) shares fell 13.1% to $0.2338 in pre-market trading. Focus Universal shares jumped over 41% on Friday after the company in a Form4 filing disclosed that CEO Desheng Wang bought 302,100 shares of stock at an average price of $0.18 per share.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eStaffing 360 Solutions, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/STAF#NASDAQ\"\u003eSTAF\u003c/a\u003e) shares declined 12.1% to $2.05 in pre-market trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eGraphex Group Limited\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GRFX#NYSE\"\u003eGRFX\u003c/a\u003e) fell 12% to $0.21 in pre-market trading after surging 13% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eShiftPixy In\u003c/strong\u003ec (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/PIXY#NASDAQ\"\u003ePIXY\u003c/a\u003e) shares fell 11.8% to $1.04 in pre-market trading. ShiftPixy recently announced the pricing of $2.5 million offering.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAgape ATP Corporation\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ATPC#NASDAQ\"\u003eATPC\u003c/a\u003e) shares declined 11.4% to $2.26 in pre-market trading after jumping 60% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAutonomix Medical In\u003c/strong\u003ec (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AMIX#NASDAQ\"\u003eAMIX\u003c/a\u003e) shares fell 10.9% to $0.60 in pre-market trading after jumping 14% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eTheriva Biologics, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TOVX#NASDAQ\"\u003eTOVX\u003c/a\u003e) fell 10% to $5.31 in today's pre-market trading after gaining over 25% on Friday.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eUnited States Steel Corporation\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/X#NYSE\"\u003eX\u003c/a\u003e) shares dipped 5.8% to $35.70 in pre-market trading. Vice President Kamala Harris has expressed her support for American ownership of United States Steel, amidst ongoing foreign acquisition attempts.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eDiversified Energy Company PLC\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DEC#NYSE\"\u003eDEC\u003c/a\u003e) declined 5.6% to $11.54 in pre-market trading. Keybanc analyst Tim Rezvan, last week, initiated coverage on Diversified Energy with an Overweight rating and announced a price target of $18.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNow Read This: \u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/news/24/09/40677064/this-analyst-with-87-accuracy-rate-sees-over-24-upside-in-nvidia-here-are-5-stock-picks-for-last-wee\"\u003eThis Analyst With 87% Accuracy Rate Sees Over 24% Upside In Nvidia \u0026#8211; Here Are 5 Stock Picks For Last Week From Wall Street\u0026#8217;s Most Accurate Analysts\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n","url":"https://www.benzinga.com/news/24/09/40681382/why-zhibao-technology-shares-are-trading-higher-by-around-19-here-are-20-stocks-moving-premarket","image":"https://cdn.benzinga.com/files/images/story/2024/09/03/movers-image.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/09/03/movers-image.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/09/03/movers-image.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":57,"name":"News","description":""},{"tid":23,"name":"Pre-Market Outlook","description":""},{"tid":2,"name":"Markets","description":""},{"tid":24,"name":"Movers","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":920812,"name":"AMIX","description":null},{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":911591,"name":"ATPC","description":null},{"tid":906810,"name":"AZI","description":null},{"tid":824244,"name":"BJDX","description":null},{"tid":909656,"name":"CDT","description":null},{"tid":11148,"name":"CYCC","description":"Cyclacel Pharmaceuticals"},{"tid":656519,"name":"DEC","description":""},{"tid":604272,"name":"FCUV","description":"Focus Universal"},{"tid":853945,"name":"GRFX","description":null},{"tid":688502,"name":"PIXY","description":null},{"tid":911675,"name":"PMNT","description":null},{"tid":613558,"name":"POLA","description":"Polar Power Inc."},{"tid":867133,"name":"QSG","description":null},{"tid":43267,"name":"SHLS","description":""},{"tid":12889,"name":"SIFY","description":"Sify Technologies Limited"},{"tid":98263,"name":"STAF","description":"STAFFING 360 DEGR"},{"tid":858984,"name":"TOVX","description":null},{"tid":16722,"name":"X","description":"United States Steel Corp."},{"tid":908451,"name":"ZBAO","description":null}],"tags":[{"tid":134703,"name":"Gainers","description":""},{"tid":139492,"name":"Losers","description":""},{"tid":753246,"name":"Premarket Movers","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 40681382\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 40681382\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 40681382\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":40679715,"author":"Avi Kapoor","created":"Tue, 03 Sep 2024 00:59:25 -0500","updated":"Tue, 03 Sep 2024 00:59:26 -0500","title":"Hello Group, Zscaler And 3 Stocks To Watch Heading Into Tuesday","teaser":" ","body":"\u003cp\u003eWith U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eWall Street expects \u003cstrong\u003eHello Group Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MOMO#NASDAQ\"\u003eMOMO\u003c/a\u003e) to report quarterly earnings at 28 cents per share on revenue of $372.52 million before the opening bell, according to data from \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003eBenzinga Pro\u003c/a\u003e. Hello Group shares fell 0.6% to $6.60 in after-hours trading.\u003c/li\u003e\n\u003cli\u003eAnalysts expect \u003cstrong\u003eZscaler, Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ZS#NASDAQ\"\u003eZS\u003c/a\u003e) to post quarterly earnings at 69 cents per share on revenue of $567.93 million. The company will release earnings after the markets close. Zscaler shares gained 0.1% to $200.00 in after-hours trading.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAptose Biosciences Inc\u003c/strong\u003e. (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) shares rose in Friday's after-hours trading after the company announced a $10 million loan through a Facility Agreement with \u003cstrong\u003eHanmi Pharmaceutical Co.\u003c/strong\u003e Aptose shares jumped 69.3% to $0.6874 in the after-hours trading session.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCheck out our \u003ca href=\"https://www.benzinga.com/premarket/\"\u003epremarket coverage here\u003c/a\u003e\u003c/em\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eAfter the markets close,\u003cstrong\u003e HealthEquity, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/HQY#NASDAQ\"\u003eHQY\u003c/a\u003e) is projected to post quarterly earnings at 70 cents per share on revenue of $284.87 million. HealthEquity shares fell 0.6% to $79.10 in the after-hours trading session.\u003c/li\u003e\n\u003cli\u003eAnalysts expect \u003cstrong\u003eSportsman\u0026#8217;s Warehouse Holdings, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SPWH#NASDAQ\"\u003eSPWH\u003c/a\u003e) to report a quarterly loss at 9 cents per share on revenue of $285.03 million after the closing bell. Sportsman\u0026#8217;s Warehouse shares fell 1% to $2.08 in the after-hours trading session.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCheck This Out: \u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/24/08/40666406/top-2-real-estate-stocks-that-could-blast-off-this-quarter\"\u003eTop 2 Real Estate Stocks That Could Blast Off This Quarter\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eImage generated using AI tools\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/news/earnings/24/09/40679715/hello-group-zscaler-and-3-stocks-to-watch-heading-into-tuesday","image":"https://cdn.benzinga.com/files/images/story/2024/09/03/wall-street-ai17.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/09/03/wall-street-ai17.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/09/03/wall-street-ai17.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":16888,"name":"Earnings","description":""},{"tid":57,"name":"News","description":""},{"tid":23,"name":"Pre-Market Outlook","description":""},{"tid":2,"name":"Markets","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":139636,"name":"HQY","description":"HealthEquity, Inc."},{"tid":145786,"name":"MOMO","description":"Momo Inc."},{"tid":137376,"name":"SPWH","description":"Sportsman's Warehouse Holdings, Inc"},{"tid":713442,"name":"ZS","description":""}],"tags":[{"tid":23352,"name":"Stocks To Watch","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 40679715\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 40679715\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 40679715\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":40662386,"author":"Benzinga Newsdesk","created":"Fri, 30 Aug 2024 15:32:54 -0500","updated":"Fri, 30 Aug 2024 15:32:55 -0500","title":"Aptose shares are trading higher after the company announced a $10 million loan through a Facility Agreement with Hanmi Pharmaceutical Co.","teaser":"","body":"","url":"https://www.benzinga.com/wiim/24/08/40662386/aptose-shares-are-trading-higher-after-the-company-announced-a-10-million-loan-through-a-facility-ag","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":726669,"name":"WIIM","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 40662386\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 40662386\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 40662386\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":40662317,"author":"Benzinga Newsdesk","created":"Fri, 30 Aug 2024 15:31:02 -0500","updated":"Fri, 30 Aug 2024 15:31:02 -0500","title":"Aptose Biosciences Secures $10M Loan From Hanmi Pharmaceutical For Tuspetinib Development; Companies To Negotiate New Co-Development Agreement For AML Treatment","teaser":"Aptose Biosciences Inc. (\"Aptose\" or the \"Company\") (NASDAQ:APTO, TSX:APS), a clinical-stage precision oncology company developing tuspetinib, a highly differentiated oral kinase inhibitor for the treatment of patients","body":"\u003cp\u003eAptose Biosciences Inc. (\"Aptose\" or the \"Company\") (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e, TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APS#TSX\"\u003eAPS\u003c/a\u003e), a clinical-stage precision oncology company developing tuspetinib, a highly differentiated oral kinase inhibitor for the treatment of patients with acute myeloid leukemia (AML), today announced that it received a $10 million loan through a Facility Agreement with Hanmi Pharmaceutical Co. Ltd. (\"Hanmi\"). The loan is convertible as prepayment of milestone obligations under the Future Collaboration Agreement (as defined hereinafter) or repayable after the expected completion of a triple drug combination trial with tuspetinib in newly diagnosed AML patients. Aptose will use the proceeds from such loan for the development of tuspetinib.\u003cbr /\u003e\u003cbr /\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eBeyond the $10 million Facility Agreement, Aptose and Hanmi have agreed to negotiate a new tuspetinib co-development collaboration agreement (the \"Future Collaboration Agreement'), intended to provide additional funding to accelerate clinical development of tuspetinib. Aptose licensed tuspetinib from Hanmi Pharmaceutical in November 2021.\u003c/p\u003e\n","url":"https://www.benzinga.com/news/24/08/40662317/aptose-biosciences-secures-10m-loan-from-hanmi-pharmaceutical-for-tuspetinib-development-companies-t","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":57,"name":"News","description":""},{"tid":87,"name":"Contracts","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"},{"tid":620136,"name":"TSX:APS","description":""}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 40662317\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 40662317\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":40271560,"author":"Benzinga Newsdesk","created":"Thu, 08 Aug 2024 16:51:21 -0500","updated":"Thu, 08 Aug 2024 16:51:22 -0500","title":"Aptose Biosciences Q2 2024 GAAP EPS $(0.43) Beats $(0.86) Estimate","teaser":"Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.86) by 50 percent.","body":"\u003cp\u003eAptose Biosciences (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.86) by 50 percent.\u003c/p\u003e\n","url":"https://www.benzinga.com/news/earnings/24/08/40271560/aptose-biosciences-q2-2024-gaap-eps-0-43-beats-0-86-estimate","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":16888,"name":"Earnings","description":""},{"tid":862672,"name":"Earnings Beats","description":"Coverage of Earnings Beats."},{"tid":57,"name":"News","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 40271560\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 40271560\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":39334923,"author":"Benzinga Newsdesk","created":"Fri, 14 Jun 2024 10:03:56 -0500","updated":"Fri, 14 Jun 2024 10:03:57 -0500","title":"HC Wainwright \u0026 Co. Reiterates Buy on Aptose Biosciences, Maintains $7 Price Target","teaser":"HC Wainwright \u0026 Co. analyst Joseph Pantginis reiterates Aptose Biosciences (NASDAQ:APTO) with a Buy and maintains $7 price target.","body":"\u003cp\u003eHC Wainwright \u0026amp; Co. analyst Joseph Pantginis reiterates Aptose Biosciences (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/APTO#NASDAQ\"\u003eAPTO\u003c/a\u003e) with a Buy and maintains $7 price target.\u003c/p\u003e\n","url":"https://www.benzinga.com/news/24/06/39334923/hc-wainwright-co-reiterates-buy-on-aptose-biosciences-maintains-7-price-target","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":57,"name":"News","description":""},{"tid":72,"name":"Price Target","description":""},{"tid":39823,"name":"Reiteration","description":""},{"tid":67,"name":"Analyst Ratings","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 39334923\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 39334923\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 39334923\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":39330142,"author":"Benzinga Newsdesk","created":"Fri, 14 Jun 2024 06:34:09 -0500","updated":"Fri, 14 Jun 2024 06:34:10 -0500","title":"Aptose Showcases Clinical And Preclinical Results For Tuspetinib (TUS) At The 2024 EHA Hybrid Congress","teaser":"\n\tTUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid Leukemia (AML) and Differentiate TUS from other Investigational","body":"\u003cul\u003e\n\u003cli\u003eTUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid Leukemia (AML) and Differentiate TUS from other Investigational Drugs in AML\u003c/li\u003e\n\u003c/ul\u003e\n\u003cul\u003e\n\u003cli\u003eTUS Monotherapy and TUS+VEN Doublet Therapy Active in Difficult-to-treat Genetic Subgroups, FLT3 Wildtype AML\u003c/li\u003e\n\u003c/ul\u003e\n\u003cul\u003e\n\u003cli\u003eTUS Shown to Target VEN Resistance Mechanisms and Retain Activity on VEN-Resistant AML Cells in Preclinical Study\u003c/li\u003e\n\u003c/ul\u003e\n\u003cul\u003e\n\u003cli\u003eTUS+VEN+Azacitidine (AZA) Triplet Trial to Treat Newly Diagnosed AML Patients; Clinical Sites Being Activated\u003c/li\u003e\n\u003c/ul\u003e\n","url":"https://www.benzinga.com/news/24/06/39330142/aptose-showcases-clinical-and-preclinical-results-for-tuspetinib-tus-at-the-2024-eha-hybrid-congress","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":57,"name":"News","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[{"tid":18923,"name":"healthcare","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 39330142\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 39330142\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 39330142\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":39319365,"author":"Benzinga Newsdesk","created":"Thu, 13 Jun 2024 13:11:02 -0500","updated":"Thu, 13 Jun 2024 13:11:03 -0500","title":"Aptose Biosciences Shares Move Higher; Traders Circulate Zacks Article Titled \"Aptose Biosciences Upgraded to Buy: What Does It Mean for the Stock?\"","teaser":"\u003ca href=\"https://www.zacks.com/stock/news/2288032/aptose-biosciences-apto-upgraded-to-buy-what-does-it-mean-for-the-stock\" title=\"https://www.zacks.com/stock/news/2288032/aptose-biosciences-apto-upgraded-to-buy-what-does-it-mean-for-the-stock\"\u003ehttps://www.zacks.com/stock/news/2288032/aptose-biosciences-apto-upgraded-to-buy-what-does-it-mean-for-the-stock\u003c/a\u003e","body":"\u003cp\u003e\u003ca href=\"https://www.zacks.com/stock/news/2288032/aptose-biosciences-apto-upgraded-to-buy-what-does-it-mean-for-the-stock\" title=\"https://www.zacks.com/stock/news/2288032/aptose-biosciences-apto-upgraded-to-buy-what-does-it-mean-for-the-stock\"\u003ehttps://www.zacks.com/stock/news/2288032/aptose-biosciences-apto-upgraded-to-buy-what-does-it-mean-for-the-stock\u003c/a\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/news/24/06/39319365/aptose-biosciences-shares-move-higher-traders-circulate-zacks-article-titled-aptose-biosciences-upgr","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":57,"name":"News","description":""},{"tid":17374,"name":"Rumors","description":""},{"tid":67,"name":"Analyst Ratings","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":146192,"name":"APTO","description":"Aptose Biosciences"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 39319365\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 39319365\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 39319365\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"}],"partnersRelease":{"contentStock":{"APTO":{"name":"APTO"}},"content":{"41846036":{"id":41846036,"author":"Seeking Alpha","created":"Fri, 08 Nov 2024 10:55:31 -0400","updated":"Fri, 08 Nov 2024 10:58:08 -0400","title":"Warning: APTO is at high risk of performing badly","teaser":"","body":"","url":"https://seekingalpha.com/warnings/4266299-warning-apto-is-high-risk-of-performing-badly?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"41859583":{"id":41859583,"author":"TipRanks","created":"Fri, 08 Nov 2024 18:08:47 -0400","updated":"Fri, 08 Nov 2024 18:13:16 -0400","title":"Aptose Biosciences Advances AML Triplet Therapy","teaser":"Aptose Biosciences (TSE:APS) has released an update. Aptose Biosciences is advancing the development of its promising drug tuspetinib as part of a ...","body":"Aptose Biosciences (TSE:APS) has released an update. Aptose Biosciences is advancing the development of its promising drug tuspetinib as part of a ...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-advances-aml-triplet-therapy?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"41859934":{"id":41859934,"author":"Seeking Alpha","created":"Fri, 08 Nov 2024 18:22:04 -0400","updated":"Fri, 08 Nov 2024 18:28:17 -0400","title":"Aptose Biosciences GAAP EPS of -$0.37 beats by $0.27","teaser":"","body":"","url":"https://seekingalpha.com/news/4268575-aptose-biosciences-gaap-eps-of-0_37-beats-0_27?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"41862784":{"id":41862784,"author":"TipRanks","created":"Sat, 09 Nov 2024 00:09:14 -0400","updated":"Sat, 09 Nov 2024 00:13:41 -0400","title":"Aptose Biosciences Reports Q3 2024 Financial Highlights","teaser":"Aptose Biosciences ( ($APTO) ) has released its Q3 earnings. Here is a breakdown of the information Aptose Biosciences presented to its investors. ...","body":"Aptose Biosciences ( ($APTO) ) has released its Q3 earnings. Here is a breakdown of the information Aptose Biosciences presented to its investors. ...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-reports-q3-2024-financial-highlights?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"41868039":{"id":41868039,"author":"Seeking Alpha","created":"Sun, 10 Nov 2024 08:00:19 -0400","updated":"Sun, 10 Nov 2024 08:03:59 -0400","title":"Warning: APTO is at high risk of performing badly","teaser":"","body":"","url":"https://seekingalpha.com/warnings/4270464-warning-apto-is-high-risk-of-performing-badly?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"42085816":{"id":42085816,"author":"TipRanks","created":"Wed, 20 Nov 2024 08:41:25 -0400","updated":"Wed, 20 Nov 2024 08:43:05 -0400","title":"Aptose Biosciences initiates TUSCANY Phase 1/2 study","teaser":"Aptose Biosciences (APTO) announced initiation of the TUSCANY study, tuspetinib, TUS, in combination therapy with azacitidine, AZA, and venetoclax,...","body":"Aptose Biosciences (APTO) announced initiation of the TUSCANY study, tuspetinib, TUS, in combination therapy with azacitidine, AZA, and venetoclax,...","url":"https://www.tipranks.com/news/the-fly/aptose-biosciences-initiates-tuscany-phase-1-2-study?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"42091150":{"id":42091150,"author":"TipRanks","created":"Wed, 20 Nov 2024 10:56:12 -0400","updated":"Wed, 20 Nov 2024 11:09:31 -0400","title":"Aptose Biosciences price target lowered to $2 from $7 at H.C. Wainwright","teaser":"H.C. Wainwright lowered the firm\u0026#39;s price target on Aptose Biosciences (APTO) to $2 from $7 and keeps a Buy rating on the shares. The firm expects s...","body":"H.C. Wainwright lowered the firm's price target on Aptose Biosciences (APTO) to $2 from $7 and keeps a Buy rating on the shares. The firm expects s...","url":"https://www.tipranks.com/news/the-fly/aptose-biosciences-price-target-lowered-to-2-from-7-at-h-c-wainwright?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"42136650":{"id":42136650,"author":"TipRanks","created":"Fri, 22 Nov 2024 09:05:15 -0400","updated":"Fri, 22 Nov 2024 09:17:07 -0400","title":"Aptose Biosciences to sell 40M shares at 20c in public offering","teaser":"Aptose Biosciences (APTO) announced the pricing of its \u0026#34;reasonable best efforts\u0026#34; public offering with participation from the CEO and existing and n...","body":"Aptose Biosciences (APTO) announced the pricing of its \"reasonable best efforts\" public offering with participation from the CEO and existing and n...","url":"https://www.tipranks.com/news/the-fly/aptose-biosciences-to-sell-40m-shares-at-20c-in-public-offering?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"42137554":{"id":42137554,"author":"TipRanks","created":"Fri, 22 Nov 2024 09:27:36 -0400","updated":"Fri, 22 Nov 2024 09:47:13 -0400","title":"Aptose Biosciences Announces $8 Million Public Offering","teaser":"An update from Aptose Biosciences ( ($TSE:APS) ) is now available. Aptose Biosciences Inc., a clinical-stage oncology company, has announced an $8 ...","body":"An update from Aptose Biosciences ( ($TSE:APS) ) is now available. Aptose Biosciences Inc., a clinical-stage oncology company, has announced an $8 ...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-announces-8-million-public-offering?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},"42177410":{"id":42177410,"author":"TipRanks","created":"Mon, 25 Nov 2024 17:52:55 -0400","updated":"Mon, 25 Nov 2024 18:21:29 -0400","title":"Aptose Biosciences Boosts Capital with $8M Offering","teaser":"Aptose Biosciences ( ($TSE:APS) ) has provided an announcement. Aptose Biosciences Inc., a Canadian company specializing in precision oncology, has...","body":"Aptose Biosciences ( ($TSE:APS) ) has provided an announcement. Aptose Biosciences Inc., a Canadian company specializing in precision oncology, has...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-boosts-capital-with-8m-offering?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]}},"partnerContent":{"APTO":["41846036","41859583","41859934","41862784","41868039","42085816","42091150","42136650","42137554","42177410"]},"sortedContent":[{"id":42177410,"author":"TipRanks","created":"Mon, 25 Nov 2024 17:52:55 -0400","updated":"Mon, 25 Nov 2024 18:21:29 -0400","title":"Aptose Biosciences Boosts Capital with $8M Offering","teaser":"Aptose Biosciences ( ($TSE:APS) ) has provided an announcement. Aptose Biosciences Inc., a Canadian company specializing in precision oncology, has...","body":"Aptose Biosciences ( ($TSE:APS) ) has provided an announcement. Aptose Biosciences Inc., a Canadian company specializing in precision oncology, has...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-boosts-capital-with-8m-offering?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":42137554,"author":"TipRanks","created":"Fri, 22 Nov 2024 09:27:36 -0400","updated":"Fri, 22 Nov 2024 09:47:13 -0400","title":"Aptose Biosciences Announces $8 Million Public Offering","teaser":"An update from Aptose Biosciences ( ($TSE:APS) ) is now available. Aptose Biosciences Inc., a clinical-stage oncology company, has announced an $8 ...","body":"An update from Aptose Biosciences ( ($TSE:APS) ) is now available. Aptose Biosciences Inc., a clinical-stage oncology company, has announced an $8 ...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-announces-8-million-public-offering?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":42136650,"author":"TipRanks","created":"Fri, 22 Nov 2024 09:05:15 -0400","updated":"Fri, 22 Nov 2024 09:17:07 -0400","title":"Aptose Biosciences to sell 40M shares at 20c in public offering","teaser":"Aptose Biosciences (APTO) announced the pricing of its \u0026#34;reasonable best efforts\u0026#34; public offering with participation from the CEO and existing and n...","body":"Aptose Biosciences (APTO) announced the pricing of its \"reasonable best efforts\" public offering with participation from the CEO and existing and n...","url":"https://www.tipranks.com/news/the-fly/aptose-biosciences-to-sell-40m-shares-at-20c-in-public-offering?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":42091150,"author":"TipRanks","created":"Wed, 20 Nov 2024 10:56:12 -0400","updated":"Wed, 20 Nov 2024 11:09:31 -0400","title":"Aptose Biosciences price target lowered to $2 from $7 at H.C. Wainwright","teaser":"H.C. Wainwright lowered the firm\u0026#39;s price target on Aptose Biosciences (APTO) to $2 from $7 and keeps a Buy rating on the shares. The firm expects s...","body":"H.C. Wainwright lowered the firm's price target on Aptose Biosciences (APTO) to $2 from $7 and keeps a Buy rating on the shares. The firm expects s...","url":"https://www.tipranks.com/news/the-fly/aptose-biosciences-price-target-lowered-to-2-from-7-at-h-c-wainwright?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":42085816,"author":"TipRanks","created":"Wed, 20 Nov 2024 08:41:25 -0400","updated":"Wed, 20 Nov 2024 08:43:05 -0400","title":"Aptose Biosciences initiates TUSCANY Phase 1/2 study","teaser":"Aptose Biosciences (APTO) announced initiation of the TUSCANY study, tuspetinib, TUS, in combination therapy with azacitidine, AZA, and venetoclax,...","body":"Aptose Biosciences (APTO) announced initiation of the TUSCANY study, tuspetinib, TUS, in combination therapy with azacitidine, AZA, and venetoclax,...","url":"https://www.tipranks.com/news/the-fly/aptose-biosciences-initiates-tuscany-phase-1-2-study?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":41868039,"author":"Seeking Alpha","created":"Sun, 10 Nov 2024 08:00:19 -0400","updated":"Sun, 10 Nov 2024 08:03:59 -0400","title":"Warning: APTO is at high risk of performing badly","teaser":"","body":"","url":"https://seekingalpha.com/warnings/4270464-warning-apto-is-high-risk-of-performing-badly?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":41862784,"author":"TipRanks","created":"Sat, 09 Nov 2024 00:09:14 -0400","updated":"Sat, 09 Nov 2024 00:13:41 -0400","title":"Aptose Biosciences Reports Q3 2024 Financial Highlights","teaser":"Aptose Biosciences ( ($APTO) ) has released its Q3 earnings. Here is a breakdown of the information Aptose Biosciences presented to its investors. ...","body":"Aptose Biosciences ( ($APTO) ) has released its Q3 earnings. Here is a breakdown of the information Aptose Biosciences presented to its investors. ...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-reports-q3-2024-financial-highlights?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":41859934,"author":"Seeking Alpha","created":"Fri, 08 Nov 2024 18:22:04 -0400","updated":"Fri, 08 Nov 2024 18:28:17 -0400","title":"Aptose Biosciences GAAP EPS of -$0.37 beats by $0.27","teaser":"","body":"","url":"https://seekingalpha.com/news/4268575-aptose-biosciences-gaap-eps-of-0_37-beats-0_27?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":41859583,"author":"TipRanks","created":"Fri, 08 Nov 2024 18:08:47 -0400","updated":"Fri, 08 Nov 2024 18:13:16 -0400","title":"Aptose Biosciences Advances AML Triplet Therapy","teaser":"Aptose Biosciences (TSE:APS) has released an update. Aptose Biosciences is advancing the development of its promising drug tuspetinib as part of a ...","body":"Aptose Biosciences (TSE:APS) has released an update. Aptose Biosciences is advancing the development of its promising drug tuspetinib as part of a ...","url":"https://www.tipranks.com/news/company-announcements/aptose-biosciences-advances-aml-triplet-therapy?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["APTO"],"tags":[]},{"id":41846036,"author":"Seeking Alpha","created":"Fri, 08 Nov 2024 10:55:31 -0400","updated":"Fri, 08 Nov 2024 10:58:08 -0400","title":"Warning: APTO is at high risk of performing badly","teaser":"","body":"","url":"https://seekingalpha.com/warnings/4266299-warning-apto-is-high-risk-of-performing-badly?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["APTO"],"tags":[]}]},"postData":null,"pressRelease":{"contentStock":{"APTO":{"name":"APTO"},"TSX:APS":{"name":"TSX:APS"}},"content":{"39868424":{"id":39868424,"author":"Globe Newswire","created":"Fri, 19 Jul 2024 17:00:00 -0400","updated":"Fri, 19 Jul 2024 17:00:01 -0400","title":"Aptose Announces Receipt of Deficiency Notice from Nasdaq","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/07/g39868424/aptose-announces-receipt-of-deficiency-notice-from-nasdaq","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},"40094946":{"id":40094946,"author":"Globe Newswire","created":"Thu, 01 Aug 2024 07:00:00 -0400","updated":"Thu, 01 Aug 2024 07:00:01 -0400","title":"NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40094946/nodthera-announces-appointment-of-greg-chow-as-chief-financial-and-business-officer","image":[],"channels":[{"name":"Biotech"},{"name":"Press Releases"},{"name":"General"}],"stocks":["APTO"],"tags":[]},"40270129":{"id":40270129,"author":"Globe Newswire","created":"Thu, 08 Aug 2024 17:06:51 -0400","updated":"Thu, 08 Aug 2024 17:06:51 -0400","title":"Aptose Reports Results for the Second Quarter 2024","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40270129/aptose-reports-results-for-the-second-quarter-2024","image":[],"channels":[{"name":"Earnings"},{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},"40405839":{"id":40405839,"author":"Globe Newswire","created":"Thu, 15 Aug 2024 16:30:00 -0400","updated":"Thu, 15 Aug 2024 16:30:00 -0400","title":"Aptose Announces Adjournment of its Special Meeting of Shareholders","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40405839/aptose-announces-adjournment-of-its-special-meeting-of-shareholders","image":[],"channels":[{"name":"News"},{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},"40662273":{"id":40662273,"author":"Globe Newswire","created":"Fri, 30 Aug 2024 16:30:02 -0400","updated":"Fri, 30 Aug 2024 16:30:02 -0400","title":"Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40662273/aptose-receives-10-million-through-a-facility-agreement-with-hanmi-negotiating-future-collaboratio","image":[],"channels":[{"name":"News"},{"name":"Financing"},{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[{"name":"Partnerships"}]},"40740419":{"id":40740419,"author":"Globe Newswire","created":"Thu, 05 Sep 2024 16:15:00 -0400","updated":"Thu, 05 Sep 2024 16:15:01 -0400","title":"Aptose Announces Results from Special Meeting of Shareholders","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/09/g40740419/aptose-announces-results-from-special-meeting-of-shareholders","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},"41857163":{"id":41857163,"author":"Globe Newswire","created":"Fri, 08 Nov 2024 17:01:00 -0400","updated":"Fri, 08 Nov 2024 17:01:01 -0400","title":"Aptose Reports Results for the Third Quarter 2024","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g41857163/aptose-reports-results-for-the-third-quarter-2024","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},"42085504":{"id":42085504,"author":"Globe Newswire","created":"Wed, 20 Nov 2024 08:30:00 -0400","updated":"Wed, 20 Nov 2024 08:30:01 -0400","title":"Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g42085504/aptose-initiates-tuscany-phase-12-study-for-newly-diagnosed-aml-patients-to-receive-tuspetinib-bas","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},"42136063":{"id":42136063,"author":"Globe Newswire","created":"Fri, 22 Nov 2024 09:00:00 -0400","updated":"Fri, 22 Nov 2024 09:00:03 -0400","title":"Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g42136063/aptose-biosciences-inc-announces-pricing-of-8-million-public-offering","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},"42175192":{"id":42175192,"author":"Globe Newswire","created":"Mon, 25 Nov 2024 17:15:00 -0400","updated":"Mon, 25 Nov 2024 17:15:01 -0400","title":"Aptose Biosciences Inc. Announces Closing of $8 Million Public Offering","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g42175192/aptose-biosciences-inc-announces-closing-of-8-million-public-offering","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]}},"pressContent":{"APTO":["39868424","40094946","40270129","40405839","40662273","40740419","41857163","42085504","42136063","42175192"],"TSX:APS":["39868424","40270129","40405839","40662273","40740419","41857163","42085504","42136063","42175192"]},"sortedContent":[{"id":42175192,"author":"Globe Newswire","created":"Mon, 25 Nov 2024 17:15:00 -0400","updated":"Mon, 25 Nov 2024 17:15:01 -0400","title":"Aptose Biosciences Inc. Announces Closing of $8 Million Public Offering","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g42175192/aptose-biosciences-inc-announces-closing-of-8-million-public-offering","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},{"id":42136063,"author":"Globe Newswire","created":"Fri, 22 Nov 2024 09:00:00 -0400","updated":"Fri, 22 Nov 2024 09:00:03 -0400","title":"Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g42136063/aptose-biosciences-inc-announces-pricing-of-8-million-public-offering","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},{"id":42085504,"author":"Globe Newswire","created":"Wed, 20 Nov 2024 08:30:00 -0400","updated":"Wed, 20 Nov 2024 08:30:01 -0400","title":"Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g42085504/aptose-initiates-tuscany-phase-12-study-for-newly-diagnosed-aml-patients-to-receive-tuspetinib-bas","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},{"id":41857163,"author":"Globe Newswire","created":"Fri, 08 Nov 2024 17:01:00 -0400","updated":"Fri, 08 Nov 2024 17:01:01 -0400","title":"Aptose Reports Results for the Third Quarter 2024","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/g41857163/aptose-reports-results-for-the-third-quarter-2024","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},{"id":40740419,"author":"Globe Newswire","created":"Thu, 05 Sep 2024 16:15:00 -0400","updated":"Thu, 05 Sep 2024 16:15:01 -0400","title":"Aptose Announces Results from Special Meeting of Shareholders","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/09/g40740419/aptose-announces-results-from-special-meeting-of-shareholders","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},{"id":40662273,"author":"Globe Newswire","created":"Fri, 30 Aug 2024 16:30:02 -0400","updated":"Fri, 30 Aug 2024 16:30:02 -0400","title":"Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40662273/aptose-receives-10-million-through-a-facility-agreement-with-hanmi-negotiating-future-collaboratio","image":[],"channels":[{"name":"News"},{"name":"Financing"},{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[{"name":"Partnerships"}]},{"id":40405839,"author":"Globe Newswire","created":"Thu, 15 Aug 2024 16:30:00 -0400","updated":"Thu, 15 Aug 2024 16:30:00 -0400","title":"Aptose Announces Adjournment of its Special Meeting of Shareholders","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40405839/aptose-announces-adjournment-of-its-special-meeting-of-shareholders","image":[],"channels":[{"name":"News"},{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},{"id":40270129,"author":"Globe Newswire","created":"Thu, 08 Aug 2024 17:06:51 -0400","updated":"Thu, 08 Aug 2024 17:06:51 -0400","title":"Aptose Reports Results for the Second Quarter 2024","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40270129/aptose-reports-results-for-the-second-quarter-2024","image":[],"channels":[{"name":"Earnings"},{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]},{"id":40094946,"author":"Globe Newswire","created":"Thu, 01 Aug 2024 07:00:00 -0400","updated":"Thu, 01 Aug 2024 07:00:01 -0400","title":"NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/08/g40094946/nodthera-announces-appointment-of-greg-chow-as-chief-financial-and-business-officer","image":[],"channels":[{"name":"Biotech"},{"name":"Press Releases"},{"name":"General"}],"stocks":["APTO"],"tags":[]},{"id":39868424,"author":"Globe Newswire","created":"Fri, 19 Jul 2024 17:00:00 -0400","updated":"Fri, 19 Jul 2024 17:00:01 -0400","title":"Aptose Announces Receipt of Deficiency Notice from Nasdaq","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/07/g39868424/aptose-announces-receipt-of-deficiency-notice-from-nasdaq","image":[],"channels":[{"name":"Press Releases"}],"stocks":["APTO","TSX:APS"],"tags":[]}]},"ratingsSummary":{"aggregateRatings":{"Buy":5,"Hold":0,"Overweight":2,"Sell":0,"Underweight":0},"consensusPriceTarget":"13.14","consensusRating":"Buy","consensusRatingValue":86.85714285714286,"highestPriceRating":{"date":"2023-09-07","firm":"Cantor Fitzgerald","price":"38.00"},"highestPriceTarget":"38.00","lowestPriceRating":{"date":"2024-11-20","firm":"HC Wainwright \u0026 Co.","price":"2.00"},"lowestPriceTarget":"2.00","mostRecentFirms":[{"date":"2024-11-20","name":"HC Wainwright \u0026 Co."},{"date":"2024-05-16","name":"Canaccord Genuity"},{"date":"2024-04-03","name":"Piper Sandler"},{"date":"2023-11-10","name":"RBC Capital"},{"date":"2023-09-07","name":"Cantor Fitzgerald"}],"numRatings":25,"numUniqueRatings":7,"ratings":[{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"2.00","adjusted_pt_prior":"7.00","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","date":"2024-11-20","exchange":"NASDAQ","id":"673e237cebb2e50001e72479","importance":0,"isin":"CA03835T3091","name":"Aptose Biosciences","notes":"","pt_current":"2","pt_prior":"7.00","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"12:59:24","updated":1732125645,"url":"https://www.benzinga.com/stock/APTO/ratings","url_calendar":"https://www.benzinga.com/stock/APTO/ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"7.00","adjusted_pt_prior":"7.00","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","cusip":"03835T309","date":"2024-06-14","exchange":"NASDAQ","id":"666c5b3f03c1590001f7b4ca","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"7.0000","pt_prior":"7.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"11:01:19","updated":1718377401,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"6.00","adjusted_pt_prior":"15.00","analyst":"Canaccord Genuity","analyst_name":"John Newman","currency":"USD","cusip":"03835T309","date":"2024-05-16","exchange":"NASDAQ","id":"66462a107b871e0001f847c5","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"6.0000","pt_prior":"15.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"11:45:20","updated":1715874411,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Maintains","adjusted_pt_current":"5.00","adjusted_pt_prior":"5.00","analyst":"Piper Sandler","analyst_name":"Edward Tenthoff","currency":"USD","cusip":"03835T309","date":"2024-04-03","exchange":"NASDAQ","id":"660d7c4595f06000015f8d64","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"5","pt_prior":"5.00","rating_current":"Overweight","rating_prior":"Overweight","ticker":"APTO","time":"11:56:53","updated":1712159903,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Maintains","adjusted_pt_current":"23.00","adjusted_pt_prior":"23.00","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","cusip":"03835T309","date":"2024-03-27","exchange":"NASDAQ","id":"6603f33fcad84c0001828868","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"23.0000","pt_prior":"23.00","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"06:21:51","updated":1711534945,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"5.00","adjusted_pt_prior":"12.00","analyst":"Piper Sandler","analyst_name":"Edward Tenthoff","currency":"USD","cusip":"03835T309","date":"2024-02-01","exchange":"NASDAQ","id":"65bbfa46b95b290001dc5bec","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"5","pt_prior":"12.00","rating_current":"Overweight","rating_prior":"Overweight","ticker":"APTO","time":"15:08:38","updated":1706818179,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"18.00","adjusted_pt_prior":"23.00","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T309","date":"2023-11-10","exchange":"NASDAQ","id":"654e7c1932478400018ed095","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"18.0000","pt_prior":"23.00","rating_current":"Outperform","rating_prior":"Outperform","ticker":"APTO","time":"13:53:13","updated":1699642434,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"38.00","adjusted_pt_prior":"","analyst":"Cantor Fitzgerald","analyst_name":"Li Watsek","currency":"USD","cusip":"03835T309","date":"2023-09-07","exchange":"NASDAQ","id":"64f9dec458cdda000125eb34","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"38.0000","pt_prior":"","rating_current":"Overweight","rating_prior":"Overweight","ticker":"APTO","time":"10:31:32","updated":1694097186,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"12.00","adjusted_pt_prior":"37.00","analyst":"Piper Sandler","analyst_name":"Edward Tenthoff","currency":"USD","cusip":"03835T309","date":"2023-08-11","exchange":"NASDAQ","id":"64d67536c08c530001684443","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"12.0000","pt_prior":"37.00","rating_current":"Overweight","rating_prior":"Overweight","ticker":"APTO","time":"13:51:50","updated":1691776342,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"23.00","adjusted_pt_prior":"40.00","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T309","date":"2023-08-11","exchange":"NASDAQ","id":"64d65afc704f3b0001d03ec9","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"23.0000","pt_prior":"40.00","rating_current":"Outperform","rating_prior":"Outperform","ticker":"APTO","time":"11:59:56","updated":1691769628,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"23.00","adjusted_pt_prior":"12.00","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","cusip":"03835T309","date":"2023-08-11","exchange":"NASDAQ","id":"64d624972e59fb0001502737","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"23.0000","pt_prior":"12.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"08:07:51","updated":1691755707,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"15.00","adjusted_pt_prior":"50.00","analyst":"Oppenheimer","analyst_name":"Matthew Biegler","currency":"USD","cusip":"03835T309","date":"2023-08-11","exchange":"NASDAQ","id":"64d617d0c08c5300016828ae","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"15.0000","pt_prior":"50.00","rating_current":"Outperform","rating_prior":"Outperform","ticker":"APTO","time":"07:13:20","updated":1691752431,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Adjusts","adjusted_pt_current":"23.00","adjusted_pt_prior":"12.00","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","cusip":"03835T309","date":"2023-06-12","exchange":"NASDAQ","id":"6487217f18fb560001fa2554","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"23.0000","pt_prior":"12.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"09:45:35","updated":1686583343,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"38.00","adjusted_pt_prior":"6.00","analyst":"Cantor Fitzgerald","analyst_name":"Li Watsek","currency":"USD","cusip":"03835T309","date":"2023-06-12","exchange":"NASDAQ","id":"64872c8c799d420001840209","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"38.0000","pt_prior":"6.0000","rating_current":"Overweight","rating_prior":"","ticker":"APTO","time":"10:32:44","updated":1686580423,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"50.00","adjusted_pt_prior":"9.00","analyst":"Oppenheimer","analyst_name":"Matthew Biegler","currency":"USD","cusip":"03835T309","date":"2023-06-12","exchange":"NASDAQ","id":"6487210d18fb560001fa2505","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"50.0000","pt_prior":"9.0000","rating_current":"Outperform","rating_prior":"Outperform","ticker":"APTO","time":"09:43:41","updated":1686577479,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"37.00","adjusted_pt_prior":"45.00","analyst":"Piper Sandler","analyst_name":"Edward Tenthoff","currency":"USD","cusip":"03835T309","date":"2023-06-07","exchange":"NASDAQ","id":"64808f2cc6d8dd00019b32f5","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"37.0000","pt_prior":"45.0000","rating_current":"Overweight","rating_prior":"Overweight","ticker":"APTO","time":"10:07:40","updated":1686147071,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"40.00","adjusted_pt_prior":"75.00","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T309","date":"2023-06-07","exchange":"NASDAQ","id":"6480823d8b27730001ca2831","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"40.0000","pt_prior":"75.00","rating_current":"Outperform","rating_prior":"Outperform","ticker":"APTO","time":"09:12:29","updated":1686143579,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"135.00","adjusted_pt_prior":"","analyst":"Oppenheimer","analyst_name":"Matthew Biegler","currency":"USD","cusip":"03835T200","date":"2023-05-09","exchange":"NASDAQ","id":"645a595ac9cb030001a857c6","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"9.0000","pt_prior":"","rating_current":"Outperform","rating_prior":"","ticker":"APTO","time":"10:31:54","updated":1683642755,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"75.00","adjusted_pt_prior":"","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T200","date":"2023-05-09","exchange":"NASDAQ","id":"645a53f1c9cb030001a85439","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"5.0000","pt_prior":"","rating_current":"Outperform","rating_prior":"","ticker":"APTO","time":"10:08:49","updated":1683641362,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"180.00","adjusted_pt_prior":"","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","cusip":"03835T200","date":"2023-05-09","exchange":"NASDAQ","id":"645a2090c9cb030001a83ec6","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"12.0000","pt_prior":"","rating_current":"Buy","rating_prior":"","ticker":"APTO","time":"06:29:36","updated":1683628218,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"120.00","adjusted_pt_prior":"195.00","analyst":"Canaccord Genuity","analyst_name":"Carey Macrury","currency":"USD","cusip":"03835T200","date":"2023-03-27","exchange":"NASDAQ","id":"642183505ce4fa00014fbe80","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"8.0000","pt_prior":"13.0000","rating_current":"Buy","rating_prior":"","ticker":"APTO","time":"07:51:44","updated":1679918123,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"75.00","adjusted_pt_prior":"","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T200","date":"2023-03-24","exchange":"NASDAQ","id":"641d9f20c9c7840001d3fb15","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"5.0000","pt_prior":"","rating_current":"Outperform","rating_prior":"","ticker":"APTO","time":"09:01:20","updated":1679662914,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"75.00","adjusted_pt_prior":"90.00","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T200","date":"2022-11-02","exchange":"NASDAQ","id":"636260a44731360001d1666f","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"5.0000","pt_prior":"6.00","rating_current":"Outperform","rating_prior":"","ticker":"APTO","time":"08:20:52","updated":1667391690,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"90.00","adjusted_pt_prior":"105.00","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T200","date":"2022-05-10","exchange":"NASDAQ","id":"627a51f772b50e0001b6bc22","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"6.00","pt_prior":"7.00","rating_current":"Outperform","rating_prior":"","ticker":"APTO","time":"07:52:23","updated":1652183587,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"180.00","adjusted_pt_prior":"210.00","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","cusip":"03835T200","date":"2021-12-21","exchange":"NASDAQ","id":"61c1ac0ad089bf000144a64c","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"12.00","pt_prior":"14.00","rating_current":"Buy","rating_prior":"","ticker":"APTO","time":"05:27:22","updated":1640082494,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"}],"uniqueRatingsFromLastThreeYears":[{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"2.00","adjusted_pt_prior":"7.00","analyst":"HC Wainwright \u0026 Co.","analyst_name":"Joseph Pantginis","currency":"USD","date":"2024-11-20","exchange":"NASDAQ","id":"673e237cebb2e50001e72479","importance":0,"isin":"CA03835T3091","name":"Aptose Biosciences","notes":"","pt_current":"2","pt_prior":"7.00","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"12:59:24","updated":1732125645,"url":"https://www.benzinga.com/stock/APTO/ratings","url_calendar":"https://www.benzinga.com/stock/APTO/ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Maintains","adjusted_pt_current":"5.00","adjusted_pt_prior":"5.00","analyst":"Piper Sandler","analyst_name":"Edward Tenthoff","currency":"USD","cusip":"03835T309","date":"2024-04-03","exchange":"NASDAQ","id":"660d7c4595f06000015f8d64","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"5","pt_prior":"5.00","rating_current":"Overweight","rating_prior":"Overweight","ticker":"APTO","time":"11:56:53","updated":1712159903,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"6.00","adjusted_pt_prior":"15.00","analyst":"Canaccord Genuity","analyst_name":"John Newman","currency":"USD","cusip":"03835T309","date":"2024-05-16","exchange":"NASDAQ","id":"66462a107b871e0001f847c5","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"6.0000","pt_prior":"15.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"APTO","time":"11:45:20","updated":1715874411,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"120.00","adjusted_pt_prior":"195.00","analyst":"Canaccord Genuity","analyst_name":"Carey Macrury","currency":"USD","cusip":"03835T200","date":"2023-03-27","exchange":"NASDAQ","id":"642183505ce4fa00014fbe80","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"8.0000","pt_prior":"13.0000","rating_current":"Buy","rating_prior":"","ticker":"APTO","time":"07:51:44","updated":1679918123,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"15.00","adjusted_pt_prior":"50.00","analyst":"Oppenheimer","analyst_name":"Matthew Biegler","currency":"USD","cusip":"03835T309","date":"2023-08-11","exchange":"NASDAQ","id":"64d617d0c08c5300016828ae","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"15.0000","pt_prior":"50.00","rating_current":"Outperform","rating_prior":"Outperform","ticker":"APTO","time":"07:13:20","updated":1691752431,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"18.00","adjusted_pt_prior":"23.00","analyst":"RBC Capital","analyst_name":"Gregory Renza","currency":"USD","cusip":"03835T309","date":"2023-11-10","exchange":"NASDAQ","id":"654e7c1932478400018ed095","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"18.0000","pt_prior":"23.00","rating_current":"Outperform","rating_prior":"Outperform","ticker":"APTO","time":"13:53:13","updated":1699642434,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"38.00","adjusted_pt_prior":"","analyst":"Cantor Fitzgerald","analyst_name":"Li Watsek","currency":"USD","cusip":"03835T309","date":"2023-09-07","exchange":"NASDAQ","id":"64f9dec458cdda000125eb34","importance":0,"isin":"CA03835T2002","name":"Aptose Biosciences","notes":"","pt_current":"38.0000","pt_prior":"","rating_current":"Overweight","rating_prior":"Overweight","ticker":"APTO","time":"10:31:32","updated":1694097186,"url":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/APTO/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/APTO/analyst-ratings"}]},"recentNewsQuery":{"excludeAutomated":true,"limit":3,"tickers":"APTO","type":["story","benzinga_reach","marketbeat"]},"splitsData":[{"cusip":"03835T200","date_announced":"2023-06-05","date_distribution":"2023-06-06","date_ex":"2023-06-06","date_recorded":"2023-06-06","exchange":"NASDAQ","id":"647f0203c6d8dd00019ad5bb","importance":0,"name":"Aptose Biosciences","notes":"","optionable":true,"ratio":"1:15","split_type":"Reverse Stock Split","ticker":"APTO","updated":1686045312}],"sponsoredPosts":[],"technicals":{"rsi":22.289854327935473}},"showGovLink":false,"symbol":"APTO","sidebar":{"id":59458,"title":"Cryptocurrency /Money Sidebar","type":"sidebar","dynamic":false,"blocks":[{"blockName":"acf/sidebar-related-posts","attrs":{"name":"acf/sidebar-related-posts","data":{"title":"Learn About Cryptocurrency","related_posts":[95574,105115,296872,296517],"style":"money"},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","posts":[{"id":95574,"slug":"what-is-ethereum","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2021/01/12102515/0bo235rhqec-768x512.jpg","published_at":"2024-03-21T09:26:57.000000Z","url":"/money/what-is-ethereum/","title":"What is Ethereum?","seotitle":"","author":{"name":"Anna Yen","gravatar":"//secure.gravatar.com/avatar/51dfafb02597374d0cd8da0cdc86a3b9?d=mm"},"date":"March 21st, 2024","description":"Learn about this leading blockchain platform that supports decentralized applications and smart contracts."},{"id":105115,"slug":"how-to-earn-interest-on-ethereum","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2021/03/29142306/0bo235rhqec-1-768x512.jpg","published_at":"2021-03-29T14:36:35.000000Z","url":"/money/how-to-earn-interest-on-ethereum/","title":"How to Earn Interest on Ethereum","seotitle":"","author":{"name":"Ryan McNamara","gravatar":"//secure.gravatar.com/avatar/8acd10f73d8a83ef13da39a2cbe047da?d=mm"},"date":"March 29th, 2021","description":"Earning interest on your Ethereum is a great way to grow your cryptocurrency holdings. Find out how to earn interest on your Ethereum in 4 easy steps."},{"id":296872,"slug":"best-cryptocurrencies-to-invest-in-for-november-2024","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/11/10181630/best-crypto-to-invest-768x512.jpg","published_at":"2024-11-25T13:26:48.000000Z","url":"/money/best-cryptocurrencies-to-invest-in-for-november-2024/","title":"10 Best Cryptocurrencies to Invest in for November 2024","seotitle":"10 Best Cryptocurrencies to Invest In for November 2024","author":{"name":"Caden Pok","gravatar":"//secure.gravatar.com/avatar/be39fe5efbca3e3f0b9133317520c725?d=mm"},"date":"November 25th, 2024","description":"Discover the 10 best cryptocurrencies to invest in for November 2024. Stay ahead in the crypto market with our expert insights and analysis! Learn more now!"},{"id":296517,"slug":"best-altcoins","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/10/30173251/best-altcoins-768x512.jpg","published_at":"2024-10-31T08:38:09.000000Z","url":"/money/best-altcoins/","title":"10 Best Altcoins in November 2024","seotitle":"Top 10 Best Altcoins • Benzinga Crypto","author":{"name":"Ishan Jain","gravatar":"//secure.gravatar.com/avatar/744edc395b489bbe265452a916cf7659?d=mm"},"date":"October 31st, 2024","description":"Discover the best altcoins to invest in for high potential returns. Our top altcoin picks include Ethereum, Solana, Ripple, Dogecoin, Toncoin."}]},{"blockName":"acf/news-feed","attrs":{"name":"acf/news-feed","data":{"primary_header":false,"header_see_more_text":"","header_see_more_link":"","title":"Top Cryptocurrency News","description_visible":true,"thumbnail_hidden":false,"see_all_text":null,"see_all_link":null,"feed_type":"parsely","topics":[],"channels":[],"news_custom_urls":"","news_primary_channel":"","posts_limit":null,"news":null,"style":"rated","load_more":null,"show_newsletter_block":false,"hide_tickers":false,"newsletter_title":null,"newsletter_form_id":null,"newsletter_description":null,"newsletter_style":null,"newsletter_utm_label":null,"newsletter_show_position":null,"news_feed_mode":"default","excluded_authors":""},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","top_posts":[{"id":42197276,"author":"Khyathi Dalal","created":"Tue, 26 Nov 2024 14:12:44 -0400","updated":"Tue, 26 Nov 2024 14:12:45 -0400","title":"Anthony Scaramucci: Trump Win Is 'The Greatest Political Comeback In US History,' Crypto Surge Following It Was 3 Years Overdue","teaser":"Scaramucci discussed Trump\u0026#39;s election win, crypto policy implications, and potential cabinet appointments. He predicts a loyalty-focused administration.","body":"","url":"https://www.benzinga.com/markets/cryptocurrency/24/11/42197276/anthony-scaramucci-trump-win-is-the-greatest-political-comeback-in-us-history-crypto-surge-following-it-was-3-years-overdue","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/Anthony-Scaramucci--Photo-by-World-Econo.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/Anthony-Scaramucci--Photo-by-World-Econo.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/Anthony-Scaramucci--Photo-by-World-Econo.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"News"},{"name":"Top Stories"}],"stocks":[],"tags":[{"name":"Anthony Scaramucci"},{"name":"Donald Trump"},{"name":"Expert Ideas"},{"name":"Stories That Matter"}]},{"id":42173824,"author":"Chris Katje","created":"Mon, 25 Nov 2024 16:24:21 -0400","updated":"Mon, 25 Nov 2024 16:24:22 -0400","title":"If You Invested $1,000 In XRP Token When SEC Lawsuit Caused Mass Panic, Here's How Much You'd Have Today","teaser":"The cryptocurrency XRP Token (CRYPTO: XRP) from Ripple is soaring in price over the last week with a new filing for an XRP exchange-traded fund adding to optimism for the crypto.","body":"","url":"https://www.benzinga.com/general/education/24/11/42173824/if-you-invested-1000-in-xrp-token-when-sec-lawsuit-caused-mass-panic-heres-how-much-youd-have-today","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/untitled.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/untitled.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/untitled.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"Education"},{"name":"Top Stories"}],"stocks":[{"name":"$XRP"}],"tags":[{"name":"Gary Gensler"},{"name":"ICYMI"},{"name":"if you invested"},{"name":"if you invested 1000 catalyst"},{"name":"ripple"},{"name":"Ripple Labs"},{"name":"SEC"}]},{"id":42199083,"author":"Khyathi Dalal","created":"Tue, 26 Nov 2024 15:45:40 -0400","updated":"Tue, 26 Nov 2024 15:45:41 -0400","title":"Bitcoin, Ethereum, Dogecoin Drop Further: 'Black Friday Came Early,' Says Trader Touting 'Good Discounts'","teaser":"Cryptocurrency markets are trading lower on Tuesday.","body":"","url":"https://www.benzinga.com/markets/cryptocurrency/24/11/42199083/bitcoin-ethereum-dogecoin-drop-further-black-friday-came-early-says-trader-touting-good-discounts","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/Cryptocurrency-Photo-by-SvetlanaParnikov.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/Cryptocurrency-Photo-by-SvetlanaParnikov.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/Cryptocurrency-Photo-by-SvetlanaParnikov.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"News"}],"stocks":[{"name":"$BTC"},{"name":"$DOGE"},{"name":"$ETH"},{"name":"$MKR"},{"name":"$SAND"},{"name":"$SHIB"},{"name":"$SOL"},{"name":"$XLM"}],"tags":[{"name":"Expert Ideas"},{"name":"Stories That Matter"}]},{"id":42173367,"author":"Khyathi Dalal","created":"Mon, 25 Nov 2024 15:57:49 -0400","updated":"Mon, 25 Nov 2024 15:57:50 -0400","title":"Shiba Inu Burn Rate Soars 487% In A Day: What Is Going On?","teaser":"Shiba Inu (CRYPTO: SHIB) has gained traction amid rising burn rates, sparking optimism among technical analysts about bullish momentum for the token.","body":"","url":"https://www.benzinga.com/markets/cryptocurrency/24/11/42173367/shiba-inu-burn-rate-soars-487-in-a-day-what-is-going-on","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Shiba-Inu-Shibarium.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Shiba-Inu-Shibarium.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Shiba-Inu-Shibarium.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"News"},{"name":"Top Stories"}],"stocks":[{"name":"$SHIB"}],"tags":[{"name":"MemeCoins"}]},{"id":42190182,"author":"Murtuza Merchant","created":"Tue, 26 Nov 2024 10:10:37 -0400","updated":"Tue, 26 Nov 2024 10:10:38 -0400","title":"Binance Founder Changpeng Zhao Says Meme Coins Are Getting 'A Little Weird' — But Dogecoin, Shiba Inu Aren't The Culprits","teaser":"Binance founder and former CEO Changpeng Zhao on Tuesday voiced concerns about the current state of meme coins, calling their proliferation “a little weird.”","body":"","url":"https://www.benzinga.com/markets/cryptocurrency/24/11/42190182/binance-founder-changpeng-zhao-says-meme-coins-are-getting-a-little-weird-but-dogecoin-shiba-inu-arent-the-culprits","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/Dogecoin-and-Shiba-Inu.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/Dogecoin-and-Shiba-Inu.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/Dogecoin-and-Shiba-Inu.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"News"},{"name":"Top Stories"}],"stocks":[{"name":"$DOGE"},{"name":"$SHIB"}],"tags":[{"name":"Changpeng Zhao"},{"name":"Expert Ideas"},{"name":"MemeCoins"}]}]},{"blockName":"acf/page-sidebar-placement","attrs":{"name":"acf/page-sidebar-placement","data":{"widget":{"ID":94647,"post_author":"353","post_date":"2020-12-28 11:04:28","post_date_gmt":"2020-12-28 16:04:28","post_content":"\u003c!-- wp:acf/newsletter-subscription-box {\"name\":\"acf/newsletter-subscription-box\",\"data\":{\"title\":\"Future Finance Newsletter\",\"_title\":\"field_title\",\"form_id\":\"6d120c76-8a53-4729-9627-e36a737e2a30\",\"_form_id\":\"field_form_id\",\"style\":\"default\",\"_style\":\"field_style\",\"mobile_only\":\"0\",\"_mobile_only\":\"field_mobile_only\",\"description\":\"\\u003cul\\u003e\\r\\n \\t\\u003cli\\u003eInsider Interviews\\u003c/li\\u003e\\r\\n \\t\\u003cli\\u003eNews \\u0026amp; Show Highlights\\u003c/li\\u003e\\r\\n \\t\\u003cli\\u003eCompletely FREE\\u003c/li\\u003e\\r\\n\\u003c/ul\\u003e\",\"_description\":\"field_description\",\"redirect_url\":\"\",\"_redirect_url\":\"redirect_url\",\"utm_label\":\"Sign Up\",\"_utm_label\":\"field_utm_label\"},\"align\":\"\",\"mode\":\"edit\"} /--\u003e","post_title":"Future Finance Newsletter","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"crypto-newsletter-sign-up","to_ping":"","pinged":"","post_modified":"2024-06-11 03:10:07","post_modified_gmt":"2024-06-11 07:10:07","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=94647","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":""}]}},"__N_SSP":true},"page":"/quotev2/[ticker]","query":{"ticker":"APTO"},"buildId":"R05fxUUF7rvKgc3Bg3jzA","isFallback":false,"isExperimentalCompile":false,"gssp":true,"scriptLoader":[]}</script></body></html>